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ABSTRACT
An in vitro culture technique for the quantitation of pinocytosis
in the rat visceral yolk sac was modified, by removing calf serum from
the incubation medium, to permit determination of the rate of uptake of
substrates in the absence of competing serum proteins. Study of the
125Endocytic Index of I-labelled PVP in the absence of calf serum
indicated that the substrate provided a suitable marker for determination
of the rate of fluid ingestion in serum-free medium. From measurements
of the ratesof ingestion of [ U^^Cl sucrose, *2^I-labelled dBSA and
colloidal [ Aul gold in the presence and absence of calf serum, it was
concluded that the first substrate is ingested essentially in the fluid
phase, while the other two are ingested mainly adsorbed to the plasma
membrane. A detailed study of the uptake of I-labelled dBSA in the
presence of a non-radioactive analogue permitted a kinetic analysis of
the affinity of this substrate for binding sites on the plasma membrane.
125The rate of ingestion of homologous I-labelled IgG indicated that it
is ingested mainly in the adsorbed phase but at a slower rate than 
125I-labelled dBSA. On re-incubation of yolk sacs ’loaded’ in vitro 
with I-labelled IgG a significant percentage of the released radio­
activity was macromolecular and tentatively identified as 125I-labelled 
IgG. This finding contrasted sharply with that for either 125I-labelled 
PVP, with which little radioactivity was released, or 125I-labelled 
dBSA, with which virtually all the radioactivity released was in a low 
molecular weight form. The observation that IgG can escape from the 
tissue intact is compatible with the suggestion that the rat yolk sac is 
instrumental in the transmission of passive immunity from mother to 
fetus prior to birth. A number of investigations were performed in an 
attempt to distinguish the mechanism of release. The findings suggest 
that release occurred by way of a separate transport vesicle as proposed 
by A. E. Wild.
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G E N E R A L  I N T R O D U C T I O N
C H A P T E R  1
1Throughout the work reported in this thesis the rat yolk sac has been 
employed as a model system for the investigation of the uptake of extra­
cellular materials by pinocytosis. It is therefore pertinent to review 
the literature on the structure and function of this tissue in order that 
a detailed study of the mechanisms involved in the uptake of substrates 
may be related to the morphological and ultrastructural features of the 
tissue, enabling the observed pinocytic behaviour to be viewed in a 
broader context.
During the latter half of gestation, and following inversion of the 
embryo, the yolk sac of the rodent completes development by losing both 
Reichert’s membrane and the parietal yolk sac so that the fetus is 
surrounded by only two membranes, the visceral yolk sac and the amnion 
(see Fig. la), both of which persist until term (Beck and Lloyd, 1968).
The visceral yolk sac is composed of three cellular layers each separated 
by a fibrous membrane; Fig. lb illustrates the arrangement of these 
layers. The external layer, which in vivo is in close contact with the 
uterine wall, consists of columnar vitelline epithelial cells attached 
to the fibrous visceral basement membrane. Below this membrane is a 
further layer consisting of mesenchymal or fibroblast-like cells 
(Wislocki and Padykula, 1953); within this layer the vitelline vessels, 
which extend around the yolk sac are found. The mesenchymal cells rest 
on another thick fibrous membrane known as the serosal basement membrane 
and below this layer, adjacent to the amnionic cavity is a final thin 
layer of mesothelial cells.
The fetus itself is contained in a second inner membrane, the amnion, 
which is entirely separate from the yolk sac.
The outer (uterine) surface of the yolk sac has two distinct 
regions. A highly folded or villous region extending from the chorioal­
lantoic placenta and equivalent to approximately one third of the total
Rat Visceral Yolk Sac
yolk sac area; the remainder of the surface is less villous but 
individual epithelial cells are identical at the ultrastructural level.
Gillman et al. (1948) and Everett (1933, 1935) showed that in vivo 
the yolk sac is highly active in the uptake of a number of dyes and 
further studies have shown that in vivo this tissue is able to ingest a 
variety of other substances. For example: ferritin (Lambson, 1966), 
ferritin and Trypan Blue (Krzyzowska-Gruca and Schiebler, 1967), horse­
radish peroxidase (Beck et al., 1967, 1969; Seibel, 1974), vitamin 
(Padykula, 1966), thorotrast (Carpenter and Ferm, 1966) and gammaglobulin 
(Anderson, 1959; Halliday, 1957). Similarly, using an organ culture 
method 125I-labelled PVP (Williams et al., 1975a), 125I-labelled BSA 
(Williams et al., 1975b), [ U^C] sucrose and colloidal ^^Au (Roberts et al., 
1977) have been shown to be accumulated by the tissue in vitro.
These studies indicate that the columnar epithelial cells are
responsible for the ingestion of such materials, but the physiological
significance of this intense pinocytic activity is not yet certain. One
suggestion is that the yolk sac acts as a barrier to protect the developing
fetus from foreign materials such as maternal antibodies and drugs which
et £l.,
may be harmful (Wilson, 1959). Lloyd7(1974) showed that when a bisazo
dye, Trypan Blue, was injected into the maternal system a considerable 
amount of dye could be detected in the epithelial layer at the yolk sac 
but none was found in the amniotic cavity or the fetus. A further 
function that has been proposed for the yolk sac is that the tissue plays 
a major role in embryotrophic nutrition (Beck and Lloyd, 1968). It was 
shown that after ingestion of horseradish peroxidase loss of enzymic 
activity occurred and it was suggested that hydrolysis of this exogenous 
protein occurred intralysosomally and that the amino acids so produced, 
are passed to the fetal tissues in vivo as a source of building materials 
(Beck and Lloyd, 1968; Beck ejt al,, 1970), A further possible role
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is the transmission of passive immunity from mother to fetus. Brambell
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(1970) was able to show the selective transport of immunoglobulins across 
the yolk sac of the rabbit and a similar process may well occur in the rat.
Whether or not the yolk sac can perform some of these functions in 
vivo is an open question but the demonstration of the full capacities of 
the epithelial cells of this tissue in vitro using culture techniques is 
likely to be informative. It is also of importance when considering 
properties of the yolk sac as an organ to consider its morphology. Its 
outermost layer is comprised of columnar epithelial cells whose nuclei 
are situated near the basal end of each cell. Furthermore, the apical 
surface of each cell has a prominent, microvillous brush-border which 
carries a glycocalyx that has been shown to be composed of mucopoly­
saccharide, by staining with ruthenium red and examination under the 
electron microscope (Jollie and Triche, 1971). It is further believed 
that this coating may extend across the whole surface, its role being to 
facilitate the binding of substrates prior to ingestion. Between the 
microvilli, caveoli extend into the cytoplasm of the cell and in some 
cases these have been shown to be several microns deep.
The caveoli too are found to be lined with the same glycocalyx that 
covers the base of the microvilli. The glycocalyx is also observed in 
vesicles close to the caveoli which appear to have formed from the latter. 
These vesicles appear to migrate further into the cytoplasm and fuse to 
form larger vesicles within the well-defined vacuolar system of these 
cells. The process of fusion has been suggested as playing an essential 
part in the process of membrane re-cycling (Duncan and Pratten, 1977). 
Furthermore, extensive membranous infoldings are observed in the form of 
an apical canalicular system which is an interconnected system of small 
tubules or canals sometimes observed to be connected to large vacuoles 
or small vesicles (Lambson, 1966). Presumably these vacuoles and 
vesicles are in the process of formation from the canalicular system.
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Endocytosis
Endocytosis is a broad term used to describe general cellular uptake 
of substrates too large or polar to be taken up by diffusion, or for 
which no form of active transport exists. Presumably it is the major 
mode of entry of many small molecules into a number of tissues. The 
general process has been sub-divided into: ’Phagocytosis', ’Pinocytosis’ 
and 'Micropinocytosis', although more recently these processes have 
become to be regarded as convenient classifications rather than processes 
each with a different mechanistic basis. Endocytosis in its most general 
form is the capture and ingestion of substrates by invagination of the 
plasma membrane adjacent to a particle or quantity of extracellular medium 
in which a soluble substrate is dissolved. Once the membrane completely 
surrounds a portion of medium the small 'droplet-like' body or vesicle 
detaches from the remainder of the apical membrane and migrates further 
into the cell where it fuses with other such bodies to form larger vesicles.
The essential distinguishing feature of the three sub-classes of the 
process is the size of the substrate ingested. Historically the first 
process to be described was 'Phagocytosis', a process first visualized 
at the light microscope level by Metchnikoff some hundred years ago. 
'Phagocytosis' is now used to describe the ingestion of relatively large 
particulate material in the size-range from large colloidal material to 
particles such as bacteria or erythrocytes with dimensions in the order 
of 2.0 pm. Consequently such particles can be readily observed 
either under the light microscope or under only low magnification in the 
electron microscope. This type of uptake usually results in the 
phagocytic vesicle being completely filled with the ingested particle, 
there being little attendant ingestion of fluid.
'Pinocytosis' occurs by essentially the same process as 'Phagocytosis' 
but the term was coined by Lewis (1931) in order to describe the process 
of ingestion of fluid (containing finely divided colloidal or soluble
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substrates, which cannot be visualized by light microscopy) rather than 
large particles. The size of the materials ingested by 'Pinocytosis' 
ranges from small molecules e.g. sucrose (just large enough not to 
diffuse across lysosomal membranes) up to colloidal material of approximately 
20 nm dia., although this upper size limit should not be regarded as 
being rigidly defined. 'Pinocytosis' is also thought to be a con­
tinuous process in many mammalian cells but induced pinocytosis has been 
observed in the amoeba, an organism that undergoes a cycle of pinocytic 
activity lasting 30-60 min. in response to contact with the substrate 
(Chapman-Andresen, 1962).
In the rat yolk sac uptake of substrates is by pinocytosis or
micropinocytosis (Williams et al., 1975a and b) rather than by phagocytosis.
Therefore it is essential to review in more detail the processes involved
in this type of uptake. The following steps outline the main features
of pinocytosis; these are probably substantially the same in phagocytosis.
A substrate may enter a pinosome (pinocytic vesicle) either through
being ingested in the bulk fluid or by attaching to binding sites on
the cell surface prior to invagination of the plasma membrane. Jacques
(1969) proposed a general model to describe the pinocytic uptake of
solutes and derived a general equation that describes the uptake of
solutes both in the fluid and adsorbed phases (see Chapter 3, equation 3.3).
The initial surface adsorption of substrates has been investigated in a
131number of systems. The uptake of I-labelled albumin by tumour cells
(Sarcoma S 180) was followed by Ryser (1968). His data are compatible
with a two stage process, namely a rapid phase of surface adsorption
followed by a slower process of internalization of the radiotracer by
131pinocytosis. King (1968), using I-labelled albumin, demonstrated 
binding to guinea pig lung-tissue slices and found treatment with strong 
urea solutions was required to reverse this process, while Gosselin 
(1967), in studying the uptake of colloidal [ Au] gold by cultured
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macrophages, was able to determine some physical parameters of the 
binding process. Similarly, through in vivo studies of the clearance 
of foreign particles from the blood stream of the rat by the liver,
Normann (1974a and b) was able to demonstrate the importance of binding. 
Furthermore, by analysing the kinetics of the uptake process he derived 
constants for the receptor-substrate complex. Other studies by 
Soil et_ £l. (1975), using an isolated brush-border membrane technique 
showed that the binding of insulin could be followed in detail, enabling 
a number of binding parameters to be determined; these included the 
substrate-receptor binding constants, the number of binding sites and 
the affinity of such sites for the substrate.
Whether or not binding occurs, the central event in pinocytosis is
the internalization of a portion of the cell’s membrane to form a vesicle.
During this process a quantity of extracellular fluid (and possibly
adsorbed substrate) is completely surrounded by a limiting membrane to
form a pinosome which, once formed, fuses with other pinosomes to form
larger vesicles that fuse with lysosomes on migrating deeper into the
cytoplasm. This process was inferred from the findings of Straus
(1962, 1963, 1964) who found that horseradish peroxidase was ingested
by several mammalian tissues. By using histochemical techniques and
either liver or kidney cells, he was able to show that peroxidase was
initially confined to small vesicles and that with increasing time the
peroxidase passed into the larger vesicles that were acid phosphatase
positive. Mego and McQueen (1965) loaded rat liver in vivo with 
131I-labelled denatured albumin. On fractionating the tissue, at 
different time intervals after administering the radiolabelled protein, 
by density gradient centrifugation, the radioactivity was observed to 
move progressively from lighter to heavier particulate fractions and 
that proteolysis occurred in the latter. Likewise, Goetze eit al.
(1976) have recently shown that in subcellular fractions, prepared from
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rat yolk sacs that have ingested I-labelled human serum albumin
in vitro, the ingested radioactivity moves from light to dense fractions
as the time-interval between ingestion and homogenization of the tissue
increases. Other workers, (Caulfield, 1963; Miller, 1960) have been
able to visualise the passage of ferritin and haemoglobin into the
vacuolar system of cells where the battery of lysosomal enzymes is
able to hydrolyse such proteins. Obviously substrates which are not
susceptible to hydrolysis are accumulated within these vesicles.
The primary lysosomes, with which the pinosomes fuse, originate from
within the Golgi bodies. The lysosome consists of a limiting membrane
containing a number of acid hydrolases which degrade biopolymers to
their constituent monomers. The hydrolytic capacity of the lysosomal 
was
system/demonstrated in vitro by Mego and McQueen (1965) using rat liver
heterolysosomes prepared from liver cells that were previously laden 
131with I-labelled denatured albumin. By working in osmotically
protected media they were able to isolate an organelle fraction from
this tissue which, on incubation at 37°C, was found to progressively
release the digestion product [ I] iodo-tyrosine. Coffey and de Duve
(1968) have also demonstrated the hydrolysis of radiolabelled substrates
by isolated enzymic extracts from liver lysosomes. Further, the
ability to hydrolyse ingested proteins has been demonstrated in a number
131of other intact cells. For example I-labelled albumin by sarcoma
131cells (Gabathuler and Ryser, 1967), I-labelled albumin and tritium-
labelled haemoglobin by mouse macrophages (Ehrenreich and Cohn, 1967 
125and 1968), I-labelled haemoglobin by trophoblastic cells in culture
125(Contractor and Krakauer, 1976) and I-labelled asialo-fetuin by
isolated hepatocytes in culture (Tolledhaug et al., 1977).
Beck et al. (1967) were able to demonstrate, histochemically,
the
the accumulation of horseradish peroxidase in/vacuolar system of the 
vitelline epithelial cells of the rat yolk sac and they further concluded
was probably effected intralysosomally. Using an organ culture method
Williams et al. (1975a, b) demonstrated the uptake and accumulation of 
1 2. *5I-labelled PVP by the yolk sac and that in similar experiments with
ioc 125•‘■^'^I-labelled albumin, I-labelled tyrosine was released back into the 
incubation medium. These findings suggested that the yolk sac ingests 
material by pinocytosis and passes it from pinosomes to secondary 
lysosomes where, in the case of biopolymers, digestion occurs. A 
general scheme for the uptake and digestion of substrates is shown in 
Fig. lc. Williams et £l. (1975a) and Roberts et al, (1977) showed non- 
digestible substrates to accumulate within the yolk sac tissue, and 
assumed that the sites of accumulation were pinosomes and secondary 
lysosomes. The rate of uptake of the non-digestible substrate,
1 ncI-labelled PVP, was calculated and expressed in the form of an 
'Endocytic Index' which has the units yl/h/mg of yolk sac protein 
(Williams et al., 1975a). This form of expression permits the deter­
mination of the rate of uptake of a solute which accumulates within the 
#
tissue; any material released by the tissue following pinocytic capture 
makes no contribution to the rate of uptake so calculated. In studying 
the uptake of proteins (Williams et al., 1975b) the method of analysis 
was extended to allow for the effects of release from the tissue of 
hydrolysis products of labelled albumin in the form of trichloroacetic 
acid-soluble radioactivity (intact protein is insoluble in trichloroacetic 
acid). Again assuming the rate of exocytosis to be negligible, the 
total substrate uptake is then the sum of the 'tissue-associated radio­
activity' and the 'TCA-soluble radioactivity' released back into the 
culture medium.
The following work extends that of Williams and Moore by inves­
tigating the effects on uptake of several substrates (including 
175 125JI-labelled PVP and I-labelled dBSA) of removing calf serum from
(Beck et al., 1969) that the slow hydrolysis of this exogenous enzyme
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the culture medium. This has the effect of greatly simplifying the 
analysis of the kinetics and permits calculation of the associated 
kinetic constants.
125In Chapter 5 the uptake of homologous I-labelled IgG was 
followed in order to quantitate its rate of uptake, degradation and 
release. This study was extended in Chapter 6 in an attempt to probe 
the mechanism of transport of immunoglobulins across cellular barriers 
with attention focused on the hypotheses of Brambell (1958 and 1966) and 
Wild (1975). The suggestion by Brambell and Halliday (1956) that the 
yolk sac transports a higher fraction of the administered immunoglobulins 
as term approaches, prompted a study in Chapter 7 of the pinocytic 
capacity of the yolk sac tissue as a function of gestational age, using 
^■^I-labelled PVP and ^"’i-labelled dBSA as substrates as well as
IOCI-labelled IgG. In Chapter 8 preliminary studies of the effect of
125 125trypsinisation on the rates of uptake of I-labelled PVP, JI-labelled 
125dBSA and I-labelled IgG by the yolk sac are reported together with 
the results of studies in which attempts were made to isolate the cell
surface receptors.
Fig. la Diagrammatic Representation of the Arrangement of the Foetal
Rat at 16 days of Gestation
Vitelline Vessels
Villous Region
Fig. lb Diagrammatic section through the rat yolk sac
Uterine Cavity
Vitelline
Vessel Serosal Basement Membrane
Fig. le r m ~ p a t h w a y  for the
uptakeand digestion of solutes within
the „ n riiiT- -r*rh°li'ai o£ the yolk —
Pinosomes
Primary 
lysosomes
Nucleus
Secondary lysosome 
or phagolysosome
Storage
vacuole
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Membrane Release of amino acids 
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C H A P T E R  2
M A T E R I A L S  A N D  M E T H O D S
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Chemicals
[ iodide (preparation IMS.4, 5m Ci in 0.5 ml), *2^I-labelled poly(vinyl- 
125pyrrolidone) [ I-PVP: average molecular weight 30-40,000, preparation 
IM.33P], [ U^^C]sucrose (preparation CFB.146, > 350 mCi/mM), and colloidal 
[ ^ ®Au]gold (preparation GCS. IP, 4-12 mCi/mg Au) were purchased from 
the Radiochemical Centre, Amersham, Bucks., U.K. Bovine serum albumin 
(BSA, preparation 0142t), butyl PBD [ 5-(biphenyl-4-yl-)-2-(4-t-butylphenyl) 
1,3,4-oxidiazole] , 4-methylumbelliferyl 2-acetamido-2-deoxy-g-D- 
glucopyranoside and 4-methylumbelliferone were purchased from Koch-Light 
Laboratories Ltd., Colnbrook, Bucks., U.K. Toluene (scintillation 
grade) was purchased from Hopkin and Williams, Chadwell Heath, Essex,
U.K. Single strength tissue culture medium 199 (preparation TC 20, 
containing penicillin and streptomycin) and heat-inactivated calf serum 
(preparation CS07) were obtained from Wellcome Reagents Ltd,, Beckenham, 
Kent. Glycyl-L-tyrosine, L-tyrosine, poly(vinyl-pyrrolidone) [average 
molecular weight 40,000], trypsin (preparation TO 134: type IX; 
crystallized from hog pancreas), glucagon (preparation G 4250), 
lactoperoxidase (preparation L-8503, from milk) and Nigrosin were 
purchased from Sigma Chemical Company Ltd., Surrey, U.K. Rat gamma 
globulins (IgG, fraction II) from Miles Laboratories Ltd., Slough, U.K. 
Oxygen/Carbon-dioxide (95:5) from British Oxygen Ltd., Manchester, U.K.
All other chemicals were of analytical grade.
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2.1. Preparation of labelled proteins
The method used was that of Williams et al_. (1971) . Bovine serum
albumin (100 mg) was dissolved in phosphate buffer (45 ml of
0.05M Na2HP0^-KH2P0^, pH 8.0) and cooled in an ice-bath. Sodium 
125[ 1]iodide (5 mCi) was added using a 1 ml disposable syringe and the
ampoule rinsed with phosphate buffer (1.5 ml) and the washings added to 
the reaction vessel. After stirring for 2 min, chloramine-T solution 
(20 ml, 1.0 mg/ml) was added and the reaction allowed to proceed for 
8 min before being stopped by the addition of sodium metabisulphite 
solution (15.0 ml, 6.0 mg/ml). Solid potassium iodide (500 mg) was 
then dissolved in the reaction mixture to aid displacement of unreacted 
[ I]iodide during the subsequent dialysis. An equal volume of 
formalin (4% w/v formaldehyde in 0.5 MNa2C02, pH 10) was added and the 
resulting solution allowed to stand for 72 h at 4°C (Moore et al., 1977). 
The solution was then freed from inorganic iodide and formaldehyde by 
dialysis (72 h at 4°C) in Visking tubing against at least four changes 
of aqueous sodium chloride (1%, w/v). The protein concentration of 
the dialysed solution was adjusted to 0.6 mg/ml using aq. sodium 
chloride and the resultant material dispensed into sterile 5 ml screw- 
top bottles. The whole batch (Batch V) of material was frozen and 
thawed several times, to ensure that any slight changes induced in the 
protein structure by this procedure were more likely to be complete
before use. The whole batch was then finally stored at -20°C.
125 125I-labelled IgG was prepared by the same method as I-labelled
dBSA but at a l/5th scale, the formaldehyde treatment being omitted.
The concentration was estimated from the extinction of 280 nm using a
standard curve prepared in saline (1%, w/v).
2.2 Preparation of non-radioactive, formaldehyde-denatured 127I-lahened 
127albumin ( I-labelled dBSA)
Bovine serum albumin was iodinated with 127I-iodide, to the same
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extent as the radioactive analogue, by substituting 0.38 yg of potassium
125iodide for every mCi of [ 1}iodide in the above method. All con­
centrations and volumes of reagents were increased to produce a final 
127I-labelled dBSA concentration of 1.7 mg/ml. The resulting solution 
was diluted with aq. NaCl solution (1%, w/v), to produce stock solutions
of differing concentrations, then stored at -20°C.
127Attempts to prepare samples of I-labelled dBSA with a con­
centration in excess of 2.0 mg/ml resulted in precipitation of the 
protein during the dialysis procedure.
2.3 Technique for culturing yolk sacs in the presence of calf serum
The method of Williams et al. (1975a) was used with minor 
modifications. Wistar rats from an inbred colony were mated overnight, 
and pregnancy timed as from midnight if a vaginal plug was observed the 
following morning.
At 17.5 days of gestation the animals were killed by cervical 
dislocation. The yolk sacs were immediately removed and freed from 
other tissues by dissecting the uterus under a mixture of medium 199 
and 10% (v/v) calf serum that had previously been gassed with oxygen/ 
carbon dioxide (95:5) and warmed to 37°C (see Fig. 2a). Individual 
yolk sacs were each placed in a sterile 50 ml Erlemeyer flask, con­
taining gassed medium (9.0 ml, consisting of 8.0 ml TC 199 and 1.0 ml 
calf serum). Each flask was sealed with a sterile silicon rubber bung 
and placed in a thermostatted reciprocating water-bath at a temperature 
of 37 _+ 0.2°C and the shaking attachment set at 100 + 4 strokes/min, 
with a stroke length of 3.8 cm. The yolk sacs were allowed to 
equilibrate under these conditions for about 20 min prior to addition 
of 1.0 ml of a stock solution of the radiolabelled substrate (in 
medium 199) using a 5 ml safety pipette. The final concentration of 
radioactive substrates in the incubation medium was usually in the 
range 2-5 yg/ml for I-labelled PVP and 0.5-2 yg/ml for 125I-labelled
- 13 -
dBSA.
After addition of the substrate the flasks were again gassed with 
oxygen/carbon dioxide (95:5), for a period of 10 sec each. Individual 
yolk sacs were removed at regular intervals, up to 6.5 h, washed three 
times for 2 min in changes of cold saline (20 ml, 1% w/v) then placed
in a 5 ml volumetric flask and stored at -20°C until assayed (see below).
125When I-labelled dBSA was used as substrate the flasks containing 
the associated medium were returned to the water bath and incubated 
until the last yolk sac had been removed. This procedure ensured that 
the effects of any proteolytic activity in the culture medium on the 
labelled protein were uniform.
2.4 Assay of yolk sacs for their contained radioactivity
The yolk sacs were thawed and sodium hydroxide (1.0M) was added to 
a total volume of 5.0 ml. The volumetric flasks were then placed in 
a water-bath at 37°C for 1 h, prior to vigorous mixing using a 
'Rotamixer'. The flasks were then returned to the water bath for a 
further 15 min to ensure complete solution of the tissue.
Duplicate samples of the yolk-sac solution (1.0 ml) were placed 
in 3 ml disposable plastic tubes (LP3, Luckham Ltd,, Burgess Hill, 
Sussex) and the contained radioactivity assayed using a gamma spectro­
meter (Packard Instrument Ltd., Caversham, Berks.) with the tubes 
positioned in a standard geometrical relation to the crystal detector.
2.5 Determination of the protein content of yolk sacs
The protein content of each yolk sac was determined by the method 
of Lowry et al. (1951) using duplicate 0.1 ml portions of the yolk-sac 
solution as prepared above, and using bovine serum albumin (Sigma 
(London) Chemical Co. Ltd., London S.W.6; product no. A4378) as 
reference protein. The protein content of each yolk sac was expressed 
as an equivalent number of mg of bovine serum albumin.
- 14 -
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2.6 Assay of culture medium from experiments using either I-labelled
198PVP or colloidal [ Au]gold as substrates
Duplicate 1.0 ml samples of medium from each culture flask were 
pipetted into 3 ml disposable plastic tubes and the radioactivity 
assayed using a Packard gamma spectrometer, usually with a counting 
period of 30 sec. The mean count (corrected for background) was
termed the 'total radioactivity' in the culture medium.
1252.7 Assay of culture medium from experiments using a I-labelled
protein as substrate
Since proteins are hydrolysed when incubated in the presence of 
yolk-sac tissue and digestion products are released back into the 
culture medium, any estimate of the rate of uptake of protein by the 
tissue must include not only the contribution from intact protein 
present in the tissue itself but also that from ingested protein that 
has been digested and released into the medium. The latter is con­
veniently measured as the increase of the trichloroacetic acid soluble 
radioactivity in the medium produced during the incubation of the 
yolk sac.
The *total radioactivity' in the medium was determined by the same 
method (see 2.6) as used for non-digestible substrates, then trichloro­
acetic acid (20% w/v, 0.5 ml) was added to the duplicate samples to 
precipitate the contained protein. After centrifuging at 2000g for 
20 min each supernatant (approx. 1.3 ml) was decanted completely into 
a new 3 ml plastic tube and assayed again for radioactivity with a 
counting period of 300 sec. This procedure yields a value for the 
amount of protein digested during the incubation period and the mean 
value (c.p.m., corrected for background) was termed the 'TCA-soluble 
radioactivity'. Since the volume of the decanted solution of TCA- 
solubles was 1.3 ml, the observed count was multiplied by an empirical 
correction factor (1.33) so as to give the count that would have been
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observed if the same activity had been assayed using a counting volume 
of 1.0 ml. This normalization procedure removed any variation of the 
counting efficiency with the sample volume (see 2.11 for details of 
determination of the factor).
142.8 Assay of culture medium from experiments using [U C]sucrose
14Incubation medium from experiments using [U C] sucrose as sub­
strate was assayed by the method described by Roberts et al, (1977). 
Duplicate (1.0 ml) samples from each flask were placed in separate 
glass scintillation vials and scintillation ’cocktail* (10.0 ml of 
butyl-PBD; 6 g/1 in toluene: Triton X-100, 2:1 v/v) was added. The 
vials were then assayed for their contained radioactivity on a Packard 
2425 liquid scintillation spectrometer (Packard Instrument Ltd., 
Caversham, Berks.) with a sample-chamber temperature of 13°C. The 
presence of incubation medium in each sample vial provides a large 
number of substances which could ’quench' the observed count. It was 
therefore essential to correct the observed count for such 'quenching'.
This was achieved by an internal standardization method using a small
14quantity or ’spike’ of aq. [U C]sucrose solution (25 yl, containing 
approximately 10^ d.p.m.) which was added to each vial from a stock 
solution. Four standard vials were prepared each containing the ’spike’ 
of [ U^C] sucrose (25 yl), water (1.0 ml) and scintillation ’cocktail' 
(10.0 ml). The samples were then counted again and the relative 
counting efficiency calculated by the equation.
N - N s x
No
E 2.1
Where;
N = Observed sample count (c.p.m., corrected for background)X
N = Observed count of sample after ’spiking' (c.p.m., corrected s
for background)
N = Observed count of ’spiked’ standard (c.p.m., corrected for o
background)
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E = Normalisation constant.
Each sample was then divided by its own normalisation constant , 
calculated as above, to give the count which would have been observed 
if the same amount of activity had been dissolved in water rather than 
in incubation medium. This individual correction factor was incor­
porated into the appropriate computer program for the calculation of 
uptake by the yolk sac using equation 2c (see Appendix for details).
2.9 Assay of radioactivity contained in yolk sacs from experiments
14with [ U C]sucrose
Because of the possible effects of high pH or salt concentration 
on the stability of the scintillant emulsion, individual yolk sacs 
were dissolved in NaOH (0.25M, 2.0 ml) by sonication for 2 h at 37°C. 
The yolk sac protein was then dispersed by vigorous mixing using a 
'Rotamixer', neutralized with nitric acid (0.25 ml, 2.0 ml) and the 
total volume adjusted to 5.0 ml with water. Duplicate 1.0 ml samples 
were assayed for their contained radioactivity by the same method as 
used for assaying incubation medium containing [ sucrose. In all 
cases the counting emulsion was found to be stable for at least five 
days.
2.10 Technique of culturing yolk sacs in the absence of calf serum
The method of Williams et al. (1975a) described previously (2.3)
was used with several modifications.
Yolk sacs were removed from animals at 17.5 days of gestation 
and placed in gassed medium 199 containing antibiotics but no added 
calf serum. Yolk sacs were dissected as quickly as possible, (in less 
than 8 min) with the assistance of a second person, cultured in medium 
199 alone and removed from the culture flasks at approximately 30 min 
intervals following addition of the radioactive substrate up to a 
maximum period of 5.0 h.
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The methods of assay of both yolk sacs and the medium were the 
same as described above (see 2.4 - 2.7) except that the method of 
determination of the 'TCA-soluble radioactivity* in the medium was 
slightly changed as compared with 2.7. Before addition of trichloro­
acetic acid (20% w/v, 0.5 ml), 0.1 ml of calf serum was added to each 
tube to ensure complete precipitation of radioactive proteins. After 
decanting the supernatant (approx. 1.4 ml) the samples were counted 
(usually for 300 sec) and the resultant mean value (corrected for back­
ground) was multiplied by the appropriate empirical correction factor 
(1.35) to normalize the observed value of the 'TCA-soluble radio­
activity' for altered counting geometry.
2.11 Determination of counting correction factor for change in sample
volume
In sections 2.7 and 2.10 appropriate correction factors for 
different sample volumes were applied to the supernatant counts to 
enable the results to be rendered independent of the sample volume.
The correction factors used were obtained in the following manner. 
Samples of ^^I-labelled iodotyrosine and glycyl[ ^ "*1] -iodotyrosine 
were prepared by essentially the same method as described in 2.1 then 
freed from [ I]iodide by chromatography on Sephadex G-25. Calf serum 
was added to aqueous solutions of each compound to a concentration of 
10% (v/v) to provide carrier protein in the TCA-precipitation. Six 
samples (1.0 ml) of each solution in 3 ml disposable tubes were counted 
under standard geometry on a Packard gamma spectrometer to give values 
of the total activity, T. Trichloroacetic acid (20% w/v, 0.5 ml) 
was then added and the sample centrifuged at 2000 g for 20 min. The 
supernatant was then decanted into fresh tubes and the TCA-soluble 
activity, S, assayed again on the same gamma spectrometer.
The correction factor C is then simply:
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(2.II)
Where T is the total activity in a 1.0 ml of sample (c.p.m., 
corrected for background) and S the activity in the decanted supernatant 
(c.p.m., corrected for background). This method not only corrects for 
volume change but also corrects for any loss of soluble activity through 
its being trapped in the precipitate.
To estimate the correction factor for media containing no calf 
serum, 0.1 ml of water was added to each sample tube prior to the 
addition of trichloroacetic acid (20% w/v, 0.5 ml). This volume of 
water compensates for the volume change owing to addition of calf serum 
as a carrier protein (see 2.10).
The values obtained were 1.33 0.02 for cultures with calf serum
and 1.35 + 0.03 for cultures without calf serum. These two values were 
used as the appropriate correction factors throughout this thesis.
2.12 Calculation of accumulation by the yolk sac and Endocytic Index
for non-digestible substrates
In order to correct for the variable size of individual yolk sacs 
and the change in substrate specific radioactivity through radioactive 
decay, Williams et al. (1975a) used the following expression for the 
accumulation of a non-digestible radio-labelled substrate by yolk-sac 
tissue.
Where A is the quantity of radioactive substrate accumulated in a yolk 
sac by a given time, Y is the total radioactivity in the whole yolk sac 
(c.p.m., corrected for background), M is the radioactivity per microlitre 
of medium (c.p.m., corrected for background) and P the protein content 
(mg) of the individual yolk sac.
This expresses the accumulation of substrate as the volume of 
culture medium whose contained substrate is internalised per mg yolk-sac
A = Y 2. Ill
M x P
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protein and has the units of yl culture medium per mg of tissue protein. 
This form of expression has the advantage not only of normalizing the 
results of each experiment for variation in tissue size but also 
renders the results of experiments, performed on different days, 
independent of the effect of radioactive decay in the substrate and 
from any drift in efficiency of the gamma counter. Plotting the 
accumulation of radio-labelled substrate, expressed in this form against 
incubation period (h) yielded a straight line. Williams jat aT. termed 
the gradient of this plot the "Endocytic Index". It has units of 
yl per milligram of yolk-sac protein per hour of incubation. Fig. 3a 
shows a typical plot.
125 198The rates of accumulation of I-labelled PVP, colloidal [ Au]gold 
and [ U^C] sucrose were so low as to cause the concentrations of these 
substrates in the bulk medium to fall at the rate of only 0.1% per h.
Hence even with the longest incubation period (7.0 h) the depletion of 
substrate in the bulk medium is less than 1% and a negligible error is 
introduced by using the substrate concentration of the medium at the 
end of the experiment in place of M in equation 2.III.
2.13 Calculation of an Endocytic Index for a digestible substrate 
125When I-labelled proteins are used as substrates the yolk sac
is found to degrade the ingested protein to the level of its constituent
125amino acids which, in the case of I-labelled tyrosine at least, are 
released back into the culture medium. These digestion products 
appear as 'TCA-soluble radioactivity' which is estimated as described 
above (2.7). The expression for 'accumulation', A, the amount of 
substrate that would have accumulated in the tissue, had it not been 
subject to proteolysis, becomes:
Y + 10(S-F)
A * M 1 x P
As with non-digestible substrates, the numerator represents the
2.IV
total radioactivity 'processed' by the yolk sac. In the case of a
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digestible protein this is the sum of two terms, Y, the total radio­
activity retained in the whole yolk sac (c.p.m., corrected for back­
ground) and 10(S-F), the TCA-soluble radioactivity generated by the 
yolk sac and released into the culture medium (10 ml). S is the 
TCA-soluble radioactivity in the culture medium at the end of an 
incubation period (c.p.m. per ml, corrected for background). F is 
the amount of TCA-soluble radioactivity present that has been 
generated elsewhere than in the yolk sac; it is composed of two 
elements: TCA-soluble radioactivity present initially in the substrate 
preparation and any TCA-soluble radioactivity generated by proteolysis 
within the medium (e.g. by proteinase activity in the calf serum itself). 
The value of F is determined in each experiment by incubating a sample 
of medium, containing substrate but no yolk sac, for the duration of 
the experiment, then determining R, the fraction of the total radio­
activity in the medium that is TCA-soluble. F, the TCA-soluble radio­
activity of non yolk-sac origin is equal to M x R, where M is the total 
activity (c.p.m. per ml, corrected for background) in each individual 
incubation medium.
2.14 Modification of the calculation of the Endocytic Index to correct
for depletion of substrate concentration
In equation 2.IV the total medium radioactivity M of equation
2.Ill is replaced by M*. This correction is necessary because in 
125contrast to I-labelled PVP (which is ingested with an Endocytic 
Index of 1.70 _+ 0.30 yl/h/mg protein, see Section 3.5) protein 
ingestion occurs at a much greater rate (see Figs. 3.a and 3.b). This 
rapid ingestion leads to a significant fall in the concentration of 
the macromolecular form of the substrate in the medium during culture 
periods of 6 - 7 h (see Section 2.12). It was therefore necessary to
correct this value to give the mean value of the iCA-insoluble radio­
activity* in the medium (c.p.m. per ml, corrected for background) over
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the individual incubation period for each yolk sac. The equation 
for calculation of the corrected medium radioactivity is:
M* = M + 2.V
This equation adds half the observed increase in the TCA soluble activity 
per ml of medium at the end of the culture period (c.p.m. per ml medium, 
corrected for background) to the value for the 'TCA-insoluble activity' 
as determined at the end of the same period (c.p.m. per ml medium, 
corrected for background), thus giving the mean quantity of TCA- 
insoluble substrate present in the medium in the incubation period of 
the yolk sac.
2.15 Modification of the calculation of the Endocytic Index to allow for 
exocytosis of macromolecular substrate
Equations 2.Ill and 2.IV enable uptake to be calculated, for non- 
digestible and digestible substrates, respectively, when the rates of 
exocytosis are negligible. When exocytosis cannot be ignored, these 
equations give only the net accumulation of substrate by the tissue.
This quantity cannot be equated with the gross amount of substrate 
captured during the same period, since no allowance has been made for 
loss of the substrate from the tissue subsequent to capture. To 
calculate the gross rate of uptake, U, for a non-digestible substrate, 
equation 2.Ill has to be modified to correct for the loss by exocytosis 
and becomes:
u " - Y + R 2.VIM x P
Where R is the amount of non-digestible substrate released (in pl/mg 
protein) from the tissue during the incubation of the individual yolk
sac.
Likewise in calculating the gross rate of uptake of proteins, 
equation 2.IV becomes modified to:
Y + 10(S-F) 
M' x PU + R' 2.VII
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Where R' is the 'TCA-insoluble' radiotracer released from the yolk sac 
during its incubation period.
Thus, if R and R ’ can be determined accurately the true rates of 
uptake can be calculated. In practice, it is impossible to estimate 
either of these quantities accurately hence values of the Endocytic 
Index derived from the observed rates of uptake by the tissue will be 
lower than the true rates of uptake given in equations 2.VI and 2.VII, 
above. Providing the rates of release are negligible the 'true* and 
the ’observed* Endocytic Index will be indistinguishable, but, if a 
high rate of release of ingested substrate can be demonstrated,the 
’observed' Endocytic Index calculated from either equation 2.Ill or 
2.IV will be substantially lower than that derived by the above equations.
2.16 General treatment of uptake data
All uptake data were calculated using programs written for an 
ICL 4130 computer; these programs are given in the Appendix. The plots 
of uptake against time were all highly linear hence they were analysed 
by a standard linear regression program. Correlation coefficients 
greater than 0.95 were normally observed for all cultures containing 
calf serum; coefficients with values greater than 0.91 were normally 
observed for cultures without calf serum. In all cases experiments 
yielding correlation coefficients lower than above were rejected, as 
showing an abnormally high degree of scatter.
2.17 Exocytosis of radiotracer by the rat yolk sac
The rate of release of radio-labelled macromolecule associated
with the yolk sac was studied by the method of Williams et al. (1975a)
with certain modifications introduced to permit the study of digestible
substrates. Three 17.5 day yolk sacs were incubated in a sterile
50 ml Erlenmeyer flask by essentially the same method as described in
2.10 but in the presence of 125I-labelled PVP, 125I-labelled dBSA or 
125I-labelled IgG, each at a higher than normal concentration
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(5-10 yg/ml) in the culture medium. After addition of the substrate
each flask was gassed again with oxygen/carbon dioxide (95:5) for 10 sec,
sealed and re-incubated (for 3.0 h in the case of I-labelled PVP
125 125and for 2.0 h for both I-labelled dBSA and JI-labelled IgG).
At the end of this incubation period the yolk sacs were removed from
the flask, washed for 2 min in three changes of warmed,gassed medium 199
(30 ml) then placed in another flask containing fresh, gassed substrate-
free medium 199 (10 ml), sealed and returned to the water bath.
Samples of culture medium (2 x 1.0 ml) were removed at regular
intervals and placed in 3.0 ml disposable plastic tubes. The culture
medium removed was replaced by 2.0 ml of fresh, warmed medium and the
flask was gassed for 10 sec before being further incubated. The 'total
radioactivity’ present in each sample of medium was assayed on a gamma
spectrometer using standard counting geometry.
The amount of 'TCA-soluble' radioactivity released when either
^^I-labelled dBSA or ^I-labelled IgG was used as substrate was
determined by adding first calf serum (0.1 ml) then trichloroacetic
acid (20% w/v, 0.5 ml) to each tube to precipitate the protein. After
centrifugation (2000 g for 20 min) the supernatants were decanted into
new tubes and the 'TCA-soluble1 radioactivity assayed. The observed
by
count was normalised by multiplying/a factor of 1.35, the appropriate 
empirical correction factor.
At the end of the re-incubation the final medium samples were 
taken and the yolk sacs were removed, washed ( 3 x 2  min), in changes 
of cold (4°C) saline (20 ml, 1% w/v), then placed in a 5.0 ml volumetric 
flask and stored at -20°C until assayed for radioactivity as described 
in 2.4.
125With I-labelled PVP as substrate, the amount of substrate 
released over the re-incubation period was calculated using the formula.*
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T - 10 C. v + 2 7 *=(n~1) c . 2.VIIIn i (i=n) u i=o l
Where is the amount of 'total radioactivity' (c.p.m., corrected for
background) released up to the time of the sampling, and the
content of 'total radioactivity' (c.p.m. per ml medium, corrected for
background) in the i**1 sample of medium. The radioactivity released,
T was expressed in two ways. Firstly as the percentage of the n
radioactivity initially associated with the tissue (i.e. that remaining 
in the yolk-sac tissue after re-incubation plus the total released 
into the medium during the re-incubation period) and secondly as the 
amount (yg) of substrate released back into the medium from unit quantity 
of yolk-sac tissue. This second quantity was obtained by dividing Tn 
by the product of P, the protein content of the yolk sac and T, the 
activity associated with 1 yg substrate when assayed under standard 
counting geometry (c.p.m. corrected for background).
125 125With either I-labelled dBSA or I-labelled IgG as substrate, two 
species of radioactivity (i.e. 'acid-soluble' and 'acid-insoluble') 
can be released into the medium during the re-incubation period rather 
than just a single species as in the case of I-labelled PVP. It 
is therefore more informative to sum these species separately by 
applying the above calculations twice to the set of data, rather than to 
determine only the amount of undifferentiated activity released,
2.18 Release of g-N-acetylglucosaminidase by the rat yolk sac incubated 
in the presence and absence of homologous IgG.
The rate of release of the lysosomal enzyme N-acetylglucosaminidase 
was followed using the method described by Roberts et al, (1976) both 
in the presence and absence of homologous IgG at a concentration of 
10 yg/ml.
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Two yolk sacs were removed from a 17.5-day pregnant rat; one being 
placed in a flask containing medium 199 alone (15.0 ml) and the other in 
a flask containing medium 199 (15.0 ml) plus homologous IgG at a con­
centration of 10 yg/ml. The culture medium was maintained at 37°C 
under an atmosphere of 02 + C02 (95:5) in a shaking water bath set at 
100 strokes/min. Samples of the incubation medium (0.5 ml) were 
removed at intervals of 0, 15, 30, 60, 120, 180, 240 and 300 min the 
flasks being re-gassed for 10 sec with 02 + C02 (95:5). Each sample 
was placed in a 3.0 ml disposable plastic tube and centrifuged at 
1500 g for 15 min to remove detached and broken cells, decanted into 
fresh plastic tubes and stored -20°C until required for assay. At 
the end of the incubation period the yolk sac was removed from the 
flask and washed in 3 x 2 min changes of cold saline (1.0% at 4°C) and 
then homogenised using a Virtis homogenizer (Virtis Research Equipment, 
Gardiner, NY, USA.) at 4°C for 30 sec at speed setting 2 in 5 ml of 
0.01M potassium phosphate buffer pH 7.4. The yolk-sac homogenates 
were then assayed for 8-NAG activity.
2.19 Assay procedure for 8~NAG
The assay procedure utilises the ability of 8~NAG to hydrolyse 
the substrate 4-methylumbelliferyl 2-acetaraido-2-deoxy-8-D- 
glucopyranosideto the fluorescent product 4-methylumbelliferone. The 
substrate was used at a concentration of 2.5mM dissolved in citrate/ 
phosphate buffer, pH 4.3 (0.1M sodium citrate adjusted to pH 4.3 with 
0.2M sodium phosphate). To 100 yl of substrate 50 yl of incubation 
medium was added and incubated at 37°C for 10 min when the reaction 
was stopped by addition of 2.8 ml of glycine-carbonate buffer (0.17M, 
pH 10.5). The yolk-sac homogenate was diluted 100-fold with 0.01M 
potassium phosphate buffer and duplicate 20 yl samples assayed for 
8-NAG activity in the same manner as the incubation medium. Standards 
containing 1.5nM-4-methylumbelliferone contained in glycine-carbonate
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buffer (0.17M, pH 10.5) and suitable blanks were included with assay.
nmol.
The activity of 3-NAG enzyme was calculated in vityi of substrate 
hydrolysed/h and the total activity (At> released for a given time 
interval was calculated using the equation
PVe + £ t - n T 2 .x
Where P is the activity of 3“NAG in each ml of the re-incubation medium 
nmol.
iWR» is the volume of medium remaining at the sampling time t.
The released 3-NAG activity was expressed as a percentage of the total 
3-NAG activity present in the yolk sac at the beginning of the incubation 
period. This value was obtained by adding the released 3~NAG activity 
calculated for the final medium sample to the 3“NAG activity determined 
for the yolk sac tissue at the end of the incubation period. The 
results calculated in this way are shown for a number of experiments in 
Chapter 6 .
,2a ,epreear‘t'J,ti ° n of the dn-.^ctio» and incubation
of the rat visceral yolk sac
Shaker water bath set at 37°C 
100 strokes per minute
I N  V I T R O  P I N O C Y T O S I S  O F  R A D I O L A B E L L E D  
S U B S T R A T E S  B Y  T H E  R A T  Y O L K  S A C
C H A P T E R  3
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3.1 Introduction
Ryser (1968) described the process of protein uptake by mammalian 
cells as "An underdeveloped area" and put forward some criteria which 
a model culture system must fulfil in order to furnish meaningful 
results. The main criteria proposed were as follows. Firstly, the 
system used must permit distinction between adsorption and inter­
nalization. That is, the model system chosen and the methods of 
analysis used must enable the process of association with the surface 
of the cell/tissue without entry into the vacuolar system, to be dis­
tinguished clearly from the process of entry into the vacuolar system.
He indicated that this is important since certain macromolecules are 
known to adsorb strongly to cell surfaces, this process being rapid and 
essentially independent of temperature. (Ryser further suggested 
that such temperature studies were a possible method of distinguishing 
between these two processes). Secondly, in any investigation of 
pinocytosis, the method must preserve integrity of the cells since cell 
lysis will obviously distort any uptake data gathered. Suitable 
techniques should allow optimum conditions to be maintained and cellular 
integrity to be estimated by the use of dye exclusion tests or some 
other method. Finally, Ryser considered the problem caused by the 
reincorporation of the hydrolysis products, arising from ingested 
proteins, into the tissue under investigation and proposed that this 
problem could be overcome by the use of the radio-iodinated proteins.
The tyrosyl groups of proteins can be labelled with radioactive iodine 
( I or I) and on hydrolysis within cells the iodiotyrosyl residues 
released are not re-utilized in protein synthesis but liberated from 
the cell, greatly simplifying the analysis of the experimental data.
Williams et al. (1975a) reported a tissue culture technique, based 
on the 17.5-day rat yolk sac incubated in vitro, and which fulfils 
Ryser1s above criteria. The tissue was shown to survive well in vitro;
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it accumulated the macromolecular substrate I-labelled PVP linearly
with time up to 18 h. Furthermore, a high degree of cellular integrity
was observed both by ultrastructural studies and by measurement of the
release of substrate from tissue that had previously been 'loaded' with
1 2 5I-labelled PVP ija vitro. When the protein 1 2 5I-labelled BSA was used
as a substrate, its ingestion was found to occur at a higher rate than 
125that of I-labelled PVP. The theoretical model proposed by Jacques
(1969) was used to explain the mechanism of uptake. Further studies
by Moore £t al. (1977) using the same system showed adsorption of
substrate to the cell surface prior to ingestion to play an important
role in determining the rate of uptake of the substrate and that chemical 
125modifications of I-labelled BSA could radically increase the rate of 
ingestion of this protein.
Further work by Roberts ej; al. (1977) demonstrated the rat yolk
sac's ability to ingest substrates of very different chemical properties.
[ U^C] sucrose and colloidal [ ^ ^Au] gold were found to be ingested
progressively over a 6.5 h incubation period and at a similar rate to 
125I-labelled PVP itself. Moreover, subsequent re-incubation in 
substrate-free medium showed only low rates of release, again demon­
strating cellular integrity towards these substrates. Other proteins 
including *25I-labelled insulin, 1 2^I-labelled glucagon and 1 2 5I-labelled 
ribonuclease (Livesey, G., unpublished data) have also been investigated 
and shown to have high rates of uptake compared to I-labelled PVP.
Histochemical studies by Beck £t al. (1967) showed that following 
accumulation of horseradish peroxidase within the vitelline epithelium 
of the yolk sac, enzymic activity was lost and that the ingested 
material was almost entirely confined to the lysosomal system of these 
cells. In vivo studies on the uptake of ferritin (Lambson, 1966) 
demonstrated that this substrate was concentrated within the rat yolk 
sac and retained within it for long periods. The site of accumulation
125
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was shown by electronmicroscopy to be the vacuolar system of the
epithelial cells. Such observations provide strong circumstantial
125evidence that the observed hydrolysis of I-labelled BSA and other 
proteins occurs within lysosomes. The possibility that hydrolysis 
of proteins may occur on the surface of cells by membrane-bound 
peptidases of the type described by Kerr and Kenny (1974) has recently 
been investigated by Livesey (unpublished data), but to date no 
evidence of such a process has been obtained. This re-enforces the 
belief that the lysosomal system is the major if not the only site of 
the observed protein catabolism.
All the in vitro studies reported above employed a tissue culture 
technique based on Eagle’s medium containing 10% (v/v) calf serum (see 
Section 2.3 for method). This particular medium composition was 
selected because tissue incubated in it for several hours more closely 
resembled freshly excised tissue, when examined ultrastructurally, 
than did tissue incubated in medium 199 alone. Unfortunately, from 
the standpoint of analyzing the data on protein catabolism and pinocytosis 
this system has the complication that the vast excess of serum protein 
in the medium is able to compete with the tracer amounts of substrates 
offered to the tissue. This makes a rigorous analysis of the 
pinocytic process impossible when adsorption of a substrate occurs 
prior to ingestion. Hence the removal of these serum proteins becomes 
most desirable especially if the interaction of cell surface and sub­
strate are to be investigated in detail. To this end Moore (1975) 
reported some preliminary findings on the uptake of 1 2 5I-labelled PVP 
in the absence of calf serum and showed that under such conditions the 
tissue still ingested this substrate although the data were not very 
reproducible.
In this thesis the uptake experiments in the absence of calf serum 
were performed using a slightly modified version of the method of Moore
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(see Section 2.8). The main differences were the dissection time 
was reduced to as short a period as possible to try and ensure better 
tissue survival and both the sampling intervals and overall incubation 
periods were reduced.
125Using this technique, uptake of I-labelled PVP was determined
and compared to that in the presence of calf serum in order to establish
a basal rate of pinocytosis in the absence of calf serum in the same
manner as described by Williams et^  al. (1975a). Secondly, the method
was employed to follow the effects of removing calf serum from the
14medium on the uptake of other substrates: namely [U C]sucrose,
198 125colloidal [ Au]gold and I-labelled dBSA which have previously
been studied in the presence of calf serum (Roberts et al., 1977;
Moore £t al., 1977). Finally, the effects of increasing the overall
PVP concentration were investigated in the absence of calf serum in
125order to determine whether I-labelled PVP entered the cell solely 
in the fluid phase, as suggested by Williams e£ £l. (1975a), or 
entered partly by adsorbing to the plasma membrane before ingestion.
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METHODS
3.2 Uptake of I-labelled PVP in the presence and absence of calf serum
17.5-day rat yolk sacs were incubated either in medium 199 plus
10% calf serum (see Section 2.3 for method) or in medium 199 alone
125(see Section 2.10 for method). I-labelled PVP at a concentration
of 2 .0 - 5 . 0  yg per ml of medium, was used as substrate and incubations
were terminated at regular intervals up to 6.5 h. The amounts of
radioactivity in the yolk sac and medium were assayed as described in
2 . 4 and 2 .6 , respectively, and the protein content of each yolk sac
determined (see 2.5). Uptake of substrate was plotted against time
for each set of data and the related Endocytic Index calculated (see
Section 2.12 for definition and units).
125A typical uptake plot for I-labelled PVP in medium 199 plus 
10% calf serum is shown in Fig. 3a and a corresponding plot of uptake 
of the same substrate in medium 199 alone is shown in Fig. 3c. The 
results of a number of experiments of each type are given in Tables 
3.1a and 3.III. The results of Table 3. Iaare further summarized in
Table 3.II.
143.3 Uptake of [U C]sucrose in the presence and absence of calf serum 
Rat yolk sacs at 17.5 days of gestation, were incubated in medium 
199 with 10% calf serum (see Section 2.3 for details) or in medium 199 
alone (see Section 2.10 for details). The concentration of radiotracer 
employed was 0 . 1  yg/ml of culture medium and the incubations were 
terminated at regular intervals up to 6.5 h. The radioactivity was 
assayed as described in Sections 2.8 and 2.9 and the protein content 
of the yolk sacs was determined by the method of Lowry et al. (1951) 
described in Section 2.5.
The uptake of radiotracer was calculated using equation 2.Ill and 
the corresponding Endocytic Index calculated from the plot of uptake 
against time. Such results are shown in Table 3.1b for experiments
125
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in the presence and absence of calf serum, and summarized in Table 3.VII. 
Typical plots of uptake versus time are shown in Fig. 3a with calf 
serum and Fig. 3c in the absence of calf serum.
1983.4 Uptake of colloidal [ Au]gold in the presence and absence of 
calf serum
The methods used were identical to those for the uptake of 
^■’i-labelled PVP. The results for the uptake of colloidal [^^Au]gold 
in the presence and absence of calf serum are given in Table 3.1c and 
are further summarized in Table 3.VII. Typical plots of uptake 
versus time are shown in Fig. 3a and Fig. 3d.
125
3 . 5 Uptake of I-labelled dBSA in the presence and absence of calf 
serum
125In similar experiments I-labelled dBSA was used as substrate at 
concentrations of 0.6 - 1.0 yg/ml of medium. The ’total’- and 
'soluble'-radioactivities in each sample of medium were assayed (see
2 .6 and 2 . 7 for methods) together with the yolk sac radioactivity
(see 2.4). From the results of each such experiment uptake of
l^I-labelled dBSA was plotted against time and the related Endocytic
Index calculated as described in Section 2.13.
125A typical uptake plot for I-labelled dBSA in the presence of 
10% calf serum is shown in Fig. 3b together with the levels of tissue- 
associated radioactivity from the same experiment. The amount of 
radioactivity associated with the tissue is expressed in the same units 
as uptake in order to facilitate comparison of the two quantities.
Fig. 3e shows similar plots against time of both uptake and the quantity 
of tissue-associated radioactivity for a representative experiment in 
which I-labelled dBSA is ingested in the absence of calf serum.
The results of such experiments in both the presence and absence of 
calf serum, are shown in Tables 3.Ill and 3.VI and are summarized in 
Table 3.VII.
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3.6 Uptake of I-labelled PVP in the presence of unlabelled PVP 
(medium 199 alone)
In order to determine the effect of increasing the concentration of
125polyvinylpyrrolidone on the Endocytic Index of I-labelled PVP, yolk
125sacs were incubated with I-labelled PVP (2.0 yg/ml) in the presence
of unlabelled polyvinylpyrrolidone of similar size (PVP-40) in the
125absence of calf serum. The Endocytic Index of I-labelled PVP was 
determined at four different concentrations of PVP-40 (0, 10.0, 100.0 
and 10 0 0 .0 yg/ml).
The results of each experiment are shown in Table 3.V and 
summarized in Table 3.VIII.
RESULTS
3 . 7  Endocytic Index of ^^I-labelled PVP, [U^Clsucrose and colloidal
198 • •[ Aulgold in medium 199 plus 10% calf serum
Table 3.1 shows the results obtained from the uptake of
l^I-labelled PVP from medium 199 containing 10% calf serum. The
Endocytic Index (gradient) and correlation coefficient of the straight
line, fitted by linear regression analysis, are shown for each plot
together with the intercept on the ordinate axis. All plots with
values of the Endocytic Index lower than 1.1 yl/h/mg protein or with
correlation coefficients less than 0.95 were rejected as being atypical.
(Plots which fell outside these limits showed either an unusually high
degree of scatter or non-linearity but such plots constituted less than
12510% of the total data.) In all experiments I-labelled PVP was 
accumulated linearly in the yolk-sac tissue up to 7.0 h, the longest 
time period used in the current study. It should be noted that linear 
uptake has been observed for longer periods, up to 18 h by Williams 
(unpublished data). The average value for the Endocytic Index was 
found to be 1.70 ¿0.30 (S.D.) from a total of 55 experiments. This
125
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figure is in close agreement with values obtained by Williams £t al.
(1975a), Moore et al. (1977) and Roberts et al. (1977) of 1.71;
1.5 + 0.2 (S.D.); and 1.57 +0.35 (S.D.), respectively.
Table 3.II shows that there is little or no dependence of the 
125Endocytic Index of I-labelled PVP on the batch of material although
Batches 142 BA to 149 BA showed a generally increased Endocytic Index
compared to the other batches. This contrasts with the findings of
Roberts et al. (1977) who observed a significant inter-batch variation
198in the Endocytic Index of colloidal [ Au]gold in the yolk sac 
125culture system. I-labelled PVP therefore constitutes an ideal
substrate with which to monitor a basal rate of pinocytosis in the
tissue, and can be used both to check that no drift occurs in the
performance of the culture system over a prolonged period of time and
to monitor yolk sac function when modifications of the basic culture
method are made (e.g. evaluating a new substrate for toxic or
pharmacological effects that may alter the rate of pinosome formation,
or on modifying the composition of the culture medium.)
The uptake of [ U^C] sucrose was, like that of ^^I-labelled PVP,
highly linear in the presence of calf serum (see Fig. 3a) and the
mean value of the Endocytic Index was found to be 3.69 + 0.36 (S.D.)
(Table 3.VII). This was somewhat higher than the value of 2.04 _+ 0.21
(S.D.) obtained by Roberts et al. (1977) who also reported an Endocytic
125Index of 1.57 +_ 0.35 (S.D.) for I-labelled PvP. In the present
125study the mean value of Endocytic Index of I-labelled PVP, in experiments
performed in parallel with the sucrose experiments, was 2.05 +^0.33 (S.D.). 
198Colloidal [ Au]gold again showed highly linear uptake,
(see Fig. 3a) with a mean Endocytic Index of 4.56 +_ 0.62 (S.D.), more
125than twice that observed for I-labelled PVP. Values of this
magnitude have usually been found to be associated with Endocytic
125Indices obtained for proteins: for example I-labelled BSA (unfrozen)
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IgG 6.27 _+ 2.65 (S.D.) (see Chapter 5). Hence it would appear that 
198colloidal [ Au]gold may well be ingested in a manner more similar to 
that of proteins.
1253.8 Endocytic Index of I-labelled dBSA in medium 199 plus 10% 
calf serum
125A typical plot of uptake against time for I-labelled dBSA 
(Batch III) in the presence of 10% calf serum is shown in Fig. 3b.
This plot shows highly linear uptake over a 6.0 h incubation period
(Correlation Coefficient = 0.988). Also shown is the tissue level of
125I-labelled dBSA i.e. the amount of radiotracer associated with the
yolk-sac tissue at the time of sampling. It can be seen that after
2 .0 h the tissue level reaches a constant value of about 80 yl/mg
protein which is equivalent to approximately 0.08 yg of I-labelled
dBSA/mg of tissue protein. Table 3.IV shows the mean Endocytic Index
for each batch of protein and also the mean quantity of radioactivity
associated with the tissue (yl/mg protein) calculated, in each
experiment, from the amount of radioactivity found associated with
each yolk sac removed between 2 .0 h of incubation and termination of
the experiment. An overall mean was also calculated for each batch of 
12 5I-labelled dBSA from these same results (Table 3.VII).
No systematic variation in the overall mean value of the Tissue
. 125Radioactivity for the different batches of I-labelled dBSA, ingested
in the presence of calf serum, was observed (see Table 3.VII). Also
there was no correlation between the value of the Endocytic Index and
125the Mean Tissue Radioactivity for a particular batch of I-labelled dBSA.
Moore ££ al. (1977) found the Endocytic Index of formaldehyde- 
denatured bovine serum albumin to be 65.0 11.0 (S.D.) yl/h/mg protein.
This figure is in very close agreement with those values obtained in 
the current study: Batch II, 56.3 +_ 10.3 (S.D.) Batch III, 64.8 + 5.9
125gave a value of 4.8 +_ 1.5 (S.D.) (Moore et al., 1977) and I-labelled
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(S.D.); and Batch V, 69.5 +_ 6.4 (S.D.) (see Tables 3.Ill and 3.VII).
The relatively low Endocytic Index of 38.2 +_ 2.7 (S.D.) observed for 
Batch I of this material can be attributed to its period of exposure to 
formaldehyde being only 3.0 h whereas all other batches were treated 
for 72 h (Table 2a).
3.9 Reproducibility of uptake experiments using medium 199 alone
125Preliminary experiments using I-labelled PVP as substrate, 
showed that in the absence of calf serum the reproducibility of the 
uptake data was reduced compared with that of similar experiments per­
formed in the presence of 10% calf serum. Inspection of plots of 
125I-labelled PVP uptake in the absence of calf serum showed that the 
rate of uptake was substantially linear for the first few hours but an 
increased degree of scatter was observed over the remainder of the 
incubation period. A typical plot is shown in Fig. 3f and demonstrates 
the increased scatter that occurs at approximately 5 h in this case.
This increase in scatter resulted in greatly reduced correlation 
coefficients for some incubations of more than 5 h duration hence for 
experiments in the absence of calf serum the maximum incubation period 
was reduced to 5 h and individual yolk-sac incubations were terminated 
either singly at 30 min intervals or in pairs at 60 min intervals.
A similar inspection of uptake plots for I-labelled BSA in the 
absence of calf serum frequently showed a sharp reduction in the rate
of uptake after 5 h of incubation as well as an increase in scatter.
125A typical plot of the uptake of I-labelled BSA in the absence of 
calf serum is shown in Fig. 3g.
On inspecting several sets of such data with the aid of a visual 
display unit attached to the graph plotter of the ICL 4130 computer, 
it was observed that the majority of the plots showed a loss of 
linearity and increased scatter beyond 5 h of incubation. The overall 
incubation period was therefore limited to this time in subsequent
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experiments of this type and sampling performed in the same manner as 
described for 1 2 5I-labelled PVP.
Although the data collected for experiments where calf serum was 
not included in the culture medium showed slightly less reproducibility 
than for those cultures including calf serum, the sacrifice of a small 
degree of reproducibility is more than compensated for by the removal 
of a complex mixture of proteins. This allows a more detailed study of 
interactions between the yolk sac and substrate.
1253.10 Endocytic Index of____I-labelled PVP in medium 199 alone
The results of uptake experiments in which yolk sacs were 
125incubated with I-labelled PVP in medium 199 alone are shown in 
Table 3.IV and a typical plot is shown in Fig, 3c. The mean Endocytic 
Index from 11 experiments (see Table 3.VII) was 2.47 1.00 and is
significantly higher than that from similar incubations in the presence 
of 10% calf serum (1.70 +^0.30, S.D.). Removal of calf serum from 
the culture medium also leads to a fall in the reproducibility of such 
experiments as indicated by both a lowering of the correlation 
coefficient and an increase in the standard deviation of the mean 
Endocytic Index. The reduced reproducibility of such plots required 
correlation coefficients of 0.91 or greater to be accepted as being 
within the normal range as opposed to values in excess of 0 . 9 5 when 
calf serum was present.
Similarly, the removal of calf serum from the incubation medium
resulted in an increase in the mean value of the Endocytic Index for 
., standard
[tJ C]sucrose although the/deviations associated with these values 
were large (see Table 3.VII). For easy comparison a typical uptake
versus time plot is shown in Fig. 3c along with a representative plot 
for 1 2 5I-labelled PVP.
198On the other hand, colloidal [ Au]gold showed a dramatic 
increase in the Endocytic Index in the absence of calf serum,
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(see Fig. 3d), rising from 4.56 ¿0.62 (S.D.) with calf serum to 
55.62 +_ 3.4 (S.D.) in the absence of calf serum; a 12-fold increase.
This compares with similar large increases in Endocytic Index which 
were observed for I-labelled dBSA (Table 3.VII) and JI-labelled 
IgG (Chapter 5) observed on removal of calf serum from the incubation 
medium.
3.11 Effect of increasing concentration of PVP-40 on the Endocytic
125Index of I-labelled PVP in medium 199 alone
Tables 3.V and 3.VIII show the effect on Endocytic Index of
1 9 SI-labelled PVP with increased concentration of PVP-40. These
125results clearly show that the Endocytic Index of I-labelled PVP 
shows no significant change with increasing PVP-40 concentration over 
the range investigated.
1253.12 Endocytic Index of I-labelled dBSA in medium 199 alone
125The rates of uptake of Batches II, III, IV and V of JI-labelled
dBSA were determined using yolk sacs incubated in the absence of calf
serum. Fig. 3e shows uptake with time for a typical experiment using
^'’i-labelled dBSA (Batch V) in medium 199 alone. Again a highly
linear plot is observed, similar to that for the same substrate (Batch
III) incubated in medium 199 containing calf serum (Fig. 3b). Table
3.VI shows the results of a number of such experiments. The correlation
coefficients of the plots of uptake against time are if anything
125slightly higher than those for I-labelled PVP ingested in medium 
199 alone, and the relative standard deviation in the mean Endocytic 
Index is generally found to be small. The most striking feature of 
these results is the large increase in Endocytic Index in the absence 
of calf serum relative to the Endocytic Index of the same substrate 
in the presence of 10% calf serum; Batches III and V show 3.7-5.5-fold 
increases in their rates of uptake, respectively.
The amount of radioactivity associated with the tissue in such
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experiments shows that the absence of calf serum leads to a rise in 
tissue level to a maximum, at about 1.5 h, which subsequently falls with 
further incubation. This rise to a maximum value is not observed in 
plots where calf serum was present. The values of the Mean Tissue 
Radioactivity (yl/mg protein) are shown in Table 3.VI for each 
experiment and the value of overall Mean Tissue Radioactivity is shown 
in Table 3.VII. In the absence of calf serum both Batch III and V 
showed an increase in the value of the overall Mean Tissue Radioactivity 
of about 30 yl/mg protein relative to corresponding values from 
experiments in the presence of calf serum, but for Batch II no such 
increase was observed.
125 125
3 , 1 3  Comparison of results with I-labelled PVP and I-labelled 
dBSA as substrates
Table 3.VII summarizes the main findings with respect to the
uptake of these two substrates by comparing the mean values of the
Endocytic Indices determined from incubations performed both in the
presence and absence of calf serum.
125The uptake of I-labelled PVP in 10% calf serum was observed to
be highly linear up to 7.0 h and in such experiments the correlation
coefficient of the uptake plot was usually in excess of 0.95. The
125Endocytic Index of I-labelled PVP in the presence of 10% calf serum
yields a valuable and reproducible reference value for pinocytic
activity in cultured rat yolk sac (Table 3.1a) and was used at regular
intervals throughout the course of the work to confirm the reproducibility
of the pinocytic activity of the incubated tissue.
Removal of calf serum from the culture medium gives rise to a
125slightly increased rate of uptake of I-labelled PVP and somewhat 
greater variability between individual experiments so that the mean 
Endocytic Index is 2.47 +_ 1.00 (S.D.) as opposed to 1.70 + 0.30 (S.D.) 
for 10% calf serum incubations. Thus the presence of 10% calf serum
in the culture medium appears to be responsible for the depression
of pinocytic uptake, equivalent to 31% when expressed relative to the
Endocytic Index without addition of calf serum to the medium.
125When I-labelled dBSA was incubated with yolk sacs in the
presence of calf serum, highly linear uptake was almost always observed
up to 6.5 h with correlation coefficients in excess of 0.95. Again
the absence of calf serum gave rise to slightly greater variability
125between individual experiments, as for I-labelled PVP. The most
striking effect of its removal from the medium was a large increase in
125Endocytic Index of I-labelled dBSA relative to that of the same
substrate in the presence of calf serum. Batches II, III and V showed
an increase in Endocytic Index of between 4- and 6-fold.
In summary, the absence of calf serum from the culture medium
125results in a large increase m  the Endocytic Index of I-labelled
125dBSA but only a relatively small increase in that of I-labelled
PVP. Similarly, the Endocytic Index of [^C] sucrose is little
198affected by the presence of calf serum whereas that of [ Au]gold 
is greatly increased on removing calf serum from the incubation medium 
(see Tables 3.1b and c).
3.14 Discussion
Jacques (1969) proposed that a macromolecular substrate entering 
a cell by pinocytosis has two potential mechanisms of ingestion.
First, by fluid phase ingestion in which the substrate enters dissolved 
in a microscopic droplet of the extracellular liquid captured by move­
ments of the cell membrane, and second, by prior adsorption of the 
substrate to that region of the plasma membrane that invaginates to 
form the limiting membrane of the pinosome. Both of these mechanisms 
are shown diagrammatically in Fig. 3 h.
If a substrate enters a cell in the fluid phase alone, the rate 
at which it enters is dependent on the product of the concentration of
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the substrate in the extracellular liquid and the rate of fluid 
ingestion by pinocytosis, i.e.
Q - Fc 3.1
Where Q is the rate of uptake of the macromolecule (weight per 
unit time), F is the rate of fluid internalisation (volume per unit 
time) and c the substrate concentration in the extracellular liquid 
(weight per unit volume). Equation 3.1 will fully describe the uptake 
of solutes that are not adsorbed to the plasma membrane. The rate of 
ingestion of such solutes will be dependent only on the concentration 
of the substrate in the extracellular liquid and the rate of pinosome 
formation. Furthermore, if two such substrates are offered simul­
taneously to the cell both should be ingested at rates equal to those 
for separate uptake of each substrate at the same concentration.
Only if one of the substrates is present at a concentration which 
causes it to have a pharmacological effect on the process of pinosome 
formation, hence modify the value of F, will it influence the rate of 
ingestion of another substrate ingested in the same manner. Even 
when such an effect does occur, a pair of substrates undergoing simul­
taneous ingestion will be affected alike: i.e. both of them will show 
increased rates of ingestion or both will show decreased rates of 
ingestion.
At the opposite extreme, a pinocytic channel could be so flattened 
and narrow that extracellular fluid is effectively excluded from the 
nascent pinosome (although it may subsequently imbibe water intra- 
cellularly, to form a spherical pinosome, see Fig. 3h). In this 
mechanism, the only effective route of entry of the substrate is by 
adsorption to the plasma membrane. Jacques proposed the following 
equation to describe this mode of entry:
Q SRcK+c 3.II
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Where K is the dissociation constant of the substrate-surface complex,
R the maximum amount of substrate that can be adsorbed per unit area of 
cell surface (weight per unit area) and S the rate of internalisation of 
cell membrane (area per unit time). This formulation assumes that the 
process of adsorption of the substrate to the cell membrane is one in 
which equilibrium is rapidly established and, in its simplest form, 
involves a single class of adsorption sites with a relatively low 
degree of substrate specificity. The number of substrate binding sites 
is finite as implied by the presence of R in the above equation.
Such a mechanism of uptake permits a pair of substrates to compete for 
receptors on the cell surface and thus reduce each other's rate of 
ingestion relative to that when ingested alone at the same concentration. 
This feature contrasts sharply with the model described above for uptake
ivia the fluid phase alone, which precludes such competitive behaviour 
of substrates.
In a broader formulation of uptake the two mechanisms of ingestion 
can be envisaged to coexist, giving the general equation for uptake 
of:
^ " FC + K+c 3-m
If no adsorption occurs, R will be zero and 3.Ill will simplify to 3.1 
whereas if adsorptive uptake is the major route of uptake fluid phase 
ingestion can effectively be ignored and 3.Ill will simplify to 3,11.
The Endocytic Index (E) as defined by Williams et al. (1975a) is 
given by 3.Ill divided by c, the concentration of the substrate, thus:
E = —  c F +
SR
K+c 3.IV
For a non-adsorbed substrate the Endocytic Index is equal to F alone, 
hence is independent of substrate concentration and equivalent to 
the rate of capture of the extracellular liquid by the pinocytic cell. 
It was proposed by Williams et al. (1975a) that pinocytosis was
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entirely responsible for the progressive accumulation of I-labelled
PVP by the yolk sac. Furthermore, these authors tentatively equated
125the Endocytic Index of I-labelled PVP, in 10% calf serum, with the
rate of ingestion of fluid (Model I of Fig. 3h) on the assumption that 
125I-labelled PVP is not adsorbed to the plasma membrane prior to
ingestion. This suggestion was supported by the observation that the
125Endocytic Index of I-labelled PVP was independent of concentration
over a substrate concentration range of 0.15 - 1000 yg/ml and is
further supported by the observation that the Endocytic Index of
^'’i-labelled PVP in the presence of *^I-labelled BSA (Williams et al. 
1271975b) or I-labelled dBSA (see Chapter 4 Section 4.) is not
markedly depressed. From a parallel study (Roberts at al_. 1977 and
14Table VII) it appears that [U C]sucrose is a second substrate that
is ingested in the fluid phase alone, the Endocytic Index being close 
125to that of I-labelled PVP. Moreover, high concentrations of
unlabelled sucrose (1000 yg/ml) did not cause a detectable fall in the
14Endocytic Index of [U C]sucrose (Roberts at al. 1977) when the latter 
was used as tracer in concentrations of only 0 . 1  yg/ml medium, 
suggesting that adsorption plays a negligible role in the ingestion 
of this solute. Again the removal of calf serum from the incubation 
medium resulted in very similar changes in the Endocytic Index for 
[TJ^C] sucrose and ^^I-labelled PVP. These observations strongly 
suggest that both these substrates are ingested in the fluid phase.
A consequence of incubating yolk sacs in the presence of 10% 
calf serum is that the serum provides a high concentration of proteins 
that may well compete with the radiotracer for adsorption sites on the 
cell membrane, hence lower the Endocytic Index of the radiotracer. 
Williams et al. (1975b) modified the general equation for the Endocytic 
Index to allow for the effects of a second substrate, also ingested 
by adsorption to the same binding sites on the cell membrane, and
125
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obtained the expression:
E = F + ------------ 3 vKM + Ki + Me J,v
Where M is the dissociation constant of the competitor-surface complex
and i the concentration of competing substrate. This type of equation
is appropriate when one additional substrate is present which competes
for the same adsorption sites on the plasma membrane but should more
than one additional species be present, as is probably the case with
a complex mixture like serum, an even more complex expression becomes
necessary. Thus to study quantitatively the competitive effects of
substrates, the omission of calf serum from the medium becomes most
desirable since equation 3.IV then fully describes the general uptake
of a single substrate, providing it can be assumed that none of the
low molecular weight components of medium 199 acts as an effective
competitor for the same binding sites as used by proteins and other
macromolecules. Likewise, if this same assumption can be made,
equation 3.V will fully describe the competition that occurs between
two substrates forthe same adsorption sites on a pinocytic cell.
In the case of ingestion of solute in the fluid phase only, the 
rate of uptake is given by equation 3.1. This equation divided by 
c, the concentration of substrate, gives an expression for the Endocytic 
Index (E)
i.e. E - £  - F 3 .VI
This equation shows that for a non-adsorbing substrate the Endocytic 
Index is equal to the rate of fluid ingestion hence independent of 
substrate concentration provided the rate of pinosome formation is not 
altered by changes in the solute concentration.
IOCTable 3.VIII shows the Endocytic Index of I-labelled PVP to 
be independent of the concentration of PVP-40 up to a concentration of 
1000 yg/ml of culture medium (PVP-40 was used as a substitute for the
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radiotracer at high concentration because of the high cost of using 
125I-labelled PVP itself). However, since the 1 2 5I-labelled PVP 
preparation routinely used was labelled to an extent of less than one 
atom of iodine per 100 molecules of polymer, it was thought justifiable 
to substitute unlabelled polyvinylpyrrolidone of a similar molecular 
weight (PVP-40) for the radiotracer.
The observation that the Endocytic Index of the 1 2 5I-labelled PVP
in the absence of calf serum is independent of the total PVP concentration
substantiates the suggestion that 1 2 5I-labelled PVP is ingested almost
entirely via the fluid phase i.e. adsorption to the plasma membrane
plays a negligible role in the uptake of this substrate. The
experiments of Williams et al. (1975a) that showed the Endocytic Index 
125of I-labelled PVP to be independent of it s concentration were per­
formed in 10% (v/v) calf serum; hence any component of calf serum that 
adsorbed on the binding sites more avidly than 1 2 5I-labelled PVP could 
have totally displaced the I-labelled PVP from the plasma membrane 
depressing the rate of substrate ingestion and rendering it independent
of concentration. The observation of only a marginal increase in the
125Endocytic Index of I-labelled PVP in the complete absence of calf
serum indicates that this process can only be of limited quantitative
significance, if any. Thus, the observed increase of 45% in the
125Endocytic Index of I-labelled PVP in the absence of calf serum 
relative to that in the presence of 10% (v/v) calf serum can be 
attributed either to this effect or to the absence from the culture 
medium of some factor(s) present in calf serum that reduces the rate 
of vesicle formation.
In contrast, the absence of calf serum from the culture medium 
results in a large increase in the Endocytic Index of 1 2 5I-labelled 
dBSA and colloidal f98Au]gold. Of the batches of protein; Batch V 
shows the greatest effect giving a 5.5-fold increase in its Endocytic
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Index whereas colloidal [ Au]gold showed a 12-fold increase. This
125compares to only a 45% increase for I-labelled PVP in the absence
of calf serum. Clearly, the large increases in the rates of capture
of these substrates cannot be accounted for solely by an increased
rate of vesicle formation, since results with I-labelled PVP as
substrate indicate that no more than a 45% increase can be attributed
to this origin. On the contrary, these results indicate that serum
proteins compete with both 1 2^I-labelled dBSA and [^®Au]gold for
adsorption sites on the plasma membrane. Moreover, an Endocytic
125Index of 2.47 yl/h/mg protein for I-labelled PVP means that an
average yolk sac of 5.0 mg protein ingests approximately 12.5 yl/h
125of the extracellular medium, assuming I-labelled PVP is inter-
12 5nalized in the fluid phase alone. If, on the other hand, I-labelled 
dBSA were ingested entirely in the fluid phase then for Batch V 
(Endocytic Index 381.5 24.8 yl/h/mg protein) an average yolk sac
would ingest 1905 yl/h (nearly 2.0 ml per hour) of the extracellular 
medium. It would seem inconceivable that a yolk sac could turn over 
sufficient plasma membrane to maintain such a rate of internalization.
The uptake of radiotracer in the absence of calf serum is fully 
described by equation 3.IV. If, to a good approximation, the rate
of fluid phase ingestion can be equated with the Endocytic Index of 
125I-labelled PVP m  the absence of calf serum (i.e. F ■ 2,47 + 1.0
125yl/h/mg protein). Then for I-labelled dBSA (Batch V) equation 
3.IV becomes:
198
E = 381.1 = 2.47 + K+c
i.e. ¡7 = 381.1 - 2.47 = 278.63 yl/h/mg protein 3.VII
Thus adsorption accounts for 278.6 yl/h/mg protein which is equivalent
125to 99.3% of the total I-labelled dBSA ingested per hour.
125The observed competition between I—labelled dBSA and the serum
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proteins demonstrates that the adsorption centres or loci present on
the plasma membrane are essentially non-specific in nature, as would
be expected for binding sites of this type, since it would be incon-
ceivable that a highly specific receptor for I-labelled dBSA should
exist. However, it appears that the affinity of a protein for these
binding sites is dependent on certain characteristics of the protein.
Thus Moore et. al. (1977) demonstrated that a number of preparations
of bovine serum albumin that had been treated with a variety of
chemical agents were ingested at substantially different rates even
in the presence of 10% calf serum. In the current study, Table 3.VII
125shows the Endocytic Index of I-labelled dBSA (Batch I) to be 
significantly lower than that for the other batches. This is probably 
a direct result of the shortened exposure of Batch I to the formaldehyde 
solution (3.0 K).
Moore found that formaldehyde-treatment resulted in a large
125increase in the rate of uptake of I-labelled albumin and that such
treatment was not accompanied by aggregation.hence the increased uptake
must result from either chemical modification of certain groups or
a change in the general conformation of the molecule. The most
favoured reaction of formaldehyde is with the e-NH^ of lysine but
reaction with the a-NH^ and methylene bridge insertion into disulphide
bonds also occurs. It is known that the reaction of formaldehyde
with protein residues is complex and that reaction rates vary from
very fast to very slow. This would appear to be consistent with
125pinocytosis results obtained for I-labelled dBSA (Batch I) where 
a shortened exposure time (3.0 h) to formaldehyde results in a lower 
Endocytic Index than for batches exposed for longer periods (72 h) .
The dependence of the Endocytic Index of I-labelled dBSA on the 
time of treatment with formaldehyde solution would seem to indicate 
incomplete interaction within a 3.0 h period. The longer treatment
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would allow the slower reactions time to establish equilibrium which 
may modify the protein’s subsequent interactions with the yolk-sac 
plasma membrane.
125In a similar manner to I-labelled dBSA, the increase in
198Endocytic Index of colloidal [ Au]gold in the absence of calf serum 
indicates strong adsorption of this substrate to the cell surface 
prior to ingestion. It would seem that this substrate is treated 
essentially as a protein, at least during the ingestion phase. This 
is not so surprising, since the colloidal [ Au]gold used was gelatin- 
stabilized thus the results are not for the uptake of particulate gold 
but for a gelatin-stabilized colloid. Moreover, Roberts et^  al. (1977) 
found the Endocytic Index of colloidal [ Aujgold to fall progressively 
with increased concentration, demonstrating competition for binding 
sites on the plasma membrane; this behaviour is typical of a protein 
(see Chapter A).
Table 3.VII shows that, for a particular batch of 1 2 5I-labelled
dBSA, the mean amount of tissue-associated radioactivity does not
correlate with the Endocytic Index in the presence of calf serum.
Removal of calf serum leads to a rise of approximately 31% (relative
to the value of the tissue-associated radioactivity in the presence
of 10% calf serum) for Batches III and V although no change was
observed for Batch II. It should be stressed, however, that this
increase is small compared with the increase in the Endocytic Index
and indicates that a slightly higher steady state concentration of 
125I-labelled dBSA iti the tissue accompanies the higher uptake of 
this labelled protein in the absence of competing serum proteins.
If this increase were a consequence of saturating the digestive 
capacity of the yolk sac, then a progressive accumulation of radio­
activity by the tissue would be expected.
On the contrary, inspection of Fig. 3e shows that in the absence
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of calf serum the tissue radioactivity actually decreases with increased
incubation time from a maximum at about 1.5 h. Analysis of several
such plots showed that the fall in tissue radioactivity occurred for 
125each batch of I-labelled dBSA and was normally about 25% to 30% 
relative to the maximum and could be explained simply by depletion of 
radiotracer from the culture medium. For example, the rate of 
ingestion of a labelled albumin, with an Endocytic Index of 300 yl/mg 
protein, by an average sized yolk sac (containing 5 . 0  mg of tissue 
protein) would result in the substrate contained in 7500 yl of culture 
medium being ingested during a 5.0 h incubation. With a total volume 
of 10 ml of culture medium this is equivalent to a 7 5% depletion of 
available substrate, hence it seems likely that such a large fall in 
substrate concentration could adequately account for the fall in 
tissue radioactivity. (This effect is discussed further in Chapter 4, 
Section 4.7). In the presence of calf serum the Endocytic Index is 
considerably lower being about 60 yl/h/mg protein which results in 
capture of substrate from 1550 yl of medium. i.e. 15% depletion of 
radiotracer over 5.0 h. The much lower rate of radiotracer depletion 
in the presence of calf serum would account for the absence of a fall 
in the tissue radioactivity.
Each row of data refers to individual experiments in which 17.5-day rat
125yolk sacs were incubated with I-labelled PVP in the presence of calf 
serum.
125Table 3.1a Endocytic Indices of I-labelled PVT in medium 199
containing calf serum (10%, v/v)
Batch of 
125I-PVP
1 2 5I-PVP
Cone.
(pg/ml)
No. of 
yolk sacs
Endocytic
Index
(u1 /h/mg protein)
Corr. 
Coeff.
Intercept 
(pl/mg protein)
116A 5 10 1.85 0.953 + 0.71
II I f 1 1 1 . 1 2 0.965 + 0.63
II II 7 1.72 0.983 + 0.48
II II 8 1.53 0.979 + 0.26
I t I t 10 1 . 6 8 0.988 + 0.50
I I 11 10 1.76 0.998 + 0.19
117A f t 8 1.91 0.986 + 0.50
11 f t 6 1.81 0.961 + 0.51
I f I f 6 1.81 0.954 + 0.82
119A I I 7 1.53 0.991 + 1.56
I t I f 6 1.51 0.993 + 0.84
121A f t 7 1.44 0.991 + 0 .2 0
I f I I 8 1.67 0.967 + 0.26
II I f 6 1 . 1 2 0.950 + 1.03
123A 11 10 1.92 0.971 + 0.40
II II 10 1.91 0.983 + 0 . 1 1
II II 10 1.40 0.958 +  0.95
I I I t 10 1.61 0.962 + 0.26
I I II 10 1.41 0.979 + 1.25
129BA II 10 1.60 0.980 + 1.70
I t I t 8 1.58 0.973 + 0.323
II II 10 1.78 0.979 +  0 .6 6
11 I f 10 1.47 0.961
+  0.99
I f I I 7 1.39 0.998
+  0.87
130DA 11 10 1.33 0.952 + 0 .2 2
II I f 10 1.72 0.978
+  0.97
II I f 10 1.72 0.965
+  1 . 2 2
Table 3.1a (continued) Endocytic Indices of ^~^I-labelled PVP in
medium 199 containing calf serum (10%, v/v)
Batch of 
125I-PVP
1 2 5i-pvp
Cone.
. (yg/ml)
No. of 
yolk sacs
Endocytic
Index
(yl/h/mg protein)
Corr. 
Coeff.
Intercept 
(yl/mg protein)
132DA 5 10 1.58 0.967 + 0.98
II 2 .0 10 2.08 0.994 + 0.60
II II 10 1.61 0.991 + 0.39
II II 10 1.42 0.968 + 1.24
II II 8 1.57 0.991 + 1.07
II II 10 1.50 0.986 + 1.06
II II 6 1.73 0.977* + 0.15
136BA II 9 1.34 0.965 + 0.89
II II 10 1.58 0.981 + 1.41
• 1 II 10 1.27 0.985 + 0.39
140 BA II 10 1 .2 0 0.991 _ 1 .02
II II 10 1.48 0.974 . 1.50
II II 10 1.78 0.985 1 . 1 0
142BA 11 10 2.06 0.986 0 .2 0
145BA II 10 1.48 0.982 0.79
• 1 II 10 2.15 0.975 - 0 .2 2
• 1 11 7 2 .2 0 ' 0.977 0.80
II II 9 2 .0 0 0.966 0.70
II • 1 10 2 .1 0 0.979 0.41
146BA II 10 2.17 0.991 0.32
II II 10 1.97 0.975 0.97
II It 10 1 .8 8 0.987 0.71
II .. II 10 1.89 0.986 0 .6 8
149BA 11 10 2.52 0.994 0.13
II 11 10 2.17 0.968 0 .8 6
II II 10 . - 2 .0 0 0.989 1.15
• 1 11 10 1.95 0.962 0.17
II 11 10 1.61 0.963 1.40
. 14Table 3.1b Endocytic Indices of [U C]sucrose in medium 199 in the 
presence and absence of calf serum
Each row of data refers to individual experiments in which 17.5-day rat 
yolk sacs were incubated with [ U^C] sucrose either in the presence or 
absence of calf serum.
r .,14_.1 U CJ sucrose 
Cone, (yg/ml)
No. of 
yolk sacs
Endocytic
Index
(yl/h/mg
protein)
Corr, 
Coeff.
Intercept 
(yl/mg protein)
With calf 0.1 8 3.32 0.968 -0.18serum
(10%, v/v) 8 4.03 0.971 -0.24
8 3.72 0.967 +2.09
Without II 10 3.13 0.986 +0.63calf serum
II 8 4.80 0.974 -0.41II
10 4.46 0.925 +0.81
Table 3.1c Endocytic Indices of colloidal [198Au]gold with 17.5-dav volk
sacs incubated in medium 199 in the presence and absence
of calf serum
Each row of data refers to individual experiments in which 17 .5-day
rat yolk sacs were incubated with colloidal [198Au]gold either in the
presence or absence of calf serum.
[ Au] gold No. of Endocytic Corr. InterceptCone, (yg/ml) yolk sacs Index Coeff. (pl/mg protein)(yl/h/mg
protein)
With calf 1.0 8 4.87 0.975 + 1.63serum
(10%, v/v) 9 3.85 0.974 + 4.29
8 4.97 0.977 + 2.55
Without VI 10 57.82 0.966 -2 1 . 1 1calf serum 9 57.34 0.950 -23.12
51.71 0.927 +30.76
Table 3.II Summary of Endocytic Indices for different batches of
1 2 'iI-labelled PVP (medium 199 plus 10% (v/v) calf serum)
Each row of data shows the mean Endocytic Index (+ S,D.) calculated
125from a number of experiments with each batch of I-labelled PVP 
(data summarised from Table 3.1a).
Batch of 1 2 5I-PVP 
(Radiochemical Centre 
Code No.)
1 2 5i-pvp
Concentration 
(yg/ml medium)
No. of 
Experiments
Mean Endocytic 
Index (+_ S.D.) 
(yl/h/mg protein)
116A 5 6 1.61 + 0.26
117A II 3 1.84 + 0.06
119A 11 2 1.52 -
121A 11 3 1.41 + 0.28
123A II 5 1.65 + 0.26
129BA 11 5 1.57 + 0.15
130DA If 3 1.59 + 0.23
132DA 2 7 1.64 + 0 .2 2
136BA If 3 1.40 + 0.16
140 BA II 3 1.49 + 0.29
142BA II 1 2.06 -
145BA 11 5 1.99 + 0.29
146BA If 4 1.98 + 0.14
149BA II 5 2.05 + 0.33
125Table 3.Ill Pinocytosis results for I-dBSA in medium 199 containing calf
serum (10%, v/v)
Each row of data refers to uptake data obtained from 17.5-day rat yolk sacs 
125incubated with I-labelled dBSA as substrate in medium 199 containing 
10% calf serum.
Batch of 
1 2 5I-dBSA
Cone.
(yg/ml)
No. of
yolk-
sacs
Endocytic
Index
(yl/h/mg
protein)
Corr. 
Coeff.
Intercept
(yl/mg
protein)
TCA-
solubles
in
125^I-dBSA
(%)
Mean
tissue
radio­
activity
(pl/mg
protein)
I 1 . 0 12 35.9 0.957 +28.6 1.69 70.6
It 1 . 0 6 41.2 0.970 -1 1 . 6 1.39 65.8
II 1 . 0 6 37.4 0.990 +16.9 1.73 55.8
II 1 . 0 9 72.5 0.984 -26.7 4.6 80.9
II 1 . 0 9 57.1 0.989 -30.9 3.5 69.2
IV 1 . 0 10 54.7 0.971 -0.4 5.13 65.3
II 1 . 0 6 44.4 0.981 -17.7 5.13 58.8
VI 1 . 0 7 52.7 0.955 -2.5 3.5 76.9
III 1 . 0 8 67.1 0.967 -2 0 .2 1.16 73.4
II 1 . 0 8 64.8 0.988 -5.7 1.18 84.6
It 1 . 0 8 6 6 .8 0.956 +51.5 0.92 10 2 .0
II 1 . 0 8 70.4 0.986 +2 1 . 1 0.92 96.9
11 1 . 0 8 6 6 . 1 0.978 + 3.4 2.18 119.5
II 1 . 0 8 53.3 0.971 +16.8 2,18 83.6
V 0 . 6 9 62.1 0.991 -12.7 1.05 46.5
II 0 . 6 9 63.8 0.981 +2 2 .0 1.05 86.5
It 0 .6 10 76.8 0.976 -35.5 2.9 80.4
II 0 .6 10 78.9 0.936 -16.0 2.9 82.9
11 0 . 6 10 65.8 0.985 - 1.4 1.7 61.4
11 0 .6 12 71.1 0.925 +100.5 0 .0 2 61.2
II 0 .6 12 6 8 .1 0.970 +83.2 0 .0 2 78.8
VI 1 . 0 10 87.8 0.985 + 1.4 0.96 91.8
II 1 . 0 10 96.8 0.993 -1 0 .0 1 . 0 2 93.1
It 1 . 0 10 77.3 0.990 10.4 0.93 83.8
II 1 . 0 10 65.2 0.985 1 0 . 1 0.96 71.5
Table 3.IV Pinocytosis of I-labelled PVP in TC 199 alone
Each row of data refers to individual incubations performed with
. . 12517.5-day rat yolk sacs incubated with I-labelled PVP in the 
absence of calf serum.
125
Batch of 
125j-^i-pvp
1 2 5i-pvp
Concentration
(yg/ml)
No. of
Yolk-
sacs
Endocytic
Index
(yl/h/mg
protein)
Corr. 
Coeff.
Intercept
(yl/mg^
protein)
116A 5.00 6 1.06 0.948 +3.3
1» I t 10 2.95 0.939 +1 . 8
1» t t 10 4.69 0.969 -0 .8
I I I t 10 3.46 0.979 +0 . 2
I t I f 7 2.27 0.970 +2.4
117A f t 7 1.58 0.979 +3.8
I t t t 6 1.5 0.924 +1 . 8
129BA M 10 2.24 0.921 +2 . 1
130DA II 10 2.35 0.989 +1 . 1
13 2D A f t 10 2.79 0.948 +3.1
I t I t 10 2.26 0.966 +2 .0
Table 3.V Endocytic Index of I-PVP in the presence of125
unlabelled PVP in medium 199 alone
125Each row of the table refers to uptake data for I-labelled 
PVP by 17.5-day rat yolk sacs incubated in the presence of different 
concentrations of PVP-40 and a constant tracer concentration of 
1 2 5I-labelled PVP.
PVP-40 
Cone, 
(yg/ml)
No. of 
yolk-sacs
Endocytic
Index
(yl/h/mg protein)
Correlation
Coefficient
Intercept
10 10 2.06 0.986 +0.5
II 10 2.61 0.935 +2 . 1
II 8 4.10 0.973 +1.5
100 10 2.27 0.918 +2 .0
II 10 2 .2 0 0.938 +3.0
II 10 2.61 0.935 +2 . 1
1000 8 1.78 0.993 +0 .8
If 9 1.97 0.983 +2.3
II 10 3.00 0.965 2.3
II 10 2.60 0.947 1.9
Each row of the table refers to uptake data for 17.5-day rat yolk sacs 
125incubated with I-labelled dBSA in the absence of calf serum.
125Table 3.VI Endocytic Indices of I-labelled dBSA in medium 199 alone
Batch of 
1 2 5I-dBSA
125JI-dBSA
Cone.
(yg/ml)
No. of
yolk-
sacs
Endocytic
Index
(yl/h/mg
protein)
Corr. 
Coeff.
Intercept
(yl/mg
protein)
TCA-
solubles
in
1 2 5I-dBSA
<*)
Mean
tissue
radio­
activity
(yl/mg
protein)
II 1 . 0 9 142.9 0.976 +115.7 4.4 73.2
11 1 . 0 8 208.9 0.987 - 20.7 4.6 77.4
If 1 . 0 6 124.0 0.986 + 56.2 3.5 59.8
III 1 . 0 8 274.5 0.972 - 38.3 1.93 152.7
11 1 . 0 8 241.3 0.952 - 90.9 1.93 103.4
II 1 . 0 8 2 1 0 .8 0.946 +120.3 0.90 117.8
IV 1.5 9 236.6 0.940 + 95.3 1.4 86.3
If 1.5 10 228.6 0.948 + 33.1 1.4 76.1
If 1.5 10 223.7 0.974 + 15.8 3.1 8 6 .8
ft 1.5 9 230.3 0.954 + 47.7 3.1 70.6
V 0 . 6 10 407.4 0.984 + 0 .6 2.98 101.3
11 0 . 6 10 378.9 0.981 + 4.3 1.39 97.8
11 0 . 6 10 358.1 0.967 - 4.4 2.90 108.7
Table 3.VII Summary of the Endocytic Indices of I-labelled PVP,
- l o c  u  i  qp^I-labelled dBSA, fU C]sucrose and colloidal [ °Au]gold
in the presence and absence of calf serum
Summary of the uptake data obtained for 17.5-day rat yolk sacs incubated 
125 125with I-labelled PVP and I-labelled dBSA in the presence and absence 
of calf serum.
125
Substrate Medium No. of 
Experi­
ments
Mean Endocytic 
Index, + S.D. 
(yl/h/mg
protein)
Overall mean i 
tissue
radioactivity 
(yl/mg protein
1 2 5I-PVP TC 199 serum
+ 10% calf 55 1.7 + 0.30 -
1 2 5I-PVP TC 199 alone 1 1 2.47 + 1 .0 0 - i
14[U C]sucrose TC199
serum
10% calf 3 3.69 + 0.36 -
14[U C]sucrose TC 199 alone 3 4.13 + 0 .8 8 -
[ ^ ^Au] gold TC 199 
serum
+ 10% calf 3 4.56 + 0.62 - 1
:
[ *^Au] gold TC 199 alone 3 55.62 + 3.40 - !
;
1 2 5I-dBSA (Batch I) TC 199 
serum
+ 10% calf 3 38.2 + 22.7 64.1 + }7.6 I
*
;
1 2 5I-dBSA (Batch II) TC 199 
serum
+ 10% calf 5 56.3 + 10.3 70.2 + 8.7 !
1 2 5I-dBSA (Batch III) TC 199 
serum
+ 10% calf 6 64.8 + 5.9 93.3 + 16.4 |
1 2 5I-dBSA (Batch V) TC 199 
serum
+ 10% calf 7 69.5 + 6.4 71.1 + 14.8
1 2 5I-dBSA (Batch VI) TC 199 
serum
+ 10% calf 4 81.8 + 13.6 85.0 + 9.9
1 2 5I-dBSA (Batch II) TC 199 alone 3 158.6 + 44.6 70.1 + 9.2
1 2 5I-dBSA (Batch HI) TC 199 alone 3 242.2 + 31.9 124.6 + 25.4
l25I-dBSA (Batch IV) TC 199 alone 4 229.8 + 5.3 80.0 + 8 .0
l25I-dBSA (Batch V) TC 199 alone 3 381.5 + 24.8 1 0 2 . 6 + 5.6
Table 3.VIII Summary of the Endocytic Index of 
125I-labelled PVP in the presence of 
PVP, medium 199 alone 
Summary of data presented in Table 3.V
PVP-40
Concentration
(yg/ml)
No. of 
Experiments
Mean (+ S.D.) 
Endocytic Index 
(yg/h/mg protein)
0 1 1 2.47 + 1.00
10 3 2.92 + 1.06
100 3 2.14 + 0.17
1000 4 2.34 + 0.56
Up
ta
ke
 (
yl
/m
g 
pr
ot
ei
n)
3a Plot of uptake against time for ^^I-labelled PVP, [ U^C] sucrose 
198and colloidal [ Au] gold in the presence of calf serum
[ U^C] sucrose Endocytic Index ■ 4.03 yl/h/mg protein
(Correlation Coefficient « 0.971)
[ gold Endocytic Index ■ 3.85 yl/h/mg protein
(Correlation Coefficient = 0.974)
1 2 5I-labelled PVP Endocytic Index = 1.72 yl/h/mg protein
(Correlation Coefficient = 0.965)
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pig. 3b Plots of uptake and tissue level against time ior
^•^I-labelled dBSA (Batch III) in the presence of calf
serum
Endocytic Index =64.8 yl/h/mg yolk-sac protein
(Correlation Coefficient = 0.988
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3c Plot of uptake against time for ^I-labelled PVP and [ U^cl 
sucrose in the absence of calf serum
Time (hours)
1 2 5I-labelled PVP Endocytic Index - 2.24 ul/h/mg
protein
(Correlation Coefficient » 0.921)
[ U^C] sucrose Endocytic Index « 3.13 yl/h/mg
protein
(Correlation Coefficient » 0.986)
Fig.3d Plot of uptake against time for colloidal 198Au]gold in
the absence of calf serum
(Correlation Coefficient = 0.966)
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. . 125Fig.3e Plots of uptake against time for I-labelled dBSA (Batch V) 
in the absence of calf serum
Time (hours)
Endocytic Index =378.9 yl/h/mg yolk-sac protein
(Correlation Coefficient = 0.981)
Fig. 3f Plot of uptake against time for I-PVP in the 
absence of calf serum
Vertical bar indicates time beyond which loss of linearity is 
apparent.
125
30
■
0 1 2 3 4 5 6
Time (hours)
Endocytic Index ■ 2.96 yl/h/mg yolk-sac protein
(Correlation Coefficient « 0.939)
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, . 1 95Fig. 3g Plot of uptake and tissue level against time for I-dBSA 
(Batch II) in the absence of calf serum 
Vertical bar indicates time beyond which loss of linearity is 
apparent.
(Correlation Coefficient = 0.986)
Fig. 3h Diagram of possible mechanisms of pinocytic ingestion of substrates (Jacques, P. J.^1969)
Plasma
Solute entering in fluid 
Phase
Ingestion of solute both by adsorption 
and in the fluid phase
Solute ingestion by adsorption 
to plasma membrane
C H A P T E R  4
A N A L Y S I S  O F  T H E  K I N E T I C S  O F  
I N G E S T I O N  O F  1 2 5I-L A B E L L E D dBSA 
B Y  T H E  R A T  Y O L K  S A C
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4.1 Introduction
When the results reported in Chapter 3 are considered together
with the findings reported by Williams et al. (1975b), Moore et al.
(1977), and Roberts et al. (1977), they indicate that:
125(a) the uptake of I-labelled PVP occurs essentially in the fluid 
phase,
125(b) that the uptake of I-labelled albumin preparations occurs mainly 
by adsorption to the plasma membrane, and
(c) that calf serum competes with 1 2 5I-labelled albumin for binding 
sites because adsorption plays a major role in determining the rate of 
internalisation of this protein substrate. In turn the affinity of 
the substrate for binding sites on the plasma membrane was shown by 
Moore et al. (1977) to be a function of the protein structure since 
chemical modification of bovine albumin greatly increases its ability 
to bind to the plasma membrane. Similarly Morrell et al. (1971) 
have demonstrated a relationship between the structure of a number of 
serum glycoproteins and their rates of uptake by the rat liver in vivo. 
These authors were able to show that removal of terminal sialic acid 
residues from these glycoproteins caused their half-lives in the 
circulation to fall dramatically. Furthermore, using isolated rat 
liver membranes, they were able to demonstrate that binding was the 
cause of the observed high rates of uptake and that desialylation of 
glycoproteins of the plasma membrane also resulted in a dramatic fall 
in the amount of binding (Lenten and Ashwell, 1971). This observation 
demonstrates that plasma membrane sialic acid residues also play an 
essential role in the binding process. The use of a quantitative 
assay technique enabled Lenten and Ashwell to demonstrate that the 
binding of substrate was a saturable process and these authors concluded 
that only a finite number of binding sites was available for the uptake 
of such substrates. Other workers (Rodbell, 1971) reached similar
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conclusions for the binding of glucagon to liver plasma membrane.
Cuatrecasas (1971) reported competitive binding of insulin to fat cells,
while an analysis of insulin binding to isolated liver membranes (Soil
et al., 1975) indicated the presence of two classes of receptor site.
In earlier studies, Gosselin (1956 and 1967) analysed the problem
of surface binding of substrates in a study of the endocytic uptake of 
198colloidal f Au]gold by macrophages in vitro. By applying a kinetic
analysis, similar to that derived by Michaelis and Menten for the inter­
action of a substrate with an enzyme, he was able to derive a relation­
ship between substrate concentration and the rate of endocytic uptake. 
Subsequently, by plotting the reciprocal of the rate of uptake against 
the reciprocal of the substrate concentration (Lineweaver-Burk plot)
Vmax* the maximal rate of substrate uptake, and K , the receptor-s
substrate binding constant, could be calculated. Cohen et al. (1968) 
analysed the kinetics of the disappearance of radiolabelled colloidal 
gold from the blood stream of the rat and in a later study Normann 
(1974a and b) analysed the kinetics of the clearance of foreign par­
ticles from the blood stream of this species. This latter author was 
able to calculate Vmax, the "maximal phagocytic velocity", and K , the 
"Colloid-Membrane Constant", for several substrates including carbon, 
denatured BSA, lipids, colloidal gold, latex beads and formaldehyde- 
treated rabbit red cells. Moreover, he demonstrated that these sub- 
trates showed a degree of competitive inhibition when injected together 
indicating that their uptake was preceded by attachment to a limited 
number of essentially non-specific binding sites on the plasma membrane. 
In such studies the uptake of particles by macrophages and liver cells 
has been assumed to be entirely by prior adsorption to the cell 
membrane and uptake of substrate suspended or dissolved in the extra­
cellular fluid has been ignored.
In this chapter the rate of uptake of 1 2 5I-Iabelled dBSA by the
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rat yolk sac was investigated in the presence of the non-radioactive
127competing substrate I-labelled dBSA and also studied as a function 
of its own concentration. The application of a kinetic analysis 
analagous to that used in enzyme kinetics allows both the maximal 
uptake velocity, V , and the receptor-substrate dissociation constant,
U l a X
K, to be derived. Furthermore, by monitoring the effect of increased 
127concentration of I-labelled dBSA on the rate of uptake of 
^■^I-labelled PVP the rate of fluid ingestion could be monitored 
directly, avoiding any arbitrary assumptions as to its value.
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METHODS
125 1274.2 Uptake of I-labelled PVP in the presence of I-labelled dBSA
In order to determine whether iodinated, formaldehyde-denatured
albumin modified the basal rate of pinocytosis when present in tracer
concentrations, I-labelled PVP was incubated with 17.5-day yolk sacs
in the absence of calf serum (see Section 2.10 for method) but with 
127addition of I-labelled dBSA to the culture medium (see Section 2.2)
127for preparation of I-labelled dBSA at three different concentrations:
125A.25, A2.5 and 170.0 yg/ml of medium. The concentration of I-labelled 
PVP was in the normal tracer concentration range (2.0 - 5.0 pg/ml of 
medium). Yolk sacs were removed at regular intervals up to 5.0 h 
and their contained radioactivity and protein content determined as 
described in 2.4 and 2.5, respectively. The medium radioactivity was 
determined as described in Section 2.6.
For each experiment, uptake, calculated by the method described in 
Section 2.12, was plotted against time (hours) and the Endocytic Index 
(pl/h/mg protein) was derived from the data by fitting a straight line 
to the points by linear regression analysis then determining its
125gradient. The individual values of the Endocytic Index of I-labelled
127PVP in the presence of I-labelled dBSA are shown in Table 4.1 and
summarized in Table 4.II, which also includes the value of the
125 127Endocytic Index of I-labelled PVP at zero I-labelled dBSA con­
centration in the absence of calf serum. (This value is taken from 
Table 3.V; see chapter 3 for details of these individual experiments).
The results given in Table 4.II are also presented graphically 
in Fig. 4a.
125 127
4 . 3  Uptake of I-labelled dBSA m  the presence of I-labelled dBSA
125
The uptake of I-labelled dBSA (Batch V) by 17.5-day yolk sac
was studied in the absence of calf serum using a concentration of 
125 127
0 . 6  pg/ml of I-labelled dBSA and with I-labelled dBSA present in
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the culture medium at concentrations of 0-170 yg/ml. Tissue radio­
activity and protein content were determined as described in 2 . 4  and 2 . 5  
The medium total- and the TCA-soluble radioactivities were assayed
by the methods given in section 2.6 and 2.7, respectively. Uptake of 
125I-labelled dBSA was calculated as described in section 2.13 and 
plotted against time (hours). The Endocytic Index was calculated in 
the usual manner using first the full set of data for 5 . 0  h incubations 
and secondly on restricting analysis of the same data to those obtained 
in the first 3.0 h of incubation. The corresponding results of each 
experiment are shown in full in Tables 4.Ilia (5.0 h period) and 
4.Illb (3.0 h period). Some of the sets of data that appear in 
Table 4.IIIb do not appear in Table 4.Ilia. This occurs because res­
tricting the analysis of data to those gathered in the first 3 . 0  h of 
incubation often gives a linear regression line with an acceptably 
high correlation coefficient (i.e. in excess of 0.91) whereas the full 
set of data up to 5.0 h gives a correlation coefficient less than 
0.91. Occasionally the converse is true, so that a set of data con­
tributes a value to Table 4.Ilia but not Table 4.111b.
Table 4.Ilia also shows the mean amount of radioactivity associated 
with the tissue (yl/mg protein) in the period from 2.0 - 5.0 h. The 
mean value of the tissue associated radioactivity was not calculated 
for the shortened time period as there was an insufficient number of 
samples between 2.0 h and 3.0 h to give meaningful results.
The contents of Tables 4.Ilia and 4.IIIb are summarized both in 
Table 4.IV, which shows the mean values of the Endocytic Indices for 
both 3.0 h and 5.0 h sets of data together with the mean value of 
the tissue-associated radioactivity for the 5 . 0 h sets of data.
Fig. 4b which shows the same data in graphical form.
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4.4 Uptake of I-labelled dBSA when present at different concentrations 
in medium 199 alone
IOC
A number of experiments were performed in which I-labelled 
dBSA (Batch IV) was incubated with 17.5-day yolk sacs for 5.0 h.
The experiments were performed in the same manner as those in 4.3 above
but, instead of adding different concentrations of non-radioactive 
127I-labelled dBSA to the culture medium, the radiotracer alone was 
used at concentrations from 1.0 - 75 pg/ml of medium. All assay 
procedures were as in 4.2 above and the same methods of calculation 
and expression of results were used. The full sets of data relating 
to incubations up to 5.0 h were analysed.
The Endocytic Indices are shown in Table 4.V for each experiment 
together with the mean value of the tissue-associated radioactivity 
after the first 2.0 h of incubation. These same results are 
summarized in Table 4.VI and shown graphically in Fig. 4c.
RESULTS
1274.5 Effect of increasing concentrations of I-labelled dBSA on
125the Endocytic Index of I-labelled PVP
Table 4.II and Fig. 4a show the effect on the Endocytic Index of
1 2 5I-labelled PVP of different concentrations of 1 2^I-labelled dBSA.
A slight fall in Endocytic Index over the initial concentration range 
127of 0-50 pg/ml of I-labelled dBSA is suggested but increasing the 
1 27I-labelled dBSA concentration from 50 to 170 pg/ml does not lead 
to a further fall. At no concentration was the Endocytic Index 
reduced by more than 20% as compared with that of I-labelled PVP 
in medium 199 alone and, because of the large standard deviation 
associated with each mean value of the Endocytic Index, it is doubt­
ful whether even the initial fall is significant. It is thus 
unlikely that concentrations of I-labelled dBSA in the range 
0-170 pg/ml have any effect on the rate of uptake of 1 2 5I-labelled PVP.
125
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4.6 Endocytic Index of I-labelled dBSA (Batch V) in the presence
127of increasing concentrations of I-labelled dBSA (in medium 
199 alone)
125The mean values of the Endocytic Index of I-labelled dBSA in
• 127the presence of increasing concentrations of I-labelled dBSA are 
shown in Table 4.IV and in Fig. 4b. The values of the Endocytic Index 
derived from analysis of both 3.0 h and 5.0 h sets of data differ little.
Fig. 4b clearly shows a rapid fall in the Endocytic Index of
125 127I-labelled dBSA with increasing concentration of I-labelled dBSA.
. 127An increase in I-labelled dBSA concentration from zero to 170.0
yg/ml of medium leads to a reduction in Endocytic Index, from
381.5 + 24.8 to 96.8 _+ 24.9 yl/h/mg protein i.e. approx, 75%. The
125magnitude of the reduction in Endocytic Index of I-labelled dBSA
127(Batch V) caused by I-labelled dBSA (170 yg/ml) is comparable to
that caused by addition of 10% calf serum to the medium (see Table 3.IV)
being 5.5- and 4-fold, respectively. A much higher concentration
of protein is present, however, in 10% calf serum than in even the
127highest concentrations of I-labelled dBSA used.
Fig. 4b also shows the mean tissue level of radioactivity (yl/mg
127protein) to fall as the concentration of I-labelled dBSA (yg/ml)
127in the medium is raised. On increasing the I-labelled dBSA con­
centration from 0 to 170 yg/ml medium a corresponding fall in tissue 
level activity from 102.5 + 5.5 yl/mg to 23.7 + 2.0 yl/mg is observed 
(i.e. approx, 77%). The steady fall in radioactivity associated
with the tissue reflects the observed fall in Endocytic Index, and
127indicates that, at all I-labelled dBSA concentrations investigated, 
the amount of radiotracer associated with the tissue remains constant 
and equal to approximately a quarter of the amount of protein ingested 
by the tissue every hour.
125
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4,7 En-do-cy t l c  Index of I-labelled dBSA (Batch IV) at different 
concentrations (in medium 199 alone)
The results summarized in Table 4.VI and Fig. 4c show the depen­
dence of the Endocytic Index of 1 2 5I-labelled dBSA (Batch IV) on its 
concentration in the culture medium.
Inspection of Fig. 4c shows a rapid fall in Endocytic Index
with increasing substrate concentration and this fall is comparable
to that shown in Fig. 4b where the Endocytic Index for *2^I-labelled dBSA
(Batch V) is plotted against concentration of 1 2 7I-labelled dBSA.
Although the Endocytic Index for 1 2 5I-labelled dBSA (Batch IV) is
lower than that of Batch V, at a particular substrate concentration
both these plots show approximately a 60% fall in Endocytic Index
between concentrations of 1.5 yg/ml and 75 yg/ml. Similarly, when
the overall mean value of the tissue-associated radioactivity is
plotted against tracer-protein concentration a progressive decrease
with increasing substrate concentration is observed (Fig, 4c) and is
125comparable to that for I-labelled dBSA (Batch V) shown in Fig. 4b. 
DISCUSSION
4 - 8 Optimum incubation period when determining the Endocvtic Indev 
a protein in the absence of calf serum
The Endocytic Index of formaldehyde-denatured bovine serum albumin, 
ingested by 17.5-day yolk sacs in the absence of calf serum, shows a 
very substantial increase when compared with that of the same pre­
paration incubated in the presence of 10% calf serum (see Chapter 3 
for determination of the latter).
This high Endocytic Index is accompanied by a rapid depletion of 
the available substrate in the culture medium. For example, an 
average sized yolk sac (containing 5.0 mg of protein) that is pino- 
cytosing with an Endocytic Index of 300 yl/h/mg protein will capture, 
every hour, an amount of substrate equivalent to that contained in
125
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1.5 ml of culture medium. Therefore, after 5.0 h of incubation, the 
substrate contained in more than half the original culture medium 
(1 0 .0 ml total volume) will have been captured.
It should be noted, however, that the uptake of radiolabel is 
calculated using equation 2.IV (Chapter 2) and that the value for the 
amount of acid insoluble radioactivity in the medium, M ’, that is 
routinely used in these calculations of uptake is the mean amount of 
TCA-insoluble activity in the medium during an individual yolk sac 
incubation (obtained by adding, to the measured TCA-insoluble activity 
remaining in each culture medium at the end of its incubation period, 
one half of the quantity of TCA-soluble activity generated by the yolk 
sac in the same period). Even for a rapidly ingested protein, the 
value of M* so generated will be correct, provided that the substrate 
depletion proceeds in a linear manner over the incubation period. 
However, from Figs. 4b and 4c, it can be seen that the Endocytic Index 
rises as the substrate concentration falls.hence a linear decrease in 
substrate concentration may not necessarily occur.
In order to determine whether the effects of either substrate 
depletion or decreased tissue viability in the absence of calf serum 
affected the calculated values of the Endocytic Index for individual 
sets of data, despite the use of a mean value of H* calculated as 
described above, Endocytic Indices were calculated both for the data 
from the initial (3.0 h) incubation period and from the full sets of 
data relating to 5.0 h incubations. Either a fall in substrate con­
centration or an impairment of tissue function would be expected to 
be less over a 3.0 h incubation period than over a 5.0 h incubation 
period. Hence any substantial effect from either source would lead 
to deviation from a linear pattern of depletion and result in a
significant difference between these pairs of values for the Endocytic 
Index in a given experiment.
- 59 -
The results shown in Tables 4.Ilia and 4.IIIb (and again 
graphically in Fig. 4b) show no significant difference between each pair 
of values for the Endocytic Index derived using first the full set of 
data relating to a 5.0 h incubation period, then only those data, 
from the same experiment, that had been gathered in the initial 3 .0 h 
period. This finding implies that although the Endocytic Index might 
be expected to rise during the course of an experiment as a result of 
rapid substrate depletion, the net effect appears not to differ from 
that expected from a linear depletion with time. Hence the values 
derived from full, 5.0 h, sets of data were routinely analysed.
4.9 Kinetic Analysis
The general equation for the interaction of an enzyme, E, with 
its substrate, S, to give products, P, is:
E + S + P 4.1a
By restricting the analysis to the initial events only, the effect of 
the back reaction can be ignored and equation 4 .1 a simplifies to:
E s L E.S.
k3
E + P 4 ,IIa
The initial rate of formation of products, V, is given by
V = k3[E.S ] 4.Ilia
As the substrate concentration is increased saturation of the 
available enzyme occurs and 4.Ilia becomes:
V-nar ■ k3 tE ’l 4,IVa
where E' is the total concentration of both free and bound entyme. 
Uaing the above equations, Michaelis and Menten derived their wetl knowl 
relation between the observed reaction rate, V, at a particular 
substrate concentration, and the maximum rate of reaction, V for
a given amount of enzyme.
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1
V
Km
max
1
[S] + ±V 4.Vamax
From this equation it can be seen that a plot of ~  versus
V if IS 1K. 1 _J(Lineweaver Burk) gives a straight line with a gradient of —  and
1 maxand an intercept of —  on the ordinate axis.
max
From a kinetic standpoint, the binding of a macromolecular 
substrate to a binding site on the plasma membrane prior to inter­
nalization may be regarded as being analogous to the binding of an ' 
enzyme to its substrate. Internalization of the binding site-substrate 
complex is equivalent to formation of product in enzyme kinetics.
Thus, if uptake of a substrate occurs solely by its prior adsorption 
to the plasma membrane (i.e. no ingestion via the fluid phase), an 
equation similar to that describing the interaction of an enzyme and 
substrate to give products (4.1a) may be stated as:
" 1 j
R + s R.S i R.p
2 k4 4.1b
Where R and S are cell surface receptor and substrate concentrations 
respectively, R.S the receptor substrate complex and R.P the receptor 
substrate complex that has been internalized by pinocytosis.
Restricting the.study to systems where the rate of exocytosis 
of substrate is zero then the 'back reaction' can be ignored and 
4 .1 1 a becomes:
R + s i R.S k2 R.P 4.11b
From this equation the rate of internalization by adsorption to 
the membrane, q, is given as:
k3.M [R.S] 4.II
where M is the rate of membrane internalization.
The rate of substrate internalization, „ i n  reach a maxis*
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value, Q^ax, when the substrate concentration increases to such a point 
that saturation of the cell surface binding sites occurs and the rate 
of uptake becomes independent of substrate concentration. Equation 
4 .Illb then becomes:
U  “ k 3 R '] A.IVb
where R* is the total concentration of binding sites, both free and 
occupied. Assuming the rate of membrane internalization is not 
altered on increasing the substrate concentration then k^.M will be 
a constant (k^) so that:
U  -  k3 t R’l
This equation is similar to equation 4.IVa. Likewise, an 
expression equivalent to 4.Vb is obtained which relates the observed 
rate of uptake, at a given substrate concentration, to the maximum 
rate of uptake CQmax)• i.e.:
K
i  ♦ i
i ’ U  ls' T
Hence, as in the case of enzyme kinetics, a plot of against
4.VIb
should yield a straight line with an intercept on the ordinate axis
K1 cof ■=■ and a gradient of
miax Tnax
198Gosselin (1966) showed that the uptake of colloidal [ Au]gold 
by the macrophage could be described by equation 4.VIb. Furthermore, 
in studying the clearance of foreign particles from the blood, 
(Normann, 1974a and b) obtained linear double reciprocal plots and 
also demonstrated competitive inhibition between different particles 
that had been administered together, intravenously. Both of these 
studies were concerned with the uptake of solutes by phagocytosis.
It was assumed that the particles adsorbed to the cell surface prior 
to ingestion; fluid phase ingestion was considered not to be relevant.
Uptake of proteins by the yolk sac is known to be by pinocytosis
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(Williams et al. 1975a, b) involving both fluid phase and adsorptive 
phase ingestion. This mode of uptake was previously discussed 
(Chapter 3 Section 3.12) in terms of the general formulation for 
Endocytosis proposed by Jacques (1969){
SRcQ = Fc + K+c 4.1c
(N.B. S in this equation does not represent substrate but the rate of 
ingestion of cell membrane)
A value for the rate of fluid ingestion, F, was derived from an 
investigation of the Endocytic Index of 1 2 5I-labelled PVP (see Chapter 
3) its mean value being 2.47 yl/h/mg protein in the absence of calf 
serum.
Rearranging equation 4,1c and letting q equal the rate of 
ingestion by the adsorptive phase then:
q = (Q - Fc) = K+c
hence, taking reciprocals and separating terms:
K
4.11c
1
q
__ I .  1
SR * c SR 4.IIIc
Equation 4.IIIc is of the same form as equations 4.Va and 4.VIb
and the Lineweaver-Burk plot should yield a straight line with an
1 , JL
Snax
intercept of —  (or ^  ) and slope of (or £
The Endocytic Index of a substrate is equal to the rate of solute 
uptake, Q, divided by its concentration (Chapter 3, Equation 3.IV)
Q
c 4.IVc
Hence, e, the contribution to the Endocytic Index made by adsorptive 
phase uptake is given by:
SR
K+ce = E - F
and substituting for E from 4.IVc and multiplying by c:
4.Vc
q = e.c. = Q - Fc 4. Vic
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Iteing equations 4.Vc and 4.Vic the adsorptive phase rate of uptake,
q (yg/h/mg protein), can be calculated.
Fig. 4a shows a plot of Endocytic Index of 1 2 5I-labelled PVP
127versus various concentrations of ^'i-labelled dBSA (medium 199 alone).
This plot clearly shows that there is no significant change in Endocytic 
125Index of I-labelled PVP on increasing the concentration of *22I-labelled
dBSA and supports the conclusion that the rate of fluid internalization
is neither stimulated nor inhibited by the presence of formaldehyde-
denatured albumins, hence the rate of fluid ingestion, F, can be
assigned the constant value of 2.47 yl/h/mg protein in both the
127presence and absence of I-labelled dBSA.
Using this value for the rate of fluid phase uptake (F) the 
Endocytic Index for adsorptive phase uptake, e (yl/h/mg protein), was 
calculated and hence q, the rate of uptake by adsorption. Table 4.VII 
shows the values of e and q obtained with 1 2 5I-labelled dBSA Batches 
IV and V; the values for ■- and ~  are also shown in this table. These 
data are presented in the form of a Lineweaver-Burk plot in Fig. 4d.
It should be noted, however, that the points derived from low 
substrate concentrations (1.5 yg/ml, Batch IV, 0.6 and 4.85 yg/ml,
Batch V) were not included in either related plot. This was because 
of the difficulty in achieving precise measurement of low substrate 
concentrations. The error m  measurement when expressed as a 
reciprocal number is large, whereas a similar error in a high con­
centration does not result in a significant error in the reciprocal. 
Furthermore, as a result of the high percentage change in the Endocytic 
Index with substrate concentration at low substrate concentrations 
(see above) the observed Endocytic Index may be difficult to determine 
precisely.
For these two reasons, points at low concentration were not 
included in the final plots. Fig. 4d shows the best straight line
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fitted to each set of points by linear regression analysis.
the slopes and intercepts of these plots values for Q (— •)inax SR
respectively, were calculated (see Table VIII).
From 
and K,
Table 4.1 The Endocytic Index of I-labelled PVP in the presence 
127of I-labelled dBSA (medium 199 alone)
Each row of table summarizes the uptake data from a single exper­
125
iment in which a number of 17.5-day rat yolk sacs, taken from a
single pregnant animal, were incubated separately at 37°C in medium 
125199 containing I-labelled PVP (2.0-5.0 yg/ml) and removed from
the medium at regular intervals up to 5.0 h.
125
1 I-PVP 
cone.
(yg/ml)
1 2 7I-dBSA
cone.
(yg/ml)
No. of 
yolk sacs
Endocytic
Index
(yl/h/mg
protein)
Corr. 
Coeff.
Intercept
(yl/mg
protein)
5.0 4.25 10 2 .1 0 0.954 +1 . 1 2
I f I f 10 2.98 0.961 +3.20
II II 9 2.24 0.925 +4.04
I f 42.5 10 1.43 0.968 +1.26
I f 11 9 2.33 0.975 +1.98
I f 11 10 2.50 0.96 +1.99
II 170.0 10 2.18 0.964 +1.60
I I II 10 2,53 0.985 +1.74
11 M 10 1.67 0.972 +1.15
Table 4.II Summary of the Endocytic Index of 
125I-labelled PVP in the presence of 
127I-labelled dBSA (medium 199 alone) 
Data presented in Table 4.1 are summarized together 
with those, from Table 3.V.
127^'i-dBSA
concentration
(yg/ml)
No. of 
experiments
Mean Endocytic 
Index + S.D. 
(yl/h/mg protein)
0 1 1 2.47 + 1.00
4.25 3 2.44 + 0.47
42.5 3 2.09 + 0.58
170.0 3 2.13 + 0.44
alone) but in the presence of different concentrations of 
127I-labelled dBSA; data for full 5.0 h incubation period 
Each row of the table summarizes the results of a separate experiment,
125Table 4,Ilia Endocytic Index of L-labelled dBSA (Batch V) (medium 199
as described in the caption to Table 4,1. In each experiment the
„ . ,125 concentration of I-labelled dBSA was 0. 6 yg/ml of medium.
1 2 7I-dBSA
cone.
(yg/ml)
TCA
solubles
( % )
No. of 
yolk 
sacs
Endocytic
Index
(yl/h/mg
protein)
Corr. 
Coeff.
Intercept
(yl/mg
protein)
Mean
tissue
activity
(yi/mg
protein)
0 2.98 10 407.4 0.984 + 0 .6 1 0 1 . 1
11 1.39 10 378.9 0.981 + 4.3 97.81
It 2.90 10 358.1 0.967 - 4.4 108.6
4.25 2.98 9 218.7 0.972 +119.8 64.7
11 1.39 10 370.2 0.981 - 70.6 90.8
11 1.40 8 269.0 0.930 + 8.4 76,1
II 2.90 10 255.5 0.973 + 44.2 80.1
V 8.5 1.40 9 209.8 0.980 + 61,5 52.1
11 1.40 9 190.8 0.960 +152.2 59.4
II 2.90 10 258.8 0.985 + 68.5 73.3
17.0 1.40 10 200.5 0.922 + 39.6 66.5
11 1.40 10 196.2 0.921 +139.8 62.6
11 2.90 10 226.6 0,957 - 70.8 57.7
11 2.98 10 167.6 0.935 - 62.7 35.9
42.5 2.90 10 122.3 0.951 + 32.8 60.58
11 2.90 10 237.9 0.962 p» 8.9 59.5
II 2.98 8 184.9 0.989 - 0.5 39.0
85.0 2.98 7 107.8 0.967 72.4 2 1 . 2
II 1.40 9 153.1 0.991 + 26.0 36.6
11 2.90 10 123,7 0.948 + 54.1 33.8
127.5 1.39 10 56.7 0.922 + 18,0 16.5
11 1.14 9 82,9 0.977 + 0.3 2 2 .8
11 1.40 9 59.9 0.926 + 78,9 16.1
11 2.90 10 115.0 0.916 - 10.9 27.4
170.0 1.39
2.90
2.90
8
9
9
72.1
121.9
96.5
0.946
0.960
0.974
+ 19.9 
- 25.3 
+ 26.7
21.8
23.7
25.7
alone) but in the presence of different concentrations of 
127I-labelled dBSA; analysis of data restricted to those 
from the first 3.0 h of incubation only 
Each row of the table summarizes the data from an experiment, as described 
in the caption to Table 4.1. In each experiment the concentration of 
l^i-iabelled dBSA was 0.6 yg/ml of medium.
125Table 4.IIIb Endocytic Index of____I-labelled dBSA (Batch V) (medium 199
127I-dBSA 
cone .  
(yg/ml)
TCA
solubles
(%)
No. of 
yolk 
sacs
Endocytic
Index
(yl/h/mg
protein)
Corr .  
Coeff .
Intercept
(yl/mg
protein)
0 2.98 6 420.9 0.995 - 38.7
I t 1.39 6 403.4 0.963 - 70.0
I t 2.90 6 388.2 0.956 - 54.0
4.25 2.98 6 231.1 0.939 +103.1
t t 1.39 6 348.1 0.983 - 33.6
f t 1.40 6 270.3 0.866 + 54.6
t t 2.90 6 335.5 0.996 - 81.9
8.5 1.40 6 205.8 0.967 + 66.9
t t 1.40 6 229.7 0.955 +102.3
t t 2.90 6 274.5 0.983 + 44.7
t t 1.39 6 197.9 0.965 + 43.5
17.0 1.40 6 298.5 0.990 - 18.0
I f 1.40 6 287.5 0.978 +  10.8
I t 2.90 6 131.8 0.937 + 72.2
I t 2.98 6 116.3 0.987 30.9
42.5 1.40 5 140.3 0.994 - 6.0
t t 2.90 6 147.7 0.891 - 6.6
t t 2.90 6 252.6 0.953 - 34.9
85.0 2.98 6 102.8 0.946 - 62.7
t t 1.40 6 172.7 0.991 +  3.1
t t 1.40 6 168.7 0.998 + 34.2
I t 2.90 6 170.4 0.990 - 18.5
127.5 1.39 6 59.8 0.972 + 20.8
I t 1.14 6 92.9 0.960 + 74.6
t t 1.40 6 86.7 0.946 + 35.3
t t 2.90 6 134.0 0.991 - 31.7
170.0 1.39 6 73.9 0.910 - 16.5
t t 2.90 6 89.1 0.937 + 23.3
t t 2.90 6 118.9 0.979 - 13.7
127in medium 199 alone but in the presence of I-labelled dBSA 
Summary of data presented in Table 4.Ilia and 4.IIIb.
125Table 4.IV Summary of the Endocytic Indices of I-labelled dBSA (Batch V)
Analysed as 3.0 h incubations Analysed as 5.0 h incubations
127I-dBSA
concentra­
tion
(yg/ml)
No. of 
experi­
ments 
analysed
Mean (+ S.D.) 
Endocytic Index 
(yl/h/mg 
protein)
No. of 
experi­
ments 
analysed
Mean (hk S.D.) 
Endocytic Index 
(yl/h/mg 
protein)
Overall mean (+ 
S.D.) tissue ~  
radioactivity 
(yl/mg protein)
0 3 404.2 + 16.4 3 381.5 + 24.8 102.5 + 5.5
4.25 3 304.9 + 64.2 4 278.4 + 64.8 77.9 + 10.8
8.5 4 227.0 + 34.5 4 214.7 + 30.7 61.6 + 10.8
17.0 4 208.3 + 97.8 4 197.7 + 24.2 55.7 + 13.7
42.5 3 180.2 + 62.8 4 171.3 + 51.6 53.0 + 12.2
85.0 4 153 + 33.9 4 138.3 + 27.6 30.5 + 8.2
127.5 4 93.4 + 30.6 4 78.6 + 26.9 20.7 + 5.4
170.0 3 94.0 + 23.0 3 96.8 + 24.9 23.7 + 2.0
Table 4.V The effect of increasing the concentration of I-labelled dBSA 
(Batch IV) in the medium on the Endocytic Index of 
125I-labelled dBSA (Batch IV)
Each row of the table summarizes the data relating to a separate experiment, 
as described in the caption to Table 4.1.
125
125I-dBSA
cone.
(yg/ml)
No. of 
yolk 
sacs
Endocytic
Index
(yl/mg
protein)
Corr. 
Coeff.
Intercept
(yl/mg
protein)
TCA
solubles
(%)
Mean tissue 
activity 
(yl/mg 
protein)
1.5 10 223.7 0.974 +15.8 3.1 86.4
11 10 228.6 0.948 +33.1 1.4 75.5
IT 9 236.6 0.940 +95.3 1.4. 85.9
II 9 230.3 0.954 +47.7 3.1 70.7
7.68 9 156.0 0.955 +58.7 0.85 64.5
11 9 158.8 0.938 +53.0 2.32 62.0
II 10 193.6 0.931 +45.5 1.4 73.0
II 10 193.5 0.956 -25.5 3.1 71.6
38.4 1° 131.9 0.969 +  3.5 2.32 41.7
11 8 128.7 0.993 +35.0 0.85 42.2
11 10 115.3 0.989 +20.0 3.1 34.8
It 10 162.1 0.961 +  2.7 1.4 54.3
76.8 9 76.2 0.969 +45.9 3.1 26.7
II 10 121.5 0.967 - 9.3 3.1 42.3
II 8 116.9 0.994 -14.8 3.1 35.8
I-iabelled dBSA
(Batch IV) concentration on the Endocytic Index of 
125JI-labelled dBSA (Batch IV)
Summary of data presented in Table 4.V.
Table 4.VI Summary of the effect of increasing
125I-dBSA
concentration
(yg/ml)
No. of 
experiments
Mean + S.D. 
Endocytic Index 
(yl/h/mg protein)
Overall mean tissue 
radioactivity (+ S.D.) 
(yl/mg proteTn)
1.5 4 229.8 + 5.3 79.6 + 7.8
7.68 4 175.5 + 20.9 67.8+5.4
38.4 4 134.5 + 19.8 43.3 + 8.1
76.8 3 104.7 + 24.9 34.9 + 7.8
125Table 4.VII Data for double reciprocal plot for I-labelled dBSA 
(Batch IV)
The data in this Table were derived from Table 4.VI.
125I-dBSA
cone.
(yg/ml)
i x  102C
(yg/ml)
Endocytic
Index
(yl/h/mg protein)
Rate of uptake 
q x 10^
(yg/h/mg protein)
_1
q
(yg/h/mg protein)
1.5 66.7 229.8 341.0 2.933
7.68 13.0 175.5 1328.6 0.726
38.4 2.6 134.5 5068.8 0.197
76.8 1.3 104.7 7849.0 0.127
. 125Table 4.VIII Data for double reciprocal plot for I-labelled dBSA 
(Batch V)
The data in this table were derived from Table 4.IV.
Total
dBSA
cone.
(yg/ml)
1 in2 —  x 10c
(yg/ml)
Endocytic
Index
(yl/h/mg protein)
Rate of uptake
(q x 103) 
(yg/h/mg protein)
_1
q
(yg/h/mg protein)
0.6 166.7 381.5 227.4 4.40
4.85 20.62 278.4 1338.1 0.747
9.1 11.00 224.1 2016.7 0.496
17.6 5.68 197.7 3435.5 0.291
43.1 2.32 171.3 7275.3 0.138
85.6 1.12 138.3 11624.5 0.086
128.1 0.78 78.6 9748.4 0.103
170.6 0.59 96.8 16087.6 0.062
125Table 4.IX Calculated values for (SR) and K for I-labelled dBSA
Values calculated from the gradients and intercepts from Fig. 4d using a
125molecular weight of 65,000 for I-labelled dBSA.
Batch IV Batch V
< W  CSR)
16.05 yg/h/mg protein 
0.247 n moles/h/mg protein
20.19 yg/h/mg protein 
0.311 n moles/h/mg protein
K 81.97 yg/ml 
1.26 yM
82.56 yg/ml 
1.27 yM
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5.1 Introduction
In many mammalian species the fetus acquires passive immunity 
by transfer of IgG from the maternal to the fetal circulations; the 
route of transmission differs, however, from species to species. In 
man and the monkey, for example, transmission occurs before birth via 
the chorioallantoic placenta, whereas in the rabbit and guinea pig 
the yolk sac is instrumental in transmission (Wild, 1973), In other 
species such as the cow, pig, sheep, dog, rat and mouse, antibodies 
present in the colostrum or milk are adsorbed intact by the neonatal 
gut in the period immediately after birth (Halliday, 1955a, b). In 
the case of the rat, the major route of transfer has been shown to be 
post-natally via the gut, although pre-natal transmission has been shown 
by Brambell and Halliday (1956) and by Anderson (1959), These 
authors suggested that the pre-natal transport of IgG occurs by way 
of the visceral yolk sac, but this has been contested by Quinlivan 
(1964) who proposed that pre-natal transport in the rat occurs within 
the chorioallantoic placenta itself and not the yolk sac.
The precise mechanism of transcellular transport of IgG is not 
fully understood although two hypotheses have been proposed in relation 
to transport across the yolk sac of the rabbit. Brambell et al.
(1966) suggested that selection of IgG for transmission occurs as an 
intracellular event; the IgG enters the vacuolar system but in some 
way is protected from degradation by lysosomal enzymes. Wild (1975), 
on the other hand, proposed that transfer of immunoglobulins in the 
rabbit occurs via a special transport vesicle which selectively 
ingests IgG then traverses the cell avoiding fusion with lysosomes 
(see Chapter 6, Section 6.1 for further detail).
Essentially all the investigations of the uptake and transport of 
IgG in the rabbit and rat have been performed jri vivo. (Although 
Bamford (1966) studied the transmission of IgG across neonatal rat
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gut sacs cultured in vitro). Thus, using in vivo techniques,
Hemmings (1957) found that some 12% of an intrauterine dose of homo­
logous IgG was transported across the yolk sac of the rabbit. Further 
studies by Batty et al. (1954) showed that in the rabbit most members 
of a series of heterologous IgG molecules were less readily tran­
sported than rabbit IgG itself in the order: rabbit *. man > guinea pig 
> dog > horse > cow. Sonda and Schlomowitz (1972) also showed that 
the transmission of homologous IgG across the rabbit yolk sac in vivo 
to be independent of the concentration of rabbit serum albumin when 
both substrates were injected into the uterus together. These results 
demonstrate the selective nature of the transmission of immunoglobulins 
across cellular barriers with a marked preference for transport of the 
homologous immunoglobulin.
At the molecular level, the determinant for selection for tran­
smission of IgG has been shown to reside in one specific region of the 
IgG molecule (Stanworth and Stewart, 1976). The IgG molecule (see 
Fig. 5n) consists of four polypeptide chains: two heavy chains 
(mol. wt. 50-75,000) each linked, by a number of disulphide bridges, 
to a light chain (mol, wt. 20-24,000); these chains can be separated 
by reducing the disulphide bonds. Digestion of the molecule with 
papain (Porter, 1959) results in cleavage across the heavy chains to 
give three fragments of similar size: an Fc region and two identical 
Fab fragments, while treatment with pepsin destroys the Fc region 
resulting in a divalent F(ab')2 piece which retains antibody-binding 
activity.
The relative amounts of these fragments transported by the rabbit
yolk sac in vivo were investigated by Brambell et al. (1959, i960)
Their findings showed the Fc region to be transmitted almost as 
readily as the intact molecule, whereas the Fab and F(ab') fragments 
showed little or no transmission. Kaplan et al. (1965) by reducing
- 67 -
the disulphide bonds were able to show the heavy (H-chain) to retain 
the properties essential for transmission across the rabbit yolk sac 
but the Light (L-chain) showed little transmission. Furthermore, 
Morris (1963) found the Fc piece (administered to neonatal rat gut 
simultaneously with IgG) interfered with the uptake of IgG, whereas 
the Fab piece showed no interference at all when similarly administered. 
These findings are consistent with the existence of a specific
recognition site on the IgG molecule within the Fc region which allows 
its transmission across the yolk sac.
In recent work Wild and Dawson (1977) have been able to demonstrate
the presence of IgG specific receptors on the rabbit yolk sac. The
technique was based on the method of Elson et al. (1975) in which a
red blood-cell: antibody complex was presented to isolated rabbit yolk
sac cells with the result that the complex binds to the yolk-sac
epithelial cells, forming easily identified rosettes. Removal of
the Fc region^of^the^antibody^resulted in loss of rosette formation.
Other studies by/Schlamowitz/also demonstrated the binding of 
125 125I-labelled IgG and I-labelled rabbit serum albumin to 
formaldehyde-fixed rabbit yolk sac sections and that once membrane- 
bound, the IgG could not be displaced by rabbit serum albumin. These 
findings further support the conclusion that the sites to which IgG 
becomes bound are specific and it is proposed that, in the rabbit 
yolk sac at least, these binding sites are essential for transmission.
In the rat yolk sac, however, no similar evidence for the 
existence of IgG specific receptors has been obtained. In the 
previous chapter the pinocytic uptake of 125I-labelled dBSA was 
investigated and a quantitative assessment of the fraction taken up 
by a route that involved plasma membrane binding was established.
Further analysis of these data enabled the kinetic parameters relating 
to these albumin-binding sites to be calculated. The present chapter
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125reports a study of the rate of uptake of I-labelled IgG by the rat 
yolk sac in the presence and absence of calf serum. Competition 
studies were also performed using non-radioactive, I-iodinated
dBSA in order to determine whether IgG-specific receptors were 
present on the rat yolk sac. Furthermore, a modified method of 
Williams et al. (1975a), for the study of the in vitro release of 
ingested substrates, was employed to follow any release of IgG (a 
phenomenon compatible with the existence of a route for the transmission 
of IgG across the rat yolk sac _in vivo).
It was hoped that the use of these jin vitro techniques with the 
rat yolk sac would enable more conclusive data to emerge on the 
question of the possible uptake and transmission of immunoglobulins 
across the visceral yolk sac of the rat in vivo.
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METHODS
5,2 -UP B ke. of homologous 125I-labelled IgG by 17.5-day rat yolk sacs
incubated in the presence and absence of calf serum
125The rates of uptake of ^-labelled rat IgG (see Chapter 2 for 
preparation) by 17.5-day rat yolk sacs, cultured in either medium 199 
alone or medium 199 containing calf serum (10%, v/v), were determined 
by the methods previously described (Sections 2.3 and 2.10). A 
concentration of 1.0 pg of radiotracer/ml of culture medium was 
employed in all experiments and yolk sacs were removed at regular 
intervals up to 6.5 h for incubations in the presence of calf serum 
and up to 5.0 h for incubations in the absence of calf serum. The 
protein content of each yolk sac was determined (see 2,5) and the 
quantity of 'total radioactivity' present in the yolk sac and the 
quantity of 'acid soluble radioactivity’ in the medium were assayed 
as described in Section 2.4 and 2.6, respectively.
From each set of data, a plot of uptake of substrate (in pl/mg 
protein) against time enabled the related Endocytic Index to be cal­
culated (see Section 2.13).
127^•3 Effect of----I-iodinated dBSA on the uptake of ~^2~*l-labelled IgG
by 17.5-day yolk sacs incubated in medium 199 along 
In Chapter 4 it was demonstrated that competition occurred between 
125I-labelled dBSA (Batch V) and 127I-iodinated dBSA when simul­
taneously ingested by 17.5-day yolk sacs incubated in the absence of 
calf serum (see Section 4.6). In order to determine whether a
similar competitive effect could be observed when using 125I-labelled
125IgG as substrate in place of I-labelled dBSA, yolk sacs were 
125incubated with I-labelled IgG (Batch I, concentration of 1,0 ng/m 
of medium) and with I-iodinated dBSA (concentrations of 0 , 42.5 
and 170.0 pg/ml of medium). Again individual yolk sacs were removed 
at regular intervals up to 5.0 h and their radioactivity and protein
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contents determined as described in Sections 2.4 and 2.5. The medium 
•total radioactivity' and »acid soluble radioactivity» were assayed 
by the methods described in Sections 2.6 and 2.7, respectively.
1255-4 Release of I-labelled IgG from 17.5-dav rat yolk sacs re­
incubated in the absence of calf serum
17.5-day yolk sacs were incubated in medium 199 alone (10.0 ml) 
125containing I-labelled IgG (Batch I) at a concentration of 5.0 yg/ml 
(see Section 2.17 for method). After 2 h incubation the yolk sacs 
were removed from their flasks and washed in warm (37°C), gassed 
medium 199 before being re-incubated for 3.0 h in fresh medium 199 
(10.0 ml) containing no radiotracer. The quantities of 'total-' 
and 'acid soluble radioactivity' released by the re-incubated tissue 
up to a given time were calculated using equation 2.VIII (Chapter 2) 
then expressed as a percentage of the 'total radioactivity' associated 
with the yolk sac when transferred to the culture flask at the 
beginning of the re-incubation period. The percentage of 'acid 
insoluble radioactivity' released was obtained by subtracting the 
released 'acid soluble radioactivity' from the corresponding value for 
the released 'total radioactivity' at each time interval.
1255-5 ^ ± s± S l ----I-labelled IgG from 17.5-day yolk sacs re-incubated
in the presence and absence of native IgG in the culture medium
In an attempt to determine whether the release of 'acid insoluble
radioactivity’ by a yolk sac on re-incubation was a result of
desorption from the tissue surface rather than true exocytosis, the
experiment described above (5.4) was repeated but with native IgG
present in the re-incubation medium. Since a different batch of 
125I-labelled IgG was used, experiment 5.4 was also repeated as a 
necessary control.
Three yolk sacs, each taken from a different animal, were 
incubated in the same flask containing 125I-labelled IgG (Batch III
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5.0 yg/ml) for 2.0 h then washed (see Section 2.17) and re-incubated 
at 37°C in separate flasks containing medium 199 alone, In a second 
series of experiments, a further 3 yolk sacs, taken from the same 
animals, were similarly incubated with I-labelled IgG (Batch III,
5.0 yg/ml), washed as above but using medium 199 containing 10 yg/ml 
of unlabelled rat IgG, before re-incubation in medium 199 alone. 
Finally, another three yolk sacs from the same animals were incubated 
and washed as in the second series above, but on re-incubation the 
medium also contained unlabelled-IgG at a concentration of 5.0 yg/ml.
The release data were expressed in the same manner as described 
in detail in Section 2.17 of Chapter 2.
5.6 Effect of temperature on the rates of release of radioactivity
from yolk sacs previously incubated with either ^2^1-labelled 
125IgG or I-labelled dBSA
The effect of lowering the re-incubation temperature on the rate 
125of release of I-labelled IgG (Batch III) from a 17.5-day rat yolk 
sac, following its ingestion, was investigated using re-incubation 
temperatures of 21°C and 4,5°C. The experimental regime was the 
same as that described in Section 5.4 except that during the washing 
procedure the temperature of the medium was reduced to below 37°C 
and the yolk sacs re-incubated at the lower temperature.
The results shown in Tables 5.VIIId and e are for re-incubation 
temperatures of 2l°C and 4.5°C, respectively. The quantities of the 
three species of released radioactivity, each expressed as a percentage 
of the total radioactivity associated with the tissue at the start 
of re-incubation, were plotted against time for each of the lower 
temperature experiments.
For comparative purposes, the rates of release of 125I-labelled 
125PVP and I-labelled dBSA (Batch VI) at the same three temperatures 
were also investigated in equivalent experiments.
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5.7 Chromatography of the radioactive species released from 17.5-day
. . 125yolk sacs when re-incubated after ingesting I-labelled IgG
Three 17.5-day rat yolk sacs, each from a different animal, were
incubated together in a single flask for 2,0 h in medium 199 (10.0 ml)
125containing 5.0 pg/ml of I-labelled IgG (Batch III). The yolk 
sacs were then removed, washed in warm medium 199 and re-incubated 
together in 10.0 ml of fresh medium. After incubation at 37°C for
3.0 h the yolk sacs were discarded, the remaining medium was cen­
trifuged at 1000 g for 10 min to remove any detached cells and the 
supernatant was then deep-frozen until assayed.
The radioactivity released into the medium was analysed by gel 
filtration using both Sephadex G-25 and G-150 with 0.05M-phosphate 
buffered saline (pH 5.0) as elutant. A sample of the centrifuged 
medium (2.0 ml) was applied to a column (57 x 1.5 cm) of Sephadex G-25 
and eluted at 4°C at a flow rate of 0.4 ml/min. Fractions (2.0 ml) 
were collected and assayed for their contained radioactivity. An 
identical 2.0 ml sample of the re-incubation medium was applied to 
a column (57 x 1.5 cm) of Sephadex G-150, Again 2.0 ml fractions 
were collected but using a slower elution rate (0.2 ml/min). To 
both columns samples of 125I-labelled IgG (Batch III, [ 12^I]iodide,
[ 125I]iodo-L-tyrosine and glycyl [ 125I]iodo-L-tyrosine were also 
applied to establish their relative elution positions. The void 
volume (VQ) of each column was estimated with Blue Dextran.
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RESULTS
5.8 Endocytic Index of I-labelled IgG in the absence and presence 
of calf serum
Figs. 5a and 5b show representative uptake plots for ^I-labelled 
IgG (Batch III), in the presence and absence of calf serum respectively, 
together with the corresponding quantity of radioactivity associated 
with the tissue at each time interval. As with I-labelled dBSA 
(Fig. 5c), the plots of total uptake (T+S) were substantially linear, 
enabling the rate of uptake to be expressed as an Endocytic Index.
The results of a number of experiments in which the rates of 
uptake of several different batches of I-labelled IgG were deter­
mined in the absence and presence of calf serum are shown in Tables 5.1 
and 5.II respectively. These same results are summarized in Tables
5.Ill and 5.IV, respectively for ease of comparison. With each 
125batch of I-labelled IgG, the removal of calf serum from the 
culture medium resulted in a large increase in the observed Endocytic 
Index. Relative to corresponding experiments in the presence of 
calf serum Batches I - III showed increases of: 10.4-, 7.0- and 
7.2-fold in the Endocytic Index of I-labelled IgG on removing calf
serum from the medium. The increases were higher than those observed 
125with I-labelled dBSA which, under the same conditions, showed 
corresponding increases of 3.7- and 5.5-fold in the Endocytic Index 
of Batches III and V, respectively (see Chapter 3).
It should be noted that in most experiments in which 12^I-labelled 
IgG was ingested in the presence of calf serum, a marked tendency for 
a progressive rise in the amount of radioactivity associated with the 
tissue was shown (Table 5.Ill) but no such accumulation was observed 
in corresponding incubations in which calf serum was absent from 
the culture medium (Table 5.IV). In both types of incubation the 
value of the mean quantity of tissue-associated radioactivity was
125
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calculated by taking the mean of all values after the initial 2 0 h
of incubation, whether or not accumulation of radiotracer occurred.
The results also indicate that, on removing calf serum from the
medium, the quantity of tissue-associated radioactivity shows a marked
increase relative to that in the presence of calf serum. This is a
similar effect to that observed in corresponding experiments with 
125I-labelled dBSA (see Chapter 3). Tables 5.Ill and 5.IV show
values of the overall mean value of the tissue-associated radioactivity
125for each batch of I-labelled IgG in the presence and absence of 
calf serum, respectively. Taking Batch III as a typical example: 
a 4.55-fold increase in the amount of radioactivity associated with 
the tissue is observed on removing the calf serum from the culture 
medium, somewhat less than the corresponding increase in Endocytic 
Index (7.2-fold).
1255*9 -Etriocytic Index of____I-labelled IgG in the presence and absent
127 'of I-iodmated dBSA in medium 199 alone
In order to determine whether the binding sites on the plasma
membrane, responsible for the high rate of ingestion of 125I-labelled
IgG, were specific or non-specific in character, the effect of 
127I-iodinated dBSA on the rate of uptake of 125I-labelled IgG was 
studied in medium 199 alone, to avoid additional competitive effects 
from calf serum proteins.
Values of the Endocytic Index of 125I-labelled IgG (Batch I) in 
the presence of increasing concentrations of 127I-iodinated dBSA 
(0.0, 42.5, 170.0 pg/ml of culture medium) are shown in Table 5.V 
and summarized in Table 5.VI. Also shown in Table 5.V is the mean 
quantity of tissue-associated radioactivity (yl/mg protein) calculated 
for the period 2.0 h - 5.0 h for each set of data; these values are 
summarized in Table 5.VI under the heading of overall mean value of 
tissue-associated radioactivity.
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The value quoted in Table 5.VI for the mean Endocytic Index of
12S 197I-labelled IgG (Batch I) at 0.0 yg/ml of I-iodinated dBSA is
the same as that reported in Table 5.IV,but has been stated again to
aid comparison. The summarized data of Table 5.VI are shown graphically
in Fig. 5d.
127The presence of I-iodinated dBSA at a concentration of 42.5
yg/ml in the culture medium resulted in a 38% fall in the Endocytic 
125Index of I-labelled IgG relative to the value when no competing
127proteins were present. Increasing the I-iodinated dBSA con­
centration further to 170.0 yg/ml did not result in any further fall 
in the Endocytic Index.
Determination of the overall mean value of the tissue-associated
radioactivity showed it to rise and fall in a similar manner to the
corresponding value of the Endocytic Index, although the fall in the
level of tissue-associated radioactivity caused by 42.5 yg/ml of 
127I-iodinated dBSA was approx. 30% less than the corresponding fall 
in Endocytic Index.
1255.10 Release of I-labelled IgG from 17.5-day yolk sacs re-incubated 
in the absence of calf serum
The release of radioactivity from 17.5-day yolk sacs after 
125ingestion of I-labelled IgG was investigated by the method described 
in Section 5.4 and the released radioactivity expressed as the per­
centage of the total radioactivity associated with the yolk sac when
transferred to the re-incubation flask.
. . 125Results obtained using I-labelled IgG (Batch I) as substrate 
and 3 different yolk sacs are shown in Table 5.VII. Plots of the
mean percentage release for the three classes of radioactivity 
(i.e. ’total’, ’acid soluble’, and ’acid insoluble’) are shown in Fig. 5e.
Inspection of Fig. 5e shows that after 3.0 h of re-incubation 
over 87% of the tissue-associated radioactivity was released into the
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incubation medium, moreover, almost 50% of this was in the form of
'acid insoluble' species. This is in striking contrast to the
results obtained using either 125I-labelled PVP or 125I-labelled dBSA
12S(Batch VIII) in place of I-labelled IgG (Batch I) (see Table 5.Xa
and Fig. 5h for release of 125I-labelled dBSA at 37°C). With 
125I-labelled dBSA as substrate only a small percentage (approx. 5.0%) 
of radiotracer was released as 'acid insoluble' species although the 
percentage of total radioactivity' released was similar,
1255 *U  M ^ a s e  of----I-labelled IgG from 17.5-day yolk sacs r p - i n ^ . w ^
in the presence of unlabelled IgG
The possibility that the above observation simply reflected
de-adsorption of 'acid insoluble' radioactivity adhering to the tissue-
surface, was investigated using the method described in Section 5.5.
Tables 5.Villa, b and c show values of the mean percentage release
which are also plotted together in Fig. 5f for ease of comparison.
For purposes of clarity, the associated standard deviation for each
point reported in these tables was not indicated in the plot.
125For I-labelled IgG (Batch III) the percentages of 'total 
radioactivity’ released on re-incubation (Fig. 5f) show no significant 
differences between those experiments in which unlabelled-IgG was 
present in either the washing or re-incubation media and those in 
which yolk sacs were washed and re-incubated in medium 199 alone.
The amount of radioactivity released by 3.0 h of re-incubation was 
approx. 87% of the total tissue-associated radioactivity. Similarly, 
the percentages of 'acid soluble' and 'acid insoluble radioactivity' 
released show no significant differences between each type of experiment
5‘12 Please of 125I-labelled IgG, 125I-labelled PVP and 125I-lahPn  
dBSA frpm_17_.5-day yolk sacs re-incubated at lower r _
The effects of lowering the re-incubation temperature (from 37°C 
to either 21°C or 4.5°C) on the pattern of release of radio-labelled
- 77 -
125species from I-labelled IgG-laden yolk sacs are shown in Tables
5.IXa and b, respectively as well as in Fig. 5g. For purposes of
comparison, Fig. 5h and Tables 5.Xa, b and c show the rates of release
125of radioactive species derived from I-labelled dBSA in similar
experiments at these same three temperatures.
125In the case of I—labelled IgG, lowering the temperature from 
37°C to 21°C caused the amount of ingested radiotracer released over 
a 3.0 h period to fall from approx. 85% to less than 50%. Lowering 
the temperature further, to 4.5°C, resulted in an even slower release 
of 'total radioactivity', only about 21% over the same period. The 
amount of 'acid insoluble radioactivity' released is also shown in 
Fig. 5g. At 37°C a maximum of just over 40% of the 'total radio­
activity' released was found to be 'acid insoluble' and lowering the 
temperature caused the 'acid insoluble radioactivity' released to drop
in proportion to the observed fall in 'total radioactivity' released.
125Fig. 5h shows the release of I-labelled dBSA digestion 
products at three different temperatures, these experiments were 
performed in parallel with others in which the release of ^^I-labelled 
IgG digestion products was followed. At 37°C the amount of 'total 
radioactivity' released by 3.0 h was somewhat lower than in the corr­
esponding experiments with 125I-labelled IgG. For 125I-labelled 
dBSA the maximum release was approx. 63% compared to over 85% for 
125I-labelled IgG. However, at 21°C and 4.5°C the amount of ’total
radioactivity' released were found to be virtually identical with 
125those for "l-labelled IgG.
125With I-labelled dBSA, the amount of 'acid insoluble radio­
activity' released does not show any significant variation with 
temperature. It should be noted that after 50 min the release of 
'acid insoluble radioactivity' is almost complete and amounts to only 
between 5 and 12% of the 'total radioactivity'.
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The pattern of release of 'acid insoluble radioactivity' at
IOC4.5°C after ingestion of ’’i-labelled IgG was virtually identical
125to that after ingestion of I-labelled dBSA; at 50 min the amount 
released was again between 5 and 12% of the 'total radioactivity'.
On the other hand higher temperatures would appear to facilitate the 
progressive release of 'acid insoluble radioactivity' derived from 
this substrate.
1255.13 Chromatography of the digestion products of I-labelled IgG 
125and I-labelled dBSA released from 17.5-day rat yolk sacs
The size of the radioactive molecules released by 17.5-day rat
125yolk sacs that had previously ingested either I-labelled IgG or 
125I-labelled dBSA was investigated by gel chromatography on Sephadex
G-25 and G-150 (see Section 5.7 for methods).
Figs. 5j and 5k show the elution patterns obtained on Sephadex
125G-25. The total recovery for I-labelled IgG was calculated to
be 88.5% of the applied radioactivity. Three main peaks were seen
to emerge, Peak A (36.7% of recovered activity) was present in the
125void-volume, where I-labelled IgG itself elutes, peak B (3,0%)
125was found in the same position as [ I]iodide and the major peak,
C (57.3%), eluted in a position corresponding to that where the
125 125markers [ I]iodo-L-tyrosine and glycyl [ I]-iodo-L-tyrosine both
125elute. The elution pattern for I-labelled dBSA showed three 
major components A, B and C corresponding to 10, 8.8, and 80.5% of 
the applied activity, respectively. The recovery of activity 
applied to the column was about 99.0%. The three peaks eluted in 
positions corresponding to 125I-labelled dBSA, 125I[iodide] and that 
where both glycyl[125I]iodo-L-tyrosine and [ 125I]iodo-L-tyrosine elute.
The elution patterns obtained using Sephadex G-150 were similar 
to those obtained on G-25, see Figs. 51 and 5m.
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DISCUSSION
The pattern of uptake of homologous 125I-labelled IgG by the
17.5~day rat yolk sac when incubated in medium containing calf serum
(10%, v/v) was similar to that observed with other substrates already
investigated (125I-labelled PVP and 125I-labelled dBSA) in that it
was linear with time up to at least 7.0 h, the correlation coefficients
of the individual uptake plots being in excess of 0.95 (see Table 5.1).
The associated Endocytic Indices varied little between different
batches of this substrate and fell within the range 6-13 pl/h/mg
protein (see Table 5.III). On comparing these values with the mean
Endocytic Index observed for I-labelled PVP, (Table 3.VI, Chapter
3) the overall rate of ingestion of 125I-labelled IgG can be seen to
be far greater but falls in the same range (8-150 pl/h/mg^f/piitein)
125as other I—labelled proteins ingested in the presence of calf
serum (see Moore et al., 1977; Livesey, G., unpublished data).
Therefore, unlike the uptake of either 125I-labelled PVP or [ 14C]sucrose 
(Chapter 3, Section 3.12), the uptake of 125I-labelled rat immuno­
globulins cannot occur solely by simple fluid phase ingestion into 
pinocytic vesicles and the major route must either involve prior 
attachment of the substrate to the plasma membrane before inter­
nalisation into such vesicles or occur largely by some additional, 
specific route available only to immunoglobulins.
On incubation with yolk sacs, a substantial portion of the 
125I-labelled IgG present in the medium was hydrolysed to give 
125I-labelled species that were soluble in trichloroacetic acid.
125Moreover, chromatography of these I-labelled acid soluble species
on Sephadex G-25 indicated that they consisted entirely of 
125[ I]iodo-L-tyrosine and small peptides containing [125I]iodo-L-
tyrosine. This pattern of hydrolysis is essentially the same as
125that observed with other I-labelled proteins, including 125I-labelled
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dBSA, and has been attributed to full catabolism of such proteins 
within the lysosomal system of the epithelial cells of the yolk sac 
(Moore &t_ al_., 1977).
Williams et al. (1975b) showed the high rate of uptake of
1 o c 125I-labelled dBSA, relative to that of I-labelled PVP, to arise
from adsorption of this protein to the plasma membrane. If high
125values for the rate of uptake of I-labelled IgG similarly result
125from the binding of I-labelled IgG to the plasma membrane, the
absence of any competing proteins would be expected to give an increase
125of the same type as observed with I-labelled dBSA when calf serum
is removed from the medium (see Chapter 3). Incubation of 
125I-labelled IgG with yolk sacs in the absence of calf serum indeed 
resulted in a 7- to 10-fold increase in Endocytic Index (Table 5.IV), 
as compared with a 3- to 6-fold increase observed with I-labelled 
dBSA (Table 3.VI). The greater percentage increase observed with
12 5I-labelled IgG is compatible with the suggestion that certain
components of calf serum, possibly immunoglobulins,are able to compete
125 125more effectively with I-labelled IgG than with I-labelled dBSA
for binding sites on the plasma membrane. This suggestion also gains
125support from the observation that I-labelled IgG, ingested by
yolk sacs incubated in serum-free medium 199 containing (non-radio- 
127active) I-iodinated dBSA at concentrations of up to 170 yg/ml of
medium, showed a maximum reduction in Endocytic Index of only approx.
40% (Fig. 5d) as opposed to a reduction of approx. 75% in the
125Endocytic Index of I-labelled dBSA xn equivalent experiments 
(see Section 4.6).
125Although the uptake of I-labelled IgG by 17.5-day rat yolk
125sacs resembled the uptake of I-labelled dBSA in the above respects,
in two others there were marked differences between the two proteins. 
125Firstly, I-labelled IgG was seen to accumulate progressively in
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the tissue at a significant rate when incubated for 6 h in medium 
containing 10% (v/v) calf serum (see Table 5.III). This is in sharp 
contrast to equivalent experiments with 125I-labelled dBSA as 
substrate. Secondly, following in vitro accumulation of 125I-labelled 
IgG by yolk sacs» re-incubation of the tissue in substrate-free medium 
led to a rapid release of radioactivity that was superficially 
similar to that observed for 125I-labelled dBSA, but in contrast 
approximately half of the radioactivity released was found to be 
acid-insoluble.
Furthermore, the progressive rise in the level of the tissue-
associated radioactivity (Fig. 5a) contrasts with the steady-state 
. 125level observed with I-labelled dBSA in either the presence or 
absence of calf serum. In the absence of calf serum, 125I-labelled 
IgG probably does not accumulate in the tissue in the same progressive 
manner (Fig. 5b) but even in this case the mean level of the tissue- 
associated radioactivity was abnormally high compared with that 
anticipated from an analysis of the rate of production of acid-solubles 
(Livesey, G., unpublished data). By this empirical method, the 
slope of the plot of acid-soluble radioactivity against time (line 
S of Fig. 5c) is multiplied by x, the horizontal separation of the 
parallel portions of the plots S and (T + S) in hours (see Fig. 5C) 
to give the tissue content expected from the observed rate of 
production of acid-solubles. In the case of 125I-labelled dBSA the 
agreement between the observed tissue level (97.5 yl/mg protein) and 
the calculated level (89.2 yl/mg protein) was close (9% underestimated). 
For a number of other protein substrates incubated with the 17.5-day 
yolk sacs a similar degree of agreement (i.e. within + 10%) was 
invariably found (Livesey, unpublished data). For 125I-labelled 
IgG, however, the calculated value of the tissue level (66.9 pl/mg 
protein) was some 25% less than the observed level, hence well outside
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the normal range of error.
The observation that, following in vitro accumulation of 
125I-labelled IgG by the yolk sac, re-incubation of the tissue in
substrate-free medium led to rapid release of radioactivity with
approx. 50% of the radioactivity returned to the re-incubation medium
at any instant being in the form of macromolecular IgG (Fig, 5e),
contrasts sharply with the pattern observed in equivalent experiments 
125with I-labelled dBSA (Fig. 5h) which showed no progressive loss of
equal amounts of acid-soluble and -insoluble activity. Thus, unlike 
125any other I-labelled protein investigated to date (Livesey, G.,
125unpublished data), I-labelled IgG alone shows release of a
significant quantity of the tissue-associated protein back into the
medium as acid-insoluble rather than acid-soluble species. On
Sephadex G-150 the acid-insoluble material released eluted in the 
125same position as I-labelled IgG itself hence can tentatively be
identified as such. This indicates that a portion of the ingested 
125I-labelled IgG somehow escapes hydrolysis within the lysosomal
system and can pass back out of the epithelial cells into the medium.
A possible explanation of the observed release of macromolecular 
125I-labelled IgG from re-incubated yolk sacs is that 125I-labelled
IgG simply binds strongly to regions of the tissue that are not
involved in pinocytic processes and desorbs only slowly, so does not
become detached during the 3 x 2 min washing procedure prior to
re-incubation in substrate-free medium. This explanation is rendered
unlikely by the observation of identical patterns of release when
tissue was either washed in the presence of unlabelled IgG before
re-incubation or both washed and re-incubated in the presence of
unlabelled IgG (Fig. 5f). Both procedures would be expected to
125favour the release of I-labelled IgG adsorbed to the tissue surface 
and modify the rate of release of macromolecular 125I-label during
- 83 -
the re-incubation period.
The rate of release of "i-labelled IgG at 37°C appeared to be
rapid, there being little further release beyond the initial 60 min
(Fig. 5g) by when some 35% of the tissue-associated radioactivity had
been released in an acid-insoluble form. This contrasts with a
release, under the same conditions, of only approximately 5% of the
tissue-associated radioactivity in the case of 125I-labelled PVP
(Fig. 7a) and of a similar quantity of acid-insoluble radioactivity 
125in the case of I-labelled dBSA. This 5% release may represent 
either a basal level of exocytosis by the tissue or result from 
leakage from the cells following cell death or represent release of 
that residual activity, occluded between the microvilli of the tissue, 
that is not removed in the washing procedure.
Exocytosis experiments, using yolk sacs laden with 125I-labelled
IgG and re-incubation temperatures below 37°C, showed the release of
both acid-soluble and acid-insoluble radioactivity to be equally
temperature sensitive (Fig. 5g) whereas equivalent experiments with 
125I-labelled dBSA showed only the release of acid-soluble material
to be temperature sensitive. These findings strongly suggest that
125the release of acid-insoluble JI-labelled IgG from the tissue 
cannot be attributed to release of protein occluded between the villi 
or from cell death hence the release almost certainly occurs by a 
process of physiological significance.
The observation of a high rate of exocytosis of 125I-labelled 
IgG from the yolk-sac tissue implies that the true rate of capture 
will be considerably in excess of that indicated by the observed 
Endocytic Index, since that portion of the protein that enters the 
tissue and returns to the medium again in a macromolecular form will 
make no detectable contribution to the observed rate of uptake. 
Unfortunately, the net flux of macromolecular IgG out of tissue
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cannot be calculated from the results of experiments of the type 
reported in Fig. 5e without a number of arbitrary assumptions being 
made (e.g. the amount of intact IgG lost by exocytosis during the 
6 min wash period).
Although a high rate of exocytosis prevents any exact comparison
125of the Endocytic Index of I-labelled IgG with those of other 
substrates, the striking qualitative differences observed with this 
protein are worthy of further discussion since they may well be of 
biological importance.
The rat is one of the species in which IgG is thought to be 
transmitted from the mother to the fetus partly across the yolk sac 
before birth but mainly via secretion in the milk and passage across 
the gut of the neonate during the first 21 days after birth, so that 
the pup gains passive immunity by two routes (Wild, 1973). From 
the experiments reported in this chapter, the fate of i-labelled 
rat IgG within the 17.5-day rat visceral yolk sac incubated in vitro 
is atypical when compared with that of all other 125I-labelled
proteins studied in the same system. The observation that half of
125the I-labelled IgG was completely hydrolysed to the level of 
amino acids, presumably upon entering the lysosomal system, while an 
equal quantity was released back into the culture medium without 
suffering any detectable hydrolysis, suggests that these two separate 
fates may reflect the existence of two distinct intracellular routes 
by which IgG is handled within the yolk-sac tissue. It is possible 
that the mechanism which enables the IgG to escape intact from the 
incubated tissue may be involved in the transfer of passive immunity 
across the yolk sac vivo.
It is informative to consider the possible fates of IgG within 
yolk-sac tissue in relation to the ultrastructure of the tissue 
(Fig. 5i). At 37°C the rate of release of intact I-labelled IgG
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was far higher (approx, 10% per hour over the period 0,5-1,5 h) as
opposed to a value of 1-2% over the same period for ^^I-labelled
dBSA, I-labelled PVP or colloidal [ ^^Aujgold (Roberts et al,, 1977),
It is conceivable that the observed high rate of release of intact
IgG could arise from IgG simply entering the same pinocytic vesicles
as used by other substrates. If the vesicles containing IgG remain
in the apical region of the epithelial cells, rather than migrate
rapidly towards the nuclear region to fuse with the lysosomal system,
and if the membrane of the vesicles containing IgG becomes modified
through the presence of IgG so that such vesicles are more prone to
fuse again with the microvillous face of the tissue, then the higher
rate of exocytosis of IgG over other substrates could be explained.
If such a mechanism did indeed operate then the IgG would be released
back into the medium from the same face of the tissue as involved in
its uptake. (Unfortunately the design of the above experiments does
not permit determination of the face of the tissue responsible for
the observed release but the design of an incisive experiment should
prove possible.) If, however, the IgG contained within pinocytic
vesicles wasreleased by fusion of the vesicles with a region of the
epithelial cell wall below the junction complex (Fig, 5i) it would
then need to traverse the full thickness of the tissue (some 25 u) to
reach the opposite face. If, in vivo, the major fate of the non-
degraded portion of the ingested ^I-labelled IgG was release into
the vitelline blood vessels followed by clearance from the vitelline
circulation, rather than penetration of the serosal basement membrane
to reach the exocoelom, then in vitro, where there is no circulation,
125it would be expected that the I-labelled acid-insoluble activity
would accumulate progressively in these stagnant vessels. The
observed progressive accumulation of activity in the tissue when yolk
125sacs were incubated with I-labelled IgG in the presence of 10%
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of the tissue to accumulate activity at a significant rate in similar
experiments performed in the absence of calf serum requires a separate
explanation. Possibly the endothelial cells of the vitelline
capillaries are sensitive to changes in the composition of the medium
and become more permeable or loosely associated in the absence of 
125serum, so that I-labelled IgG entering the vitelline capillaries 
can diffuse out again readily.
Clearly, further experiments are needed to eliminate some of
these possible explanations, but the above preliminary experiments
• 125indicate that the atypical fate of I-labelled IgG in the in vitro 
system is worthy of further investigation, since it may well be 
related to the mechanism of transfer of passive immunity in vivo.
The experiments, described in the following chapter, were designed 
to eliminate some of the possible explanations of the above results 
and to compare the indications from such experiments with established 
hypotheses for the transfer of passive immunity across tissue barriers.
(v/v) calf serum is compatible with this suggestion, but the failure
125Table 5.1 Endocytic Index of ¿-labelled IgG for 17.5-day rat yolk sacs cultured in vitro in medium 199 plus 10% (v/v) calf serum
Each row of data relate to a single experiment in which a number of yolk sacs taken from a 17.5-day pregnant animal were
125incubated separately at 37°C in medium 199 plus 10% (v/v) calf serum to which I-labelled IgG was added at a concentration of 
1.0 yg/ml of culture medium. Yolk sacs were removed at regular intervals up to 6.5 h.
Batch of 
125I-Igß
% TCA-solubles
in 125I-IgG 
preparation
No. of 
Yolk 
Sacs
Total Uptake Tissue Radioactivity
Endocytic Index 
(yl/h/mg protein)
Correlation
Coefficient
Intercept
(yl/mg/protein)
Mean Tissue 
Radioactivity 
(yl/mg protein)
Tissue Accum­
ulation Rate 
(yl/h/mg protein)
%Correlation
Coefficient
Batch I 1.54 10 5.62 0.968 + 3.16 10,59 1,41 0.937
11 11 1.54 9 4.00 0.983 +18,60 11.86 1.46 0.866
II II 1.54 9 9.18 0.975 + 0.57 19.23 3.46 0.986
Batch II 3.5 9 7.10 0.953 + 5.26 13.52 1,16 0.762
11 It 3.5 10 5.74 0.964 + 5.35 13.68 2.06 0.964
II 11 3.6 10 14.53 0.975 + 8.58 19.97 3.04 0.879
Batch III 1.79 10 15.83 0.955 - 7,24 21.71 4.38 0.892
11 11 1.43 10 11.71 0.984 + 4.90 16.46 2.05 0.898
II 11 1.50 10 14.28 0.980 - 3,03 17,90 2.92 0.978
11 11 2.60 10 11.67 0.951 + 6.00 23.30 3.06 0.953
A
Table 5.II Endocytic Index of I-labelled IgG for 17.5-day rat yolk sacs cultured in vitro in medium 199 alone
Each row of the table relate to single experiments as described in the caption to Table 5.1 except calf serum was omitted from
the culture medium, and yolk sacs were removed at regular intervals up to 5.0 h not 6.5 h.
125
Batch of 
125I-IgG
% TCA-solubles
in 125I-IgG 
preparation
No. of 
Yolk 
Sacs
Total Uptake Tissue Radioaçtivity
Endocytic Index 
(yl/h/mg protein)
Correlation
Coefficient
Intercept 
(yl/mg protein)
Mean Tissue 
Radioactivity 
(yl/mg protein)
Tissue Accum­
ulation Rate 
(yl/h/mg protein)
Corrélation
Coefficient
Batch I 1.54 8 39.97 0.954 + 82.20 78.36 4.08 0.483
tt VI 1.61 8 56.68 0.944 + 84,60 72,68 0.51 0.096
11 11 1.61 10 54.66 0.963 + 89,30 89.90 5.25 0.457
ft tv 1.61 10 57.21 0.932 + 53,21 70.48 2.89 0.290
ft IV 1.35 7 75.93 0.985 + 48,46 75.90 12,00 0.886
Batch II 3.0 10 71.90 0.935 +144,68 99,51 0.98 0.085
11 11 3.6 8 67.31 0.953 + 95.64 107,10 16,47 0.840
If 11 4.2 10 53.2 0.971 + 34,42 84.60 5.50 0.678
Batch III 1.5 10 107.78 0.982 + 26,22 112,38 15,27 0.816
11 11 1.79 10 76.61 0,977 + 15,67 96,98 10,42 0.805
11 11 2.60 10 105.7 0.956 + 42,89 83.62 1.17 0.117
Summary of the data presented in Table 5.1
125Table 5.Ill Summarized values of the Endocytic Index of I-labelled
IgG for 17»5-day rat yolk sacs cultured in vitro in medium
199 plus 10% (v/v) calf serum
Batch of 
125I-IgG
No. of 
Exper­
iments
Endocytic Index 
(yl/h/mg protein) 
Mean + S.D.
Tissue Radioactivity 
(yl/mg protein) 
Overall mean _+ S.D.
Tissue Accumul­
ation Rate 
(yl/h/mg protein) 
Mean + S.D.
Batch I 3 6.27 + 2,65 13.89 + 4.67 2.11 + 1.17
Batch II 3 9.12 + 4.73 15.72 + 3.68 2.09 + 0.94
Batch III 4 13.37 + 2.04 19.84 + 3.20 3.10 + 0.96
125Table 5.IV Summarized values of the Endocytic Index of I-labelled 
IgG for 17.5-day rat yolk sacs cultured in vitro in medium 
199 alone
Summary of data presented in Table 5.II
Batch of 
125I-IgG
No. of 
Exper­
iments
Endocytic Index 
(yl/h/mg protein) 
Mean +_ S.D.
Tissue Radioactivity 
(yl/mg protein) 
Overall mean + S.D.
Tissue Accumul­
ation Rate 
(yl/h/mg protein) 
Mean hh S.D.
Batch I 5 56.90 + 12.78 77.46 + 7.56 4.95 + 4.32
Batch II 3 64.13 + 9.74 97.07 + 11.45 7.65 + 7.97
Batch III 3 96.7 + 17.44 97.66 + 14.39 8.95 + 7.16
rTable 5.V Endocytic Index of I-labelled IgG (Batch I) for 17.5-day yolk sacs incubated in the presence of
127different concentrations of I-iodinated dBSA in medium 199 alone
127Each row of data refers to a single experiment performed in the absence of calf serum with I-labelled dBSA added 
(to the incubation medium) at different concentrations
125
1Z/I-dBSA
Concentrations
(yg/ml)
% TCA-solubles 
in 125I-IgG 
preparation
No. of 
yolk sacs
Endocytic Index 
(yl/h/mg protein)
Correlation
Coefficient
Intercept 
(yl/mg protein)
Mean Tissue 
Activity 
(yl/mg protein)
0 1.54 8 39.97 0.954 + 82.20 78.36
II 1.61 8 56.68 0.944 + 84.60 72.68
II 1.61 10 54.66 0.963 + 89.30 89.90
II 1.61 10 57.21 0.932 + 53.21 70.48
II 1.35 7 75.93 0.985 + 48.46 75.90
42.5 1.61 6 32.1 0.939 + 79.35 58.62
II 1.61 6 30.5 0.963 + 62.3 46.00
If 1.61 6 43.18 0.957 + 47.78 56.79
170.0 1.54 9 51.90 0.916 +102.65 79.19
II 1.61 9 33.55 0.927 + 39.11 51.26
VI 1.61 6 26.08 0.971 + 40.18 38.63
r125Table 5.VI Summarized values of the Endocytic Index of I-labelled IgG
(Batch I) in the presence of different concentrations of
127I--iodinated dBSA in medium 199 alone
Summary of data presented in Table 5.V
127I-dBSA
Concentration
(yg/ml)
No. of 
Experiments
Endocytic Index 
(yl/h/mg protein) 
Mean + S.D.
Tissue Radioactivity 
(yl/mg protein) 
Overall mean + S.D.
0 5 56.90 + 12.78 77.46 + 7.56
42.5 3 35.26 + 6.91 53.80 + 6.82
170.0 3 37.18 + 13.29 56.36 + 20.76
In the following tables (5.VII - 5.Xc, inclusive) each of the columns
of data represent mean values derived from three separate, 
experiments in each of which a single yolk sac, taken from 
animal, was used.
identical 
a different
Table 5.VII Release of radioactive species derived from
^I-labelled IgG (Batch I) by 17.5-day rat yolk 
sacs re-incubated in the absence of calf serum
Mean Percentage radioactivity released + S.D.
Time
(min) acid soluble acid :Insoluble total radioactivity
0 -1.0 + 2.6 -0.6 + 2.1 1.0 + 0.1
15 12.6 4.9 27.7 5.6 40.3 5.2
30 25.0 7.7 34.2 9.4 59.2 4.3
45 30.0 9.9 40.5 11.6 70.5 4.1
60 32.7 10.2 42.8 11.2 75.5 4.8
75 34.1 11.0 45.4 12.0 79.5 3.9
90 35.4 12.2 46.1 12.5 81.6 3.9
105 36.5 12.7 47.0 13.4 83.5 3.9
120 36.5 13.0 47.8 14.0 84.3 4.0
150 37.5 13.8 49.0 14.7 86.5 3.5
180 38.4 14.5 49.7 15.1 88.1 3.5
Table 5,Villa Release of radioactive species derived from 
125I-labelled IgG (Batch III) by 17.5-day rat 
yolk sacs re-incubated at 37°C in the absence of 
calf serum
Mean Percentage radioactivity released + S.D.
(min) acid soluble acid insoluble total radioactivity
0 0.2 + 0.3 0.5 + 0.8 0.7 + 1.1
5 7.5 2.8 10.1 2.5 17.7 ‘ 5.2
15 17.0 4.5 18.6 2.1 35.3 5.730 26.8 6.9 27.2 3.5 54.0 8.645 32.6 8.4 34.0 3.5 66.4 11.660 35.3 8.9 35.0 4.8 70.3 11.275 39.5 10.5 37.5 4.4 75.4 11.290 39.7 9.0 38.3 4.6 78.0 10.9120 42.2 9.2 39.8 4.4 82.2 10.2150 44.9 8.1 40.2 6.1 84.9 10.4180 44.9 8.7 42.4 5.4 87.3 10.1
Table 5.VIIIb Release of radioactive species derived from I- 
labelled IgG (Batch III) by 17.5-day rat yolk sacs 
re-incubated at 37°C in the absence of calf serum, 
after washing in medium 199 containing unlabelled 
rat IgG (10.0 yg/ml)
125
Time Mean Percentage radioactivity released + S.D.
(min) acid soluble acid insoluble total radioactivity
0 0.4 + 0.4 0.6 + 0.6 1.0 + 0.9
5 7.9 3.6 8.0 1.2 15.9 4.6
15 17.7 6.8 16.3 1.3 34.0 5.5
30 28.7 9.8 23.5 1.8 52.2 8.3
45 34.6 11.6 27.9 3.2 62.4 9.1
60 38.1 12.2 30.5 3.6 68.6 9.5
75 41.1 12.8 32.0 4.3 73.0 9.7
90 43.1 13.3 33.7 5.6 76.8 9.4
120 45.3 13.4 35.2 6.3 80.4 8.8
150 47.6 14.0 36.2 7.3 83.7 8.8
180 49.1 14.5 36.9 7.6 86.0 9.7
Table 5.Ville Release of radioactive species derived from ^^I-
labelled IgG (Batch III) by 17 .5-day rat yolk sacs
re-incubated at 37°C in medium 199 containing
unlabelled rat IgG (5 yg/ml) after washing in
medium 199 containing unlabelled rat IgG (10.0 yg/ml)
Mean Percentage radioactiviy released + S.D.Time
(min) acid soluble acid insoluble total radioactivity
0 0.3 + 0.4 0.4 + 0.6 0.7 + 1.1
5 7.9 3.6 7.4 1.8 15.3 5.0
15 18.1 7.0 14.7 0.2 32.8 6.9
30 29.4 11.2 22.8 1.8 52.2 9.5
45 35.1 12.8 27.0 2.5 62.2 10.5
60 38.8 13.5 30.8 4.1 69.6 11.7
75 42.1 14.8 31.9 5.0 74.0 11.5
90 44.2 15.1 32.5 6.2 76.8 10.5
120 46.8 15.1 34.3 7.4 81.1 8.8
150 49.3 14.8 35.3 7.5 84.7 8.7
180 51.5 16.5 34.9 10.1 86.4 9.0
Table 5.IXa Release of radioactive species, derived from I-
labelled IgG, by 17.5-day rat yolk sacs re-incubated 
at 21°C in the absence of calf serum
125
Time
(min)
Mean Percentage radioactivity released + S.D,
acid soluble acid insoluble total radioactivity
0 0.7 + 1.3 1.7 + 0.7 2.6 + 0.8
5 2.4 0.9 4.7 2.7 7.1 2.0
15 5.0 1.0 8.4 3.0 13.4 2.4
30 8.4 0.8 11.2 2.7 19.6 2.2
45 12.1 0.5 13.5 2.6 25.6 3.0
60 13.2 1.3 16.5 3.9 29.7 3.8
75 15.0 2.1 19.2 3.9 34.2 3.1
90 17.5 3.2 18.9 2.6 36.3 2.8
120 18.4 2.6 25.3 6,1 43.6 4.4
150 19.7 3.4 26.8 7.6 46.5 5.2
180 22.0 4.4 27.5 6.4 49.5 3.7
125Table 5.IXb Release of radioactive species, derived from I- 
labelled IgG (Batch III), by 17.5-day rat yolk sacs 
re-incubated at 4.5°C in the absence of calf serum
Time Mean Percentage radioactivity released + S.D,
(min) acid soluble acid insoluble total radioactivity
0 0.7 + 0.4 1.1 + 0.6 1.7 + 1.0
5 1.7 1.0 2.6 1.1 4.3 1.9
15 2.8 0.5 5.0 4.3 7.8 4.8
30 4.1 0.5 6.6 5.1 10.7 5.4
45 4.7 0,4 7.5 4.6 12.2 4,9
60 5.2 0.1 8.6 4.8 13.8 4.7
75 5.6 0.4 8.7 5.0 14.4 4.7
90 6.7 0.4 9.7 5.5 16.4 5.4
120 7.9 0.2 10.6 5.6 18.5 5.5
150 8.7 0.9 11.9 6.0 20.6 5.3
180 12.1 3.9 10.1 1.8 22.3 5.3
• 125Table 5.Xa Release of radioactive species, derived from I- 
labelled dBSA (Batch VI), by 17.5-day rat yolk sac 
re-incubated at 37°C in medium 199 alone
Time
(min)
Mean Percentage radioactivitiy released + S.D.
acid soluble acid insoluble total radioactivity
0 3.4 + 3.6 -0.5 + 3.8 3.2 + 1.0
5 20.2 3.0 2.8 2.1 23.0 3.0
15 36.1 4.3 2.5 0.7 38.6 3.8
30 44.8 4.5 5.1 1.0 49.9 5,3
45 49.2 4.8 3.3 2.8 52.6 2.0
60 50.5 4.1 5.0 1.3 55.6 2.7
75 54.1 4.0 2.2 3.9 56.3 0.9
90 54.2 1.7 4.8 2.2 58,9 3.0
120 55.8 2.5 4.7 1.0 60.7 1.2
150 56.6 1.6 6.5 2.7 63.1 2.7
180 58.5 2.2 5.2 0.5 63.8 1.8
125Table 5.Xb Release of radioactive species, derived from I- 
labelled dBSA (Batch VI), by 17.5-day rat yolk sacs 
re-incubated at 21°C in medium alone
Mean Percentage radioactivity released + S.D.
(min) acid soluble acid insoluble total radioactivity
0 0.6 + 1.8 - 1.2 + 1.7 0.03 + 0.4
5 6.0 2.5 1.3 2.0 4.7 1.6
15 13.1 3.7 1.5 0.7 14.6 4.4
30 18.3 4.4 2.1 3.7 20.4 2.1
45 24.4 5.2 3.5 3.2 27.9 4.9
60 27.8 5.2 4.5 3.1 32.3 2.6
75 31.0 8.2 4.7 2.8 35.5 5.9
90 33.7 5.8 4.3 3.2 38.0 5.3120 36.6 8.1 10.6 8.5 47.2 7.0
150 37.5 5.5 9.6 3.7 47.1 2.0180 39.3 8.4 11.9 8.2 51.3 1.3
125Table 5.Xc Release of radioactive species, derived from I-
125labelled JI-dBSA (Batch VI), by 17.5-day rat yolk 
sacs re-incubated at 4.5°C in medium alone
Mean Percentage radioactivity released + S.D.
(min) acid soluble acid :insoluble total radioactivity
0 0.7 + 0.6 -0.2 + 1.0 0.5 + 0.5
5 3.0 1.1 0.0 0.7 3.1 0.4
15 4.9 1.7 1.0 0.7 5.9 1.1
30 7.1 1.6 1.0 0.5 8.1 1.4
45 9.5 1.7 0.9 0.3 10.5 1.9
60 10.7 2.2 1.2 0.7 11.9 2,5
75 11.4 2.7 2.0 0.3 13.3 2.4
90 12.7 2.9 2.4 0.8 15.1 3.0
120 15.1 3.0 2.6 0.4 17.6 3.4
150 16.9 3.4 2.3 0.6 19.1 3.2
180 18.7 3.6 2.5 0.2 21.2 3.6
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Fig. 5a Uptake plot versus time for I-labelled IgG (Batch III) by
17.5-day rat yolk sac in the presence of calf serum (10% y/y)
125
Gradient of the line (T+S) gives value of;
Endocytic Index »15.8 yl/h/mg protein)
(Correlation Coefficient ■ 0.955)
Gradient of the line T (tissue associated radioactivity) 
gives value of:
(T+S)
S
T
Tissue Accumulation Rate = 4.38 yl/h/mg protein) 
(Correlation Coefficient - 0.892)
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Fig. 5b Plot of uptake against time for 125I-labelled IgG (Batch III)
by 17.5-day rat yolk sac in medium 199 alone
Time (hours)
Gradient of the line (T+S) gives value of:
Endocytic Index - 105.7 pl/h/mg protein
(Correlation Coefficient = 0.956)
Horizontal displacement of plot S from line (T+S) gives 
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125,Fig. 5c Uptake plot versus time for I-labelled dBSA (Batch VI)
by 17.5-day rat yolk sac in medium 199 alone (T+S)
S
Endocytic Index - 356.9 yl/h/mg protein
(Correlation Coefficient * 0.972)
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Fig. 5d Effect of 127I-iodinated dBSA on uptake of 125I-labelled IgG 
by 17.5-day yolk sac
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Fig. 5e 125Release of I-labelled IgG (Batch I) at 37°C from 17.5-dav
rat yolk sac re-incubated in medium 199 alone
i o cFig. 5f Release of I-labelled IgG (Batch III) from 17.5-day rat
A = 17.5-day yolk sac re-incubated in medium 199 alone
B = 17.5-day yolk sac washed in medium 199 + IgG (10.0 yg/ml) 
and re-incubated in medium 199 alone
C « 17.5-day yolk sac washed in 199 + IgG (10,0 yg/ml) and 
re-incubated in medium 199 + IgG (5.0 yg/ml)
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Fig* 5g 125Release of JI-labelled IgG (Batch III) from 17.5-day
yolk sacs re-incubated at 37°C> 21°C and 4«5°C
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Fig. 5h Release of 125,__________I-labelled dBSA (Batch VI) from 17.5-day
rat yolk sacs re-incubated at 37°C, 21°C and 4.5°c
Time (min)
Fig. 5i Possible fates of I-labelled IgG within 17.5-day rat yolk sac125
A *» Amnion
E = Epithelial cell
Ex = Exocoelom
JC ■ Junction complex
MV * Microvilli
SBM ■ Serosal basement membrane
VBM = Visceral basement membrane
VBV = Vitelline blood vessel
YSC = Yolk-sac cavity
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125’loaded’ with I-labelled IgG and re-incubated in medium 199 alone
Fig. 5j Chromatography on Sephadex G25 of the radioactive species released by 17.5-day rat yolk sacs
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Fig. 5k Chromatography on 'Sephadex G25’ of the radioactive species released by 17.5-day rat yolk sac
125’loaded' with I-labelled dBSA and re-incubated in medium 199 alone
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Fig. 51 Chromatography on ’Sephadex G150' of the radioactive species released by 17.5-day rat yolk sacs
’loaded* 125with I-labelled IgG and re-incubated in medium 199 alone
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6.1 Introduction
The prenatal transmission of IgG in the rabbit has been investigated 
by a number of workers (Brambell,1949, 1966; Wild,1970, 1972, 1973; 
Hemmings,1957). Brambell et al. (1949) showed, by ligaturing the 
yolk sac stalk, that this membrane is the sole route by which passive 
immunity is transferred from mother to fetus in this species. In the 
rat, on the other hand, prenatal routes of transmission of immuno­
globulins would appear less important since the greater part of the 
passive immunity is transferred after birth (during lactation) by 
way of the gut of the neonate (Halliday, 1955b; Bangham and Terry,
1957, Brambell £t al., 1961; Jones, 1972; Rodewald, 1970, 1973;
Morris & Morris, 1974a, 1974b; Morris, 1974). It has been suggested 
that the passive immunity imparted to the rat fetus prior to birth 
is transmitted via the yolk sac (Brambell and Halliday, 1956) but 
this has been contested by Quinlivan (1964),
A number of in vivo studies have been performed in the rabbit 
and Hemmings (1957) has demonstrated that the transport mechanism for 
homologous immunoglobulins was selective although the total amount of 
IgG transmitted intact across the yolk sac was only about 12% of the 
total administered (Hemmings, 1956). Furthermore, the rabbit yolk 
sac was also shown to transmit IgM, but not IgA (Hemmings, Jones and 
Williams, 1973). Antitoxins, prepared in other species, were also 
found to be transported across the rabbit yolk sac (Batty et al.,
1954). Brambell (1966) using the same data, was able to calculate 
the relative rates of transmission. This investigation was extended 
(Brambell etal., 1960) to include the rates of transmission of 
fragments of rabbit IgG, prepared by papain digestion (Porter, 1958,
1959), by the rabbit yolk sac.
In comparison with the rabbit, transmission across rat yolk sac 
has been little studied although Anderson (1959) showed,
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autoradiographically, the presence of 131I-labelled IgG within the 
yolk sac towards the end of pregnancy, confirming the ability of the 
tissue to ingest this substrate. In the rat the study of uptake and 
transmission of immunoglobulins has been largely restricted to tran­
smission across the gut of young rats up to the age of 20 days, at 
which time Halliday (1955a) found that transport of IgG virtually 
ceased. Bangham and Terry (1957) calculated the proportion of the 
administered dose transmitted across the gut to be 7.5%. They also 
concluded that the transport was selective in nature, and Jordan and 
Morgan (1968) confirmed this by showing labelled IgG is transmitted 
but labelled albumin is not. In a later study, (Jones, 1972) 
obtained a value of 12% transmission of the administered dose.
Morris and Morris (1976) demonstrated that the proximal intestine
was responsible for transmission of some 40% of an administered dose 
of labelled IgG.
In vivo studies of the transmission of immunoglobulins, of the 
type described above, are accompanied by several difficulties which 
include: the possible existence of multiple sites of transmission, 
proteolysis of the administered substrate, dilution of transmitted 
antibodies within the rapidly growing offspring and uneven distribution 
of substrate at the transport sites. Such factors make quantitative 
assessment of the results difficult.
Potentially in vitro investigations could eliminate some of these 
problems and make more accurate assessment of the rates of uptake 
hydrolysis and transmission by a given route possible. Bamford 
(1966), using a modified method of the culture technique developed by 
Wilson and Wiseman (1954a, b), was able to incubate inverted gut sacs, 
prepared from young rats, for several hours. Their viability was 
monitored by oxygen consumption and ability to transport L'histidine 
against a concentration gradient. Using this technique he was able
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to show the transport of some IgG across the gut wall. Moreover, he 
found that IgG preparations from the rat were transmitted more readily 
than were similar fractions from the rabbit or cow. However, it 
has proved difficult to maintain cell viability in rat gut sacs 
incubated for long periods (Beck,personal communication), although 
more recently cell viability has been reported up to 3.0 h (Walker 
et al., 1976) and linear uptake of 125I-labelled PVP has been observed
over 3.0 h incubation periods with gut sacs from adult rats (Bridges, 
unpublished data).
Although in vitro study of the transport of immunoglobulins by 
rat yolk sac would avoid certain complications discussed earlier and 
clarify the role of this tissue in the transmission process, to date 
no attempts have been reported.
12*5In Chapter 5 the uptake of "i-labelled IgG was studied by the
in vitro culture techniques developed by Williams et al. (1975a and b)
and the results compared with those of 125I-labelled dBSA, a protein
that is unlikely to be transmitted in vivo. with both substrates
the results showed highly linear uptake over incubation periods of
several hours, in the presence and absence of 10.0% calf serum in
the culture medium. The release/exocytosis of ingested protein
substrates was also investigated by a modified method Williams et al.
(1975a). The results showed that while the non-specific protein 
125t-labelled dBSA underwent complete digestion, a considerable
125percentage of ingested I-labelled IgG was released intact on 
re-incubation in fresh medium. The latter finding is compatible 
with the suggestion of Brambell and Halliday (1956) that the yolk sac 
is instrumental in transmitting immunoglobulins in the rat.
Currently there are two hypotheses in circulation to explain 
how, at the molecular level, IgG selectively crosses tissue barriers. 
That proposed by F. W. R, Brambell and co-workers, 1958 and later
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revised (Brambell et_ al., 1966) states that the observed selective 
transfer of IgG is the result of intracellular events. The other, 
more recent, hypothesis proposed by Wild (1975) suggests that 
selective transfer of IgG is a result of extracellular events at 
the cell surface. According to the Brambell hypothesis transport 
across the rabbit yolk sac is envisaged to occur by IgG being ingested 
by pinocytosis, together with other proteins contained in the extra­
cellular fluid present in the uterine lumen, and, following ingestion, 
a proportion of this IgG becomes bound to specific receptors on the 
internal face of the vesicles. As these pinocytic vesicles migrate 
further into the cell, they fuse with lysosomes, and bring the vesicle 
contents into contact with lysosomal enzymes thus permitting protein 
hydrolysis. It is during this digestion phase that selection of 
those molecules to be transported is envisaged to occur: those IgG 
molecules bound to specific receptors are thought in some way to be 
protected from digestion while any other proteins, and any IgG 
itself that is not bound in this manner, become completely hydrolysed 
(see Fig. 7a). After digestion the vesicle then proceeds to fuse 
with the basal membrane releasing its contents.
The Wild hypothesis differs from that of Brambell by proposing 
that IgG binds specifically to receptors on certain regions of the 
cell surface (possibly at the base of the micro-villi) prior to 
entering the cell. When the substrate has bound to these receptors 
this region of the plasma membrane invaginates to form small 
vesicles termed 'coated vesicles' (so called because of the presence 
of a 'fuzzy' coating which, under the electron microscope, can be 
seen on their cytoplasmic surface). It is proposed that these 
vesicles contain only IgG and that the physicochemical properties 
of the cytoplasmic surface differ from those of pinosomes arising 
from other regions of the plasma membrane. This allows them to
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avoid fusion with the lysosomal compartment, hence traverse the cell 
and subsequently, on fusion with the basal membrane, release their 
contained IgG. Any IgG that does not bind to specific receptors 
would be taken up into normal pinosomes and be subject to intra- 
lysosomal hydrolysis.
The mechanism by which IgG is selectively transported across 
cells, according to the hypotheses proposed by Brambell and Wild, 
differ in certain details. In this chapter the component stages of 
the two mechanisms were first examined on a theoretical basis to 
establish the basic similarities and differences between them (see 
table below). This enabled a number of experiments to be designed 
in which significant differences of behaviour would be expected by 
the different hypothetical mechanisms.
Comparison of the Brambell and Wild models for selective transport of
homologous IgG
Component of the overall 
process considered
a. Molecular mechanism of the 
selection process for 
transported IgG.
b. Location of the receptors 
involved.
c. Saturation of the transport 
process with increasing IgG 
concentration possible?
Predicted behaviour of the model 
according to:-
Brambell Wild
Selective/preferential Selective preferential 
binding to membrane binding to membrane 
receptors. receptors. i
Pinosome or 2 lysosome Outer surface of j
(inner face). plasma membrane j
(specific regions) ;f
f!
Yes Yes
d. Minimum number of discrete 
types of pinocytic vesicle 
proposed.
e. Presence of lysosomal enzymes 
in the transport vesicles is 
suggested?
f. Can proteolysis of excess IgG 
and other proteins occur?
1
Yes
Yes
2
No
(
Yes i
g. Site of such proteolysis. Transport vesicle Separate non-trans-
(i.e. lysosomes) port vesicle (i.e.
lysosomes)
Predicted behaviour of the model 
according to:-
Component of the overall 
process considered
Brambell Wild
In test situation:-
h. Amount of IgG transported
dependent on concentration of 
ingested substrate.
Yes Yes
i. Could a non-digestible substrate 
be transported together with 
IgG?
Yes No
j. Is release of lysosomal enzymes 
from the transport vesicles 
possible?
Yes No
k. Uptake of proteins into the
lysosomal system can be inhibited 
independently of IgG uptake 
(and vice versa).
No Yes
In view of the factors considered in the above table, re-incubation 
experiments with rat yolk sacs appeared to offer a suitable in vitro 
system for further studies. The above table also outlines the design
of three experiments aimed at assessing whether the observed release
125of I-labelled IgG from yolk sacs in vitro is related to the 
phenomenon of transport across the tissue in vivo. Both hypotheses 
predict that increasing the concentration of extracellular labelled 
IgG will lead to a greater fraction of that ingested being degraded, 
rather than released again in macromolecular form, as the binding 
sites conferring protection on the ingested IgG become saturated and 
the excess is digested within the lysosomal system. Hence, if the 
¿E vitro release Phenomenon is relevant to the in vivo transport route, 
this effect is anticipated by both of the above mechanisms.
Secondly, according to the Brambell hypothesis, release of a non- 
degradable substrate that has been ingested into the same part of the 
vacuolar system as IgG would be expected to be released again on 
fusion of the secondary lysosome with the plasma membrane. The 
release of lysosomal enzymes would be expected at the same time.
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The release of both I-labelled PVP and the lysosomal enzyme 
3-N-acetylglucosaminidase were therefore studied during incubation 
of yolk sacs in medium containing homologous IgG.
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METHODS
6.2 Release of I-labelled IgG from 17.5-day rat yolk sacs loaded* 
at different substrate concentrations
Single yolk sacs removed from three different animals at 17.5
days of gestation were incubated in medium 199 alone (10.0 ml) con- 
125taining I-labelled IgG (Batch II) then re-incubated for 3.0 h in 
substrate-free medium. The experimental regime was the same as that 
described in Section 5.4 but differing concentrations of radiotracer 
(1.0, 5.0, 25.0, 75.0 and 100.0 yg/ml of medium were used in the 
initial [ loading] stage). The radioactive species released were 
assayed by the method previously described (Chapter 2, Section 2.17).
The released radioactivities, when expressed as a percentage of 
the total radioactivity associated with the tissue at the start of 
the re-incubation period were observed to rise progressively with 
time, a pattern similar to that found with Batch I ^I-labelled IgG 
(see Fig. 5e). The patterns again showed that by 120 min release was 
virtually complete, there being little or no further release in the
remaining 60 min of incubation. In order to compare the amounts of 
125I-labelled IgG at each loading concentration, the released radio­
activities were expressed in absolute units, rather than as a per­
centage of that contained in the tissue at the start of the 
re-incubation. The mean quantity of each of the different types of
radioactivity released over the final 60 min of re-incubation was
125determined and each value expressed as yg I-labelled IgG released 
per mg yolk-sac protein.
125These mean values of the quantity of I-labelled IgG released 
over the final 60 min of incubation, expressed in the above format 
are shown in Table 6.1; the individual time courses of release, from 
which these values were derived, are not reported. This table also 
shows the overall mean value of the released radioactivities for
125
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each of the groups of three separate, identical experiments performed 
at a given ’loading* concentration. The same summary data are also 
expressed graphically in Fig. 6a.
Table 6.II shows the relative proportions of acid-soluble and 
acid-insoluble radioactivity in the released radioactivity. (N.B. 
These values are expressed as a percentage of the total released 
radioactivity rather than as percentage of the total tissue-associated 
radioactivity at the start of the re-incubation.) Fig. 6b shows the 
variation of these values at the different 'loading' concentrations 
of 12^I-labelled IgG.
1256.3 Release of I-labelled PVP from 17.5-day rat yolk sacs 
re-incubated in the presence and absence of unlabelled homologous 
IgG.
In order to determine whether IgG facilitated the release of a 
substrate contained within the lysosomal system, yolk sacs were loaded 
by incubating for 2.0 h in medium 199 containing homologous IgG (10.0 
Vg/ml) and I-labelled PVP (5.0 yg/ml of medium) then re-incubated 
either in fresh medium 199 alone or in medium 199 containing homologous 
IgG (10.0 pg/ml). The experimental regime was that described in 
Section 2.17 and the released radioactivity was expressed as a per­
centage of the total tissue-associated radioactivity at the start 
of the re-incubation. These results are shown in Table 6.Ill and 
expressed graphically in Fig. 6c.
6.4 Release of the lysosomal enzyme g-N-acetylglucosaminidase 
(B-NAG) by 17.5-day rat yolk sacs incubated in the presence and 
absence of homologous IgG
The release of g-NAG by 17.5-day rat yolk sacs incubated in 
the presence and absence of homologous IgG (10.0 yg/ml) was measured 
to determine whether IgG influenced the rate of release of lysosomal 
enzymes. Six yolk sacs, taken as pairs from three different animals,
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were incubated separately at 37°C, each in 15.0 ml of medium 199.
Three of the incubation flasks contained medium 199 alone, the media 
in the other three flasks also contained homologous IgG (10.0 yg/ml). 
Samples (500 yl) of the culture medium were removed at regular intervals 
over a 5 h incubation period, centrifuged at 1500g for 15 mins to 
remove cell debris, then deep-forzen immediately until assayed for 
fJ-NAG. Full details of the experimental method the assay offi -NAG 
and calculation of the released enzyme activity can be found in 
Chapter 2, Section 2.18. The results obtained are shown in Table 
6.IV and the calculated mean values of the amount of enzyme released 
in three separate experiments are expressed graphically in Fig. 6d.
1256-5 M 3 a.se„°i____I-labelled IgG from 17.5-day rat volk sacs that
125ji^been ^ loaded» with I-labelled IgG in the presence and 
absence of glucagon
Yolk sacs, removed from three different animals at 17.5-days
of gestation, were ’loaded' with 125I-labelled IgG by being incubated
either in medium 199 alone or in medium 199 containing glucagon
at a concentration of 1.0 yg/ml; both incubation media contained 
125I-labelled IgG (Batch IV at a concentration of 5.0 yg/ml). On 
re-incubating the tissue, each species of released radioactivity 
was assayed as described in Chapter 2, Section 2.17. The progressive 
release was expressed in two ways, firstly as the percentage of the 
total radioactivity assocated with the yolk sac at the beginning of 
the re-incubation period. The values of total, acid-soluble and 
acid-insoluble radioactivities from experiments in the absence of 
glucagon, expressed in this form, can be found in Table 6.V and 
similar data from experiments in the presence of glucagon are shown 
in Table 6.VI. The mean value of each species of radioactivity
from 3 separate, identical experiments are plotted against time in 
Figs. 6e and 6f.
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Tables 6.VII and 6.VIII give the results of experiments in the presence 
and absence of glucagon, respectively, expressed in this format.
Fig. 6g shows a plot of the mean values, from 3 separate experiments, 
of the total- and acid-insoluble radioactivities reported in 
Tables 6.VII and 6.VIII.
Secondly, the amounts of substrate released in the three different
forms were expressed as the percentage of the total radioactivity
released by the yolk sac during the 3.0 h re-incubation period.
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RESULTS
6.6 Release of I-labelled IgG from rat yolk sacs * loaded' at
different substrate concentrations
The results of experiments in which the release of ingested radio-
tracer into fresh incubation medium by yolk sacs that had previously
125been exposed to I-labelled IgG (Batch II) at a number of different 
substrate concentrations, are shown in detail in Table 6.1. The 
quantity of each species of radioactivity released during the first 
2.0 h of re-incubation period in each experiment are shown together 
with the mean value for each group of three experiments performed at 
a given 'loading* concentration. The latter quantities are plotted 
in Fig. 6a which shows quite clearly that, at all substrate concentrations, 
the greater part of the total radioactivity released consists of acid 
soluble species but that the amounts of radioactivity released as 
acid-solubles rises progressively with increasing substrate con­
centration. Furthermore, this plot also shows the amount of acid 
insolubles released to increase from 24 to 890 yg/mg protein when the 
'loading concentration' was raised from 1.0 to 100 yg/ml of medium.
When expressed as a percentage of the total radioactivity released, 
the amount of acid-insolubles released was observed to fall from a 
maximum of 50%, at the lowest loading concentration (1.0 yg/ml), to 
approximately 20%, at a concentration of 25y*g/ml (Table 6.II).
However, the percentage release remained virtually constant at 20% 
up to the highest loading concentration of 100 yg/ml. The acid 
soluble species showed, of course, the reverse pattern rising from 
50% to 80% at the total radioactivity released when the 'loading 
concentration' was increased from 1 to 25 yg/ml of medium, then 
remained constant over the range 25-100 yg/ml of medium. Fig. 6b 
shows these results in graphical form.
125
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6.7 Release of I-labelled PVP by 17.5-day rat yolk sacs re-incubated 
in the presence and absence of homologous IgG
Table 6.Ill shows the activities released when homologous 
IgG is present and absent in the . incubation medium, these values 
are also plotted in Fig. 6c. Linear regression lines were fitted to 
each set of data (excluding the samples taken at 0 min) and the 
corresponding rates of release (gradients) obtained. These were 
found to be 1.90%/h and 1.51%/h with and without added IgG, respectively. 
Inspection of Fig. 6c clearly shows the presence of homologous IgG 
at a concentration of 10 yg/ml in the re-incubation medium to have 
no significant effect on the rate of release of this substrate.
6.8 Release of B~NAG from 17.5-day rat yolk sacs incubated in the
presence and absence of homologous IgG 
125As with I-labelled PVP, the release of the lysosomal enzyme 
g-NAG was followed in the presence and absence of homologous IgG 
(Section 6.4). The results shown in Table 6.IV are expressed as a 
percentage of the total 8-NAG activity which was present at the 
beginning of the incubation period. Plotting these values against 
time (Fig. 6d) showed the release of 8“NAG to be slightly higher in 
the absence of IgG than when IgG was present in the incubation medium. 
Taking 6~NAG to be a representative lysosomal enzyme, these results 
indicate that release of lysosomal enzymes is unaffected by the 
presence of IgG at a concentration of 10 pg/ml in the re-incubation 
medium.
1256.9 Release of I-labelled IgG in the presence and absence of 
glucagon
The release of radiotracer was followed after prior ingestion of 
*2^I-labelled IgG (Batch IV) in medium 199 alone (see Fig. 6e), 
Essentially the same release pattern was observed for Batches III and 
IV (see Chapter 5, Fig. 5 for Batch III), Close comparison of these
125
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two plots shows that, although the overall release patterns are similar, 
there are several small differences which should be noted.
Firstly, the total radioactivity released in the case of Batch IV 
is some 10% greater than for Batch III (Section 5.11), the maximum 
released total-radioactivity being approximately 85% for Batch III, 
compared to some 95% for Batch IV. This difference would appear to 
indicate that Batch IV is more readily released by the yolk sac and 
may possibly result from a slightly more rapid rate of processing 
associated with this particular preparation. The quantity of acid 
soluble species released was also increased for this particular batch 
of IgG and reached a maximum value of approx. 65% compared with a 
value of nearer 45% for Batch III. Conversely, the amount acid 
insoluble species released was found to be somewhat less in the case 
of Batch IV, reaching a maximum at only 30% as opposed to a value 
nearer 40% for Batch III.
The presence of glucagon at a concentration of 1.0 pg/ml in the 
incubation medium caused a profound change in the relative amounts of 
acid soluble and acid insoluble species released, whereas the per­
centage of the total radioactivity released show no change.
Rerincubation in the presence of glucagon caused the acid insoluble 
radioactivity released to rise to approximately 55% of the tissue- 
associated activity as opposed to a value of only 30% when glucagon 
was absent. (The acid soluble radioactivities showed a corresponding 
change but in the opposite direction, falling from a value of approx.
65% in the absence of glucagon to 40% when glucagon was present).
In order to compare the data more clearly the released radio­
activities were re-calculated and expressed as a percentage of total 
radioactivity released by the yolk sac. Expressed in this format, 
each experiment showed the total released radioactivity to rise from 
virtually zero to 100% at the end of the incubation period (see Fig. 6g)
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and no significant differences were observed between the two 
experiments. On the other hand, when plotting the acid insoluble 
radioactivity as a percentage of the total radioactivity released, a 
significant difference in the levels was evident. The inclusion of 
glucagon in the re-incubation medium resulted in a 22% increase in 
the radioactivity released in the form of acid insoluble species as 
compared with control experiments in which glucagon was not present. 
The acid soluble species showed a similar change but in the opposite 
direction (see Tables 6.VII and 6.VIII).
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6.10 Discussion
Hemmings (1961) demonstrated that while homologous IgG was found 
to pass freely across the rabbit yolk sac a much smaller amount of 
homologous albumin was transmitted. Similarly, Brambell (1966) 
observed that heterologous immunoglobulins (from the dog, horse and 
ox) showed lower rates of transmission than homologous IgG or even 
homologous albumin. This evidence pointed to the presence of a 
highly selective transport mechanism in the rabbit yolk sac, specific 
to homologous immunoglobulins. It is conceivable that the rat yolk 
sac may also, but to a lesser degree, transport immunoglobulins 
selectively (Halliday, 1955b; Brambell and Halliday, 1956).
In vitro experiments (see Chapter 5) showed that 17.5-day rat
yolk sacs released a considerable fraction of their ingested
125 125I-labelled IgG in a virtually intact form, whereas I-labelled
dBSA was virtually completely degraded to the level of amino acids.
Furthermore, it has been shown that other high molecular weight
125substrates such as I-labelled PVP (Chapter 7) and colloidal
1 QQ[ Au]gold (Roberts et ¿1., 1977), both of which are completely
resistant to intralysosomal hydrolysis, were virtually completely
retained within the rat yolk sacs and not released in the same manner 
125as I-labelled IgG. The striking difference between the release 
125patterns with I-labelled IgG as substrate and those with
125I-labelled dBSA and other high mol.wt. substrates, in in vitro 
incubations, may reflect the existence of a process of physiological 
significance that occurs in the rat yolk sac in vivo, namely the 
transfer across it of passive immunity in the period prior to birth.
Clark and Hardy (1969) investigated the transport of polyvinyl­
pyrrolidone (PVP 60; mol. wt. 60,000) across the ileal cells of the 
suckling rat. Although this substrate was not hydrolysed, relatively 
little transmission was observed. These findings would appear to
- 103 -
discount any suggestion that immunoglobulins are able to traverse a
tissue simply as a result of their resistance to proteolysis.
In contrast to other proteins investigated in the present study,
125the uptake of I-labelled IgG by the rat yolk sac in vitro was 
accompanied by a degree of accumulation within the tissue when incubated 
in the presence of 10% (v/v) calf serum (see Chapter 5). As already 
stated (Chapter 5), the progressive accumulation of a substrate would 
not appear to be a prerequisite for its subsequent transmission across 
the cell. There must then be some other reason for accumulation of 
this sort. If in vivo IgG passes through the epithelial cells of the 
yolk sac, enters the subjacent vitelline capillaries and is carried to 
the fetus by way of the bloodstream then in vitro, in the absence of 
any blood flow, the radiotracer would be expected to accumulate in 
the stagnant vitelline blood vessels of the yolk sac tissue. Unfor­
tunately this explanation is not readily compatible with the fact that 
no tissue accumulation was observed when 125I-labelled IgG was ingested 
in the absence of calf serum. Moreover, the suggestion that 
accumulation occurs in stagnant vitelline vessels is not compatible 
with the observation, in exocytosis experiments, of a rapid and ready 
release of the bulk of the tissue-associated acid insoluble radio­
activity derived from ingested 125I-labelled IgG, unless the integrity 
of the vitelline capillaries and retention of the acid insoluble species 
is in some way dependent on the presence of calf serum. Although this
would seem an unlikely explanation, its validity could be tested by
125a study of the release of I-labelled IgG in the presence of 10%
(v/v) calf serum. An alternative explanation of the observed rise
125in the tissue levels of I-labelled IgG in 10% calf serum incubation 
is that the protein enters the lysosomal system but the hydrolytic 
enzymes become saturated with proteins derived from the calf serum 
leading to an accumulation of radiotracer within the epithelial cells
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rather than within the vitelline vessels.
By Brambell's mechanism, the passage of immunoglobulins across
cell barriers involves binding to specific receptors (present on the
microvillous surface of the epithelial cells) prior to pinocytosis
and requires the receptor-bound IgG molecules to be, in some way,
protected from degradation by the lysosomal enzymes whereas neither
unbound IgG nor other proteins are so protected hence are subject to
hydrolysis (see Fig. 6h). When the vesicle finally traverses the
cell, fusion with the lateral or basal region of the plasma membrane
occurs and its contents are discharged. The amount of IgG so protected
and transported is limited by the number of unoccupied receptors
which will decrease with increasing concentration of immunoglobulins.
On loading yolk sacs at different concentrations of 125I-labelled
IgG then re-incubating them in substrate-free medium, the amount of
intact radiotracer released was shown to be dependent on the loading
concentration. Fig, 6b shows the amount of acid soluble and acid
insoluble radioactivity as a percentage of the amount of radioactivity
released by the yolk sac. The relationship between the amount of
acid insoluble radioactivity released and the loading-concentration is
compatible with either hypothesis but serves to demonstrate that the
number of receptor sites is finite, as proposed by both hypotheses.
Release of IgG contained within secondary lysosomes would also
lead to the release of any other molecules present in the same particles,
including those lysosomal enzymes that are not bound to the lysosomal
membrane. Similarly, if such secondary lysosomes contained a non-
125digestible substrate such as I-labelled PVP, as well as unlabelled
homologous IgG: then, during re-incubation, release of IgG would also
125be accompanied by the release of the I-labelled PVP. Experiments
. 125where yolk sacs were loaded with I-labelled PVP in the presence of 
homologous unlabelled IgG showed no change in the amount of the
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radiotracer released during a subsequent re-incubation period (Fig. 6c). 
This finding is consistent with the finding (Wild, 1974) that the rate 
of transport of PVP to the fetal circulation of the rabbit was very 
low.
Wild (1975) also studied the release of a lysosomal enzyme,
Cathepsin D, by using a fluorescent-antibody technique, but was unable
to detect the release of this enzyme. In Fig. 6d the release of
another lysosomal enzyme g-N-acetylglucosaminidase ((3-NAG) was
monitored both in the presence and absence of homologous IgG. Plots
of released enzyme activity against time showed the release of g-NAG
to be unaltered by the presence of homologous IgG,
In the rat yolk sac the binding of a substrate to the plasma
membrane does not appear to automatically protect the substrate from
125degradation since I-labelled dBSA (Moore et al., 1977) was found to 
enter the cell by 98% of it being bound to the plasma membrane surface 
but hydrolysis of the substrate was virtually complete. Hence it 
would appear that transport of a protein substrate requires more than 
binding to the plasma membrane and that a very specific type of inter­
action must be proposed in order that IgG may be protected from 
hydrolysis if transport occurs by the mechanism proposed by Brambell.
On the contrary, by Wild’s hypothesis binding of IgG occurs via 
specific receptors localized in areas of the plasma membrane from 
which coated micropinocytic vesicles form. Their small size and the 
presence of the glycocalyx may well prevent the inclusion of any
other substrates present in the extracellular fluid. This would
125account for the fact that in vivo I-labelled PVP is not transported 
in the presence of homologous IgG. Unfortunately the small size of 
micropinocytic vesicles makes it impossible to visualize, by immuno­
fluorescence techniques, any proteins contained within them (Wild, 1975). 
If it is proposed that, once formed, a micropinocytic vesicles
- 106 -
containing only IgG migrate across the cell and fuses with the base­
ment membrane where their contents are released, then to enable these 
vesicles to traverse the cell without fusion with the lysosomes they 
must have some surface property which either repels the lysosomes or 
in some other way prevents fusion. Possibly the specific receptor 
for IgG is a transmembrane protein and binding of IgG transmits some 
signal which causes a change in the properties of the outer surface 
of the vesicle, thus preventing fusion with the lysosomes. On the 
other hand, digestion of IgG occurs by its attachment to non-specific 
binding sites on the plasma membrane or its ingestion in the fluid 
phase, to give entry into ’normal* pinosomes that ultimately pass 
into the lysosomal system where hydrolysis of the contained IgG 
occurs.
The above theory suggests that the uptake and release of IgG and 
the uptake of other proteins takes place by two completely separate 
classes of vesicles: coated micropinocytic vesicles and pinocytic 
vesicles. The latter fuse with lysosomes and this results in 
digestion of their contained proteins.
If this model of Wild's is valid» and two distinct types of
pinocytic vesicle do exist in yolk sac tissues, it is possible that
exposure of rat yolk sac in vitro to certain exogenous agents may
selectively inhibit the formation of one of the classes of vesicle,
leaving the other unaffected. As a preliminary investigation of
this possible difference, yolk sacs were incubated in the presence of
glucagon an agent which has been shown (Livesey, unpublished data) to
125inhibit the uptake of I-labelled dBSA.
Pig. 6g shows the release of 125I-labelled IgG, expressed as a 
percentage of the total radioactivity released by the yolk sac, in 
the presence and absence of glucagon. Clearly there is a significant 
difference between the control experiment and that in which yolk sacs
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were ’loaded’ with IgG in the presence of glucagon, the latter showing 
an increase in the percentage of acid insoluble material released.
It should be stressed, however, that if the quantity of 'acid solubles' 
is reduced because glucagon also inhibits intralysosomal proteolysis, 
then the corresponding quantity of acid insolubles released will 
automatically constitute a greater percentage of the total radioactivity 
released. Although the quantity of radioactive protein ingested 
and released by the yolk sacs exposed to glucagon was much lower, 
being only approx. 20% of that ingested in control experiments,
Livesey (unpublished data) has found no evidence that glucagon 
interferes with intralysosomal proteolysis.
Although this study was only preliminary in nature, these data 
are best explained by proposing a two vesicle system in which the 
formation of transport vesicles is less readily inhibited than are 
those pinocytic vesicles destined to fuse with the lysosomal system. 
Thus this differential effect on the release of substrates is con­
sistent with the mechanism proposed by Wild and cannot be explained 
by the mechanism proposed by Brambell where both the quantities, 
acid soluble and acid insoluble released would be expected to be 
affected to the same extent.
In summary, the rat yolk sac like that of the rabbit, appears to 
have the ability to treat homologous immunoglobulins in an atypical 
manner and, on the basis of the in vitro exocytosis experiments 
reported in this chapter, the circumstantial evidence favours a 
mechanism for the release of IgG from the rat yolk sac tissue, that 
is like that proposed by Wild. It is clearly desirable, however, 
that these preliminary indications of the existence of a separate 
class of pinocytic vesicle in rat yolk-sac tissue are substantiated 
by more direct evidence. Differential centrifugation techniques 
using density gradients similar to those recently reported by
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Goetze et al. (1976), but using yolk sacs that have been loaded with
IgG in vivo or in vitro appear to offer one obvious approach to
investigating the existence of a separate type class of vesicle con- 
125taining only I-labelled IgG. Such studies seem worth exploring 
in future work.
’loaded’ at different substrate concentrations in medium 199 alone
This table shows the results of 3 separate experiments in which the amounts
(yg) of the different classes of radioactivity released on re-incubating
125single yolk sacs, that had been 'loaded' with I-labelled IgG at different 
concentrations, were measured. The values reported refer to the final 60 
min of the 3 h re-incubation period when release was virtually complete.
125Table 6.1 Release of I-labelled IgG (Batch II) by 17.5-day rat yolk sacs
'Loading' concent- Mean quantity of radioactivity rele- Activity released
ration of ^Z5I-labelled ased by the final 60 min of re-incu- (yg/mg protein)
IgG (yg/ml) bation (yg/ml) tissue protein) Mean S.D.)
Total radioactivity
Experiment A Experiment B Experiment C
1.0 0.061 0.047 0.036 0.048 + 0.013
5.0 0.213 0.220 0.290 0.241 0.043
25.0 1.192 0.991 1.155 1.113 0.107
75.0 1.838 2.573 2.408 2.273 0.386
100.0 4.146 3.788 6.743 4.892 1.613
Acid soluble radioactivity
1.0 0.023 0.029 0.019 0.024 + 0.005
5.0 0.102 0.154 0.145 0.134 0.028
25.0 0.925 0.726 0.947 0.866 0.122
75.0 1.480 2.164 1.970 1.871 0.353
100.0 3.343 3.176 5.489 4.003 1.290
Acid insoluble radioactivity
1.0 0.039 0.018 0.017 0.024 + 0.012
5.0 0.111 0.067 0.144 0.107 0.039
25.0 0.267 0.265 0.208 0.247 0.034
75.0 0.358 0.409 0.438 0.402 0.041
100.0 0.803 0.613 1.254 0.890 0.329
Table 6.II Variation in the relative quantities of acid soluble
and acid insoluble species in the total radioactivity
released from 17.5-day yolk sacs after loading* at
125different concentrations of I-labelled IgG 
The mean percentages of acid-soluble and acid-insoluble radio­
activity released by the end of a 3.0 h re-incubation period (cal­
culated from the data shown in Table 6.1) are shown as a func-
125tion of the 'loading* concentration of I-labelled IgG.
'Loading' concentration 
of 125I-labelled IgG 
(yg/ml of medium)
Mean percentage of 
released in
Acid solubles
the radioactivity 
the form of:
Acid insolubles
1.0 50.0 50.0
5.0 55.6 44,4
25.0 77.8 22.2
75.0 82.3 17.7
100.0 81.8 18.2
sacs re-
incubated in the presence and absence of unlabelled homo­
logous IgG
Yolk sacs were loaded with labelled substrate by incubating (2.0 h) in
125medium 199 containing I-labelled PVP (5.0 yg/ml medium), then re­
incubated either in fresh medium 199 alone or in fresh medium containing 
unlabelled homologous IgG (10.0 yg/ml of medium).
The quantity of radioactivity released is expressed as a percentage of that 
associated with the tissue at the start of the re-incubation period.
125Table 6.Ill Release of I-labelled PVP by 17.5-day rat yolk
Re-incubation Quantity of tissue-associated radioactivity Mean Released 
period released at a given time when tissue Activity ^  S.D.
(min) was re-incubated in medium 199 alone (% (%)
tissue-associated radioactivity)
0 Experiment A Experiment B Experiment C
0 0.0 1.3 1.1 0.8 + 0.7
15 4.5 5.6 5.4 5.2 + 0.6
45 5.6 5.7 8.5 6.6 + 1.7
90 5.9 7.9 8.1 7.3 + 1.2
150 7.4 9.1 9.9 8.8 + 1.3
210 9.4 10.3 11.9 10.5 + 1.3
Quantity of tissue-associated radioactivity
released in the presence of IgG at a given
time (% tissue‘-associated radioactivity)
Experiment A Experiment B Experiment C
0 2.7 3.8 0.8 2.4 + 1.5
15 4.6 7.2 3.2 5.0 + 2.0
45 5.8 8.9 6.7 7.1 + 1.6
90 5.2 9.9 7.2 7.4 + 2.4
150 7.6 13.8 7.9 9.8 + 3.5
210 9.8 14.5 10.9 11.7 + 2.4
Table 6.IV Release of g-N-acetylglucosaminidase by 17.5-day rat 
yolk sacs incubated in medium 199 alone in the pre­
sence and absence of homologous IgG (10.0 yig/ml) 
g-NAG activity was determined as described in Section 2.16.
The enzyme activity released is expressed as a percentage of the 
total enzyme-activity associated with the tissue at the start of 
the incubation period.
Time
(min)
g-NAG activity 
IgG (% tissue-
r released in the absence of 
•associated activity)
Mean release, 
+ S.D.
(%)
0 Experiment A Experiment B Experiment C
0 0.0 0.2 0.4 0.2 + 0.2
15 1.8 1.2 2.0 1.7 0.4
30 2.7 3.4 4.1 3.4 0.7
60 4.2 5.6 6.4 5.4 1.1
120 6.4 10.7 10.0 9.0 2.3
180 8.3 9.6 13.2 10.4 2.5
240 7.8 12.4 14.0 11.4 3.2
300 10.0 11.7 14.3 12.0 2.2
g-NAG activity released in presence of
IgG (% tissue-associated activity)
Experiment A Experiment B Experiment C
0- 0.5 0.3 0.2 0.3 + 0.2
15 1.6 1.7 1-5 1.6 0.1
30 2.2 2.3 2.4 2.3 0.1
60 2.7 3.4 3.9 3.3 0.6
120 4.7 5.8 6.6 5.7 1.0
180 6.4 8.4 9.4 8.1 1.5
240 6.9 9.4 11.1 9.1 2.1
300 7.3 10.0 11.3 9.5 2.0
Table 6.V Release of I-labelled IgG (Batch IV) by 17.5-day rat 
yolk sacs re-incubated in TC 199 alone 
Each column of data gives the mean value from 3 experiments in 
each of which a single yolk sac, taken from a different animal, 
was used. The released radioactivities are expressed as a per­
centage of the total radioactivity associated with the tissue at 
the start of the re-incubation period.
125
Time
(min)
Mean Percentage radioactivity released (+ S.D.)
acid soluble acid insoluble total radioactivity
0 1.5 + 0.8 0.5 + 0.4 2.0 + 0.4
5 13.0 1.5 6.6 1.5 19.6 2.2
15 27.3 3.0 13.8 3.3 41.2 5.4
30 39.6 2.8 21.6 4.6 61.3 5.0
45 48.7 4.3 24.2 3.5 72.9 3.7
60 51.1 3.4 26.6 1.9 77.8 3.4
75 58.3 2.3 26.5 1.1 84.8 1.4
90 59.6 3.5 28.6 2.7 88.3 1.4
120 63.7 3.5 30.0 2.6 93.7 1.8
150 65.3 2.5 30.2 1.9 95.5 1.6
180 67.3 2.4 28.8 2.5 96.2 1.7
Table 6.VI Release of I-labelled IgG (Batch IV) by 17.5-day rat 
yolk sacs re-incubated in TC 199 plus glucagon 
(1.0 pg/ml)
Each column of data gives the mean value from 3 experiments in 
each of which a single yolk sac, taken from a different animal, 
was used. The released radioactivities are expressed as a per­
centage of the total radioactivity associated with the tissue at 
the start of the re-incubation period.
125
Mean Percentage radioactivity released (+ S.D.) Time ___________________ _________________________ Z_________
(min) acid soluble acid insoluble total radioactivity
0 0.8 + 1.6 3.0 + 2.1 3.7 + 1.1
5 9.2 1.3 13.1 2.8 22.2 1.7
15 17.8 1.1 24.2 5.1 42.0 5.4
30 24.3 4.1 36.0 7.2 60.4 3.2
45 28.2 1.4 44.2 8.2 72.4 6.8
60 32.4 3.5 45.4 4.0 77.8 3.3
75 37.0 2.9 48.6 2.7 85.5 1.5
90 37.3 4.6 49.6 4.3 86.9 2.5
120 40.0 3.7 53.8 3.8 93.8 3.3
150 40.0 4.1 55.7 3.5 95.7 2.4
180 41.1 3.5 56.1 3.9 97.2 0.8
Table 6.VII Release of I-labelled IgG (Batch IV) by 17.5-day yolk 
sacs re-incubated in medium 199 alone 
Each column of data gives the mean value from 3 separate experiments in 
each of which the released radioactivities are expressed as a percentage 
of the total radioactivity released "by the yolk sac during its 3.0 h 
re-incubation period.
125
. Mean percentage radioactivity released (+ S.D.)Time _______________________________________________________
(min) acid soluble acid insoluble total radioactivity
0 1.6 + 0.9 0.5 + 0.4 2.0 + 0.5
5 13.5 1.4 6.8 1.6 20.4 1.9
15 28.4 2.6 14.4 3.3 42.8 4.9
30 41.2 2.6 22.4 4.5 63.7 4.2
45 50.6 3.9 25.2 3,6 75.8 2.5
60 53.1 2.8 27.7 1.9 80.8 2.1
75 60.6 1.2 27.6 1.6 88.1 0.7
90 61.9 3.3 29.8 3.0 91.7 0.5
120 66.2 3.3 31.2 2.8 97.4 0.5
150 67.9 2.4 31.4 1.8 99.3 0,6
180 70.0 2.4 30.0 2.4 100,0 0.0
125Table 6.VIII Release of I-labelled IgG (Batch IV) by 17.5-day yolk 
sacs re-incubated in medium 199 plus glucagon (1 , 0  pg/ml) 
Each column of data gives the mean value from 3 separate experiments in 
each of which the released radioactivities are expressed as a percentage 
of the total radioactivity released by the yolk sac during its 3.0 h 
re-incubation period.
. Mean percentage radioactivity released (+ S.D.)Time _____________________________________________—_____
acid soluble....acid insoluble total radioactivity
0 0.8 + 1,7 3.1 Hp 2.2 3,9 + 1.1
5 9.4 1.5 13,5 2.8 22,9 1.6
15 18.3 1.3 27.5 4.8 43.2 5.3
30 27.0 3.2 35.1 5.1 62.1 2.8
45 30.5 1.2 44.0 5,9 74.5 6.4
60 33.4 3.5 46.7 3.9 80.1 2.8
75 38.0 3.1 50.0 2.5 88.0 1.1
90 38.4 4.9 51.0 4.2 89.4 1.9
120 41.2 4.0 55,3 3.5 96,5 2.8
150 41.2 4.5 57.2 3.1 98.4 2.4
180 42.3 . 3.8 57.7 3.8 100.0 0.0
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6b Plot of acid soluble and acid insoluble radioactivity released
125by 17.5-day rat yolk sacs after ingestion of I-labelled IgG 
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Fig. 6c Effect of homologous IgG (10 yg/ml) on the rate of release 
125of I-labelled PVP from 17.5-day rat yolk sacs incubated 
in medium 199 alone
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Fig. 6d Release of 6-NAG by 17.5-day rat yolk sac re-incubated in
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1256f Release of I-labelled IgG (Batch IV) from 17.5-day rat yolk 
sac re-incubated in medium 199 plus glucagon (1.0 yg/ml)
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125Fig. 6g Release of I-labelled IgG from 17.5-day rat yolk sacs
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7.1 Introduction
It has been suggested (Brambell and Halliday, 1956) that prenatal 
transmission of immunoglobulins in the rat occurs by way of the yolk 
sac. In the previous chapter the possible mechanisms of transmission 
were discussed and a number of in vitro experiments using yolk sacs 
removed from rats at 17.5 days of gestation were described. At this 
stage of gestation the ability of the tissue to remain viable in culture 
is now well established and the experiments described in Chapters 5 and 
6 of this thesis establish the capacity of the 17.5-day tissue to 
release homologous IgG that has associated with it. Although Williams
et'al. (1976) have made a preliminary report of the rate of ingestion 
125of I-labelled PVP in vitro at slightly earlier stages of gestation, 
the ability of the tissue to ingest and release homologous IgG has only 
been investigated at 17.5 days of gestation.
The passage of immunoglobulins from the mother to the fetal rat was 
the subject of an in vivo study by Halliday (1955b). In this com­
munication the amount of antibody in the fetal blood was expressed as 
a concentration quotient (C.Q.) with respect to the maternal serum 
(Batty et al.,1954). Halliday found the C.Q. to rise from 1^128 at 17 
days to 1^32 at 20 days of gestation: indicating the progressive tran­
smission of antibodies prior to birth. Unfortunately, these data do 
not demonstrate that the capacity of the transporting tissue actually 
increases with age but only that the net amount of antibody in the 
fetal blood compared to the maternal serum increases towards the end 
of gestation.
In order to investigate whether the cells of the yolk sac change 
in their ability to ingest and transport materials as a function of 
gestational age, experiments were designed with the objectives of 
answering the following questions:
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1. Does the rate of pinosome formation change with age?
2. Do the rates of ingestion of either a non-specific protein or 
homologous immunoglobulins alter with age?
3. Are the rates of release of ingested substrates, especially 
homologous IgG,affected by the gestational age of the tissue?
4. Does the proteolytic capacity of yolk-sac tissue change 
significantly towards the end of gestation?
The rates of uptake of 125I-labelled PVP, 125I-labelled dBSA and
125I-labelled IgG were therefore determined using yolk sacs taken at 
17.5, 19.5 and 20.5 days of gestation. In other experiments, the amount 
and nature of the radioactivity released on re-incubating tissues that 
had ingested one of these substrates were also investigated in an attempt 
to answer the third of these questions. Finally, the proteolytic 
capacity of the yolk sac towards 125I-labelled dBSA and 125I-labelled 
IgG was compared at different stages of gestation.
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METHODS
125 1257.2 Uptake of I-labelled PVP, I-labelled dBSA and homologous
1 *) C-^-labelled IgG by rat yolk sacs removed at 17.5, 19.5 and 
20.5 days of gestation
125The rates of uptake of the substrates I-labelled PVP,
■^i-labelled dBSA (Batch VI) and homologous *^I-labelled IgG (Batch 
III) were determined in the presence of calf serum (10%, v/v) using 
yolk sacs taken from 17.5-, 19.5- and 20.5-day pregnant animals (see 
Section 2.3 for details of method). The quantities of total radio­
activity present in the yolk sacs and in the media were assayed as 
described in Section 2.4 and 2.6, respectively and the protein content 
of each yolk sac was determined by the method of Lowry (see Section 2.5).
The concentration of radiotracer employed was 1.0 yg/ml for both
125j_iateiied dBSA and 3I-labelled IgG and 2.0 pg/ml for i-labelled
PVP.
Uptake, expressed as pl/mg yolk-sac protein, was plotted against 
time and the related Endocytic Index calculated as described in Sections 
2.12 and 2.13. The results, for each substrate at the different days 
of gestation, are shown in Tables 7.1 to 7.VI.
7.3 Release of 125I-labelled PVP, 125I-labelled dBSA and 125I-labelled 
IgG on re-incubating 17.5-, 19.5- and 20.5-day rat yolk sacs that 
had accumulated these substrates in vitro
Single yolk sacs, taken from three different animals on one of the
above days of gestation, were incubated in medium 199 alone (10.0 ml)
containing the radiotracer at a concentration of 5.0 yg/ml (see Section
1252.17 for method). In the case of I-labelled IgG, 15.5-day yolk 
sacs were also studied in equivalent experiments. After 2 h of incubation 
the yolk sacs were removed from each flask, washed ( 3 x 2  min) in 
changes of warm (37°C) gassed medium then re-incubated for 3.0 h in
fresh substrate-free medium.
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The radioactivity released was assayed by the methods described in 
Chapter 5, Section 5.4. For 125I-labelled dBSA and *25I-labelled IgG 
the quantities of total, acid soluble, and acid insoluble radioactivity 
released by 17.5-, 19.5- and 20.5-day yolk sacs are each shown in 
Tables 7.Vila and b, 7.Villa and b. [The rates of release of these 
substrates from 17.5-day yolk sacs are taken from Chapter 5; Tables 
5.IXa (for *2^I-labelled dBSA) and Table 5.VIII (for *2^I-labelled IgG)]. 
The percentage of tissue-associated radioactivity released from 17.5-,
12S19.5- and 20.5-day yolk sacs that had ingested I-labelled PVP are 
shown in Table 7.IX.
125The amounts of I-labelled PVP released by 17.5-, 19,5- and
20.5- day yolk sacs are plotted together against time in Fig. 7a;
125corresponding results for the release of I-labelled dBSA (Batch VI)
are shown separately in Figs. 7b-7d. Similarly, Figs. 7e-7g show the
125results of equivalent experiments using I-labelled IgG (Batch III) 
and 17.5-, 19.5 and 20.5-day yolk sacs, respectively.
Since insufficient Batch III IgG was available to include 15.5-day 
tissues in the same series of experiments, the release of 125I-labelled 
IgG by 15.5-day yolk sacs had to be determined with a fresh batch of 
125I-labelled IgG (Batch IV), A further set of data on 17.5-day tissues 
was also collected for this material to provide a necessary control.
These data are shown in Figs. 7h and 7i, respectively.
- 113 -
RESULTS
125 1257.4 Endocytic Indices of I-labelled PVP, I-labelled dBSA and 
125I-labelled IgG for yolk sacs at 17.5, 19.5 and 20.5 days of 
gestation
125The results of uptake experiments, using I-labelled PVP as
substrate are presented in Tables 7.1 and 7.II. Those data relating
to 17.5-day yolk sacs are derived from Table 3.1a (Chapter 3) but are
quoted again for purposes of comparison. It can clearly be seen from
125Table 7.II that the Endocytic Index of I-labelled PVP shows no
significant change with increasing age of the yolk sac. Likewise,
125with I-labelled dBSA as substrate, no significant change in Endocytic
Index was evident with increased age (see Tables 7.Ill and 7.IV). In 
125addition, with I-labelled dBSA as substrate, the overall mean value 
of the tissue-associated radioactivity did not differ significantly 
between 17.5- and 19.5-day yolk sacs but an increased level was observed 
at 20.5 days although this latter value was subject to a large standard 
deviation.
125Unlike the Endocytic Index of either I-labelled PVP or
125I-labelled dBSA, the observed Endocytic Index of 125I-labelled IgG
(Batch III) given in Tables 7.V and 7.VI shows a slight decrease with
increased gestational age, falling from 13.4 pl/h/mg protein at 17.5
days to 9.3 yl/h/mg protein at 20.5 days of gestation. Unfortunately
only two satisfactory sets of data relating to the uptake of 125I-labelled
IgG by 20.5-day yolk sacs were obtained. [Although several other sets
were obtained, the resultant uptake plots were non-linear or showed a
high degree of scatter and consequently were rejected (see Chapter 2,
Section 2.15). As a result of this difficulty, this particular batch
of substrate became exhausted before any further acceptable plot could
125be obtained.] Furthermore, with I-labelled IgG as substrate, the 
overall mean value of the tissue-associated radioactivity was higher
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for 17.5-day yolk sacs than for either 19.5- or 20.5-days yolk sacs, 
the latter two showing little difference in values (Table 7.VI). As
with the value of the tissue-associated radioactivity, the mean rates 
of accumulation by the tissue also showed no significant difference 
between 19.5 and 20.5 days, but the values on both of these days were 
slightly lower than that at 17.5 days.
7.5 Release of 125I-labelled PVP, 125I-labelled dBSA and 125I-labelled 
IgG from 17.5-, 19.5— and 20.5-day yolk sacs on re-incubation in 
substrate-free medium
The amounts of the non-digestible substrate, 12^I-labelled PVP, 
released up to a given time on re-incubating yolk sacs taken at 17.5,
19.5 and 20.5 days of gestation are plotted in Fig. 7a. For 17.5-
and 19.5-day yolk sacs the amount of substrate released was only a
small percentage of that ingested by the tissue, this being no more
than 6% over the 3.0 h re-incubation period. Fig. 7a also clearly
shows the release patterns at these two times to be virtually identical,
each showing a slight gradient, equivalent to a rate of release of
approx. 1% per h, beyond the first 30 min of re-incubation,
In contrast, equivalent plots for 20.5-day yolk sacs showed the 
125amount of I-labelled PVP released to reach a value of approx, 10% 
after 150 min of re-incubation. Beyond this time a rapid and atypical 
increase in the amount of released radiotracer occurred, the amount of 
total radioactivity released rising to more than 20% over the next 
30 min. Calculated over the period 60 to 150 min, the rate of release 
was found to be approx. 2.0% per h; this is almost twice that for
17.5 or 19.5-day yolk sacs over the equivalent time interval.
Equivalent experiments using the readily degraded protein
125I-labelled dBSA as radiotracer showed a very different pattern of
125results compared with those for I-labelled PVP. Figs. 7b, 7c and 7d 
show the release of radioactivity with time for 17.5-, 19,5- and 20.5-day
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yolk sacs, respectively. The total radioactivity released rose rapidly 
to a maximum level of 60 to 75% of the radioactivity associated with the 
tissue at the beginning of the re-incubation period. The differences 
between each age group were only marginal. In each case the acid 
soluble radioactivity released closely followed the total radioactivity 
while the difference between each corresponding pair of these values 
(the acid insoluble radioactivity) was equivalent to only approx.
5-10% after 3.0 h re-incubation. The quantities of acid soluble and 
acid insoluble radioactivity released at 3.0 h of re-incubation showed 
no significant dependence on the day of gestation.
Figs. 7h and 7i show the release of radioactivity from 17.5-day 
and 15.5-day yolk sacs after ingestion of a different batch of 
^2^I—labelled IgG (Batch IV) • The amount of total radioactivity 
released by the yolk sacs appears to be somewhat lower at 15.5-days 
than at 17.5-days of gestation (i.e. 20% lower after 3.0 h re-incubation). 
On the other hand the amount of acid soluble radioactivity released 
appears to be approximately the same on both days so that a significantly 
lower amount of acid insoluble radioactivity is released in the case 
of 15.5-day yolk sacs. When expressed as a percentage of the amount 
of tissue-associated radioactivity, the acid insoluble radioactivity 
released in the case of the 15.5-day yolk sac is much less than for
17.5-day yolk sacs. Thus these results suggest that at the earlier 
age the yolk sac is restricted in its ability to release 125I-labelled 
IgG intact.
7.6 Discussion
In the previous chapter the mechanism by which 125I-labelled IgG 
is ingested by and released from the yolk sac in vitro was investigated 
in relation to the hypotheses advanced by Brambell (1966) and Wild 
(1975). While the bulk of the work reported in this thesis relates 
to yolk sacs taken at 17.5 days of gestation, the investigations in
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this chapter were designed to determine whether the rate of pinocytic 
uptake, the proteolytic capacity of the tissue or the rate of release 
of any of the three different substrates from the tissue depended
significantly on the gestational age of the yolk sacs.
125The non-digestible substrate, I-labelled PVP, was shown in
Chapter 3 to be ingested and progressively accumulated by the 17.5-day
yolk sac and to enter essentially in the fluid phase, From the
Endocytic Indices shown in Table 7.II it is apparent that the rate of
pinocytosis remains unaltered in yolk sacs removed at 17.5 - 20.5 days
of gestation. Williams £t al. (1976) found similar results with yolk
sacs taken at 15.5 and 17.5 days of gestation. Taken together, these
findings indicate that the yolk-sac tissue ingests the surrounding
medium at a rate of approximately 2 pl/h/mg protein and that this
capacity remains substantially the same over the period 15,5 - 20.5
days of gestation. Moreover, the rate of release of this substrate
was very low, being about 1.0% per h for 17.5- or 19.5-day yolk sacs
and slightly higher (2.0% per h) for 20.5-day yolk sacs. This release
of substrate may well result from one of several causes. Firstly, the
lysis of cells resulting in liberation of their contained substrate;
secondly, exocytosis of substrate from the vacuolar system and, thirdly,
slow release of extracellular substrate during the re-incubation period
due to its slow de-adsorption from the cell surface or diffusion out of
pockets of bulk medium occluded between the microvilli that cover the
uterine face of the tissue. Nevertheless, such small differences in
the rates of release at different stages of gestation would not affect
significantly the calculated values for the rate of fluid ingestion.
The rate of uptake of the digestible substrate 125I-labelled dBSA
was also observed to remain independent of the gestational age of the
tissue. Since the basal rate of uptake of the non-digestible 
125substrate I-labelled PVP was also constant, the finding that the
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rate of uptake of the digestible substrate, I-labelled dBSA (a 
substrate whose major route of uptake has been shown to be by adsorption 
to the tissue surface), is also independent of the gestational age, 
implies that the number of available binding sites for this protein also 
remains unchanged. Furthermore, these results indicate that the 
capacity of the yolk sac to ingest and degrade proteins to the level of 
their constituent amino acids remains a prominent characteristic of the 
tissue and shows no signs of diminished activity as the end of gestation 
approaches.
It is interesting that the Endocytic Index of ^I-labelled IgG
was observed to fall with increased age of the yolk sac. This does not
necessarily indicate reduced uptake of this substrate by the tissue since,
in the two previous chapters, it was observed that on re-incubating
125yolk sacs that had previously ingested I-labelled IgG, a substantial
proportion of the ingested substrate was released in a macromolecular
form. The observed fall in Endocytic Index with age may well result
from a modification of the percentage of ingested IgG so released rather
than the amount ingested (since the method of deriving values of the
Endocytic Index would neglect the contribution to the total uptake made
by substrate released in a macromolecular form).
125Analysis of the release patterns for I-labelled IgG indicates 
that no change occurs between 17.5 and 19.5 days but, at 20,5-days, 
the percentage of the tissue-associated radioactivity released over a
3.0 h re-incubation period was reduced and,of that portion released, a 
greater fraction was in the form of acid insoluble species. This 
observation is compatible with the above suggestion that the fall in 
the Endocytic Index on day 20.5 may well be a reflection of the inc­
reased proportion of acid insoluble radioactivity released from the
tissue rather than a reduction in the pinocytic capacity of the tissue
125towards I—labelled IgG.
125
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From these data it would appear that during the time interval 15.5 to
20.5 days of gestation the yolk sacs’ ability to release immunoglobulins 
intact actually increases.
A final point worthy of note is that during the latter days of 
gestation the protein content of the yolk sac increases rapidly from 
about 5-6 mg at 17.5 days to some 10-12 mg at the age of 20.5 days, as 
a result of rapid growth of the tissue. Furthermore, it was also noted 
that the diameter of the yolk sac increases rapidly, more than doubling 
in the same time period. Such an expansion in diameter requires an 
attendant 4-fold increase in surface area (assuming the yolk sac to be 
approximately spherical in shape). During this time the amount of 
tissue protein only doubles hence a certain amount of stretching or 
unfolding at the yolk sac must occur. The rapid expansion may well be 
the cause of the frailty which has been generally observed to be associated 
with rat yolk sacs towards the end of gestation especially those at
20.5-days (Roberts, G.; personal communication). The more delicate 
state of the yolk sac at 20.5 days probably explains why such tissues
failed to show reproducible uptake of 125I-labelled IgG, showed rapid 
125release of I-labelled PVP after 150 min of re-incubation and showed 
decreased reproducibility in the release plots. Possibly, weakening 
of the yolk sac immediately prior to birth would be advantageous to 
the fetus in that its escape through this cellular barrier would be made 
considerably easier, hence decreasing the neonatal mortality rate for 
the species.
The above findings may be relevant to the biological function of 
the tissue. If the yolk sac is involved in the transmission of IgG 
to the rat fetus in the last few days of gestation, as suggested by
The results obtained for 15,5-day yolk sacs would appear to support
this finding, in that less 5I-labelled IgG was released by yolk sacs
of this age compared to yolk sacs taken at 17.5-days of gestation.
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Brambell and Halliday (1956), then, as term approached, if a relatively 
greater percentage of ingested ^-labelled IgG was released from the 
yolk sac rather than digested within its lysosomal system, then in vivo 
a greater amount could be transmitted to the fetus to provide it with 
passive immunity immediately before birth.
Table 7.1 Uptake of I-labelled PVP by 17.5-, 19.5- and 20.5-day rat 
yolk sacs from medium 199 containing calf serum (10%, v/v)
Each line of the table shows the data from a separate experiment in which 
yolk sacs, taken from a single animal at the day of gestation indicated, 
were incubated separately in medium 199 containing 10% calf serum and 
^^I-labelled PVP (2.0 pg/ml of medium).
125
Age of 
yolk sacs 
(days)
No. of 
yolk sacs
Endocytic Index 
(pl/h/mg protein)
Correlation
Coefficient
Intercept 
(pi/mg protein)
17.5 10 2.10 0.979 +0.41
ft 10 2.17 0.991 +0.32
II 10 2.52 0.994 +0.13
II 10 1.61 0.963 +1.40
19.5 10 1.88 0.987 +0.71
II 10 2.17 0.968 +0.86
II 10 1.89 0.986 +0.68
20.5 10 1.97 0.975 +0.97
It 10 2.00 0.989 +1.15
II 10 1.95 0.962 +0.17
Table 7.II Summary of the Endocytic Indices
of 125I-PVP for 17.5-, 19.5- and
20.5-day rat yolk sacs
This table summarizes the data of Table 7.1.
Age of 
yolk sac 
(days)
No. of 
experiments
Mean Endocytic 
Index (S.D.) 
(yl/h/mg protein)
17.5 4 2.10 + 0.38
19.5 3 1.98 + 0.17
20.5 3 1.97 + 0.03
125Table 7.Ill Uptake of I-labelled dBSA (Batch VI) by 17.5-, 19.5- and
20.5-day rat yolk sacs in medium 199 containing calf serum 
(10%. v/v)
Age of 
yolk sacs 
(days)
No. of 
yo Ik 
sacs
Endocytic
Index
(yl/h/mg
protein)
Correlation
Coefficient
Intercept
(yl/mg
protein)
% TCA 
Solubles 
in
125I-dBSA
Mean Tissue 
Radioactivity 
(yl/mg protein)
17.5 (See Chapter 3 Table 3.II for individual results)
19.5 10 103.6 0.981 -18.3 0.60 74.9
II 10 78.6 0.980 +13.3 0.60 61.3
II 10 92.6 0.970 -20.5 0.93 82.3
20.5 10 66.9 0.972 - 7.9 0.63 50.7
II 10 86.0 0.984 - 3.7 0.96 120.3
If 10 104.0 0.984 -26.3 1.04 146.9
Table 7.IV Summary of the Endocytie Indices of I-labelled 
dBSA (Batch VI) for 17.5-, 19.5- and 20.5-day rat 
yolk sacs
125
Age of 
yolk sacs 
(days)
No. of 
Experiments
Mean + S.D. 
Endocytic Index 
(yl/h/mg protein)
Overall mean tissue 
radioactivity; + S.D. 
(yl/mg proteTn)
17.5 4 81.8 + 13.6 85.0 + 9.9
19.5 3 91.6 + 12.5 72.8 + 10.7
20.5 3 85.6 + 18.5 106.0 + 49.7
r125Table 7.V Endocytic Indices of I-labelled IgG (Batch III) for 19.5- and 20.5-day rat yolk sacs in the presence of calf 
serum (10%, v/v)
Age of 
yolk sac 
(days)
No. of 
yolk 
sacs
Endocytic
Index
(yl/h/mg
protein)
Correlation
Coefficient
Intercept
(yl/mg
protein)
% TCA Solubles
. 125t t „ m  I-IgG
Mean Tissue 
radioactivity 
(yl/mg protein)
Rate of accumulation of 
tissue radioactivity 
(yl/h/mg protein)
Correlation
Coefficient
17.5 See Chapter 5 Table 5.1 for individual results
19.5 10 8.82 0.972 +2.79 2.01 13.19 1.15 0.885
f l 9 10.45 0.965 +0.35 2.60 13.16 1.21 0.652
I f 10 10.95 0.993 -3.00 2.01 14.51 1.99 0.918
20.5 10 10.36 0.980 +1.9 1.79 16.00 2.13 0.891
I t 10 8.16 0.952 +6.45 2.39 12.55 0.85 0.695
Table 7.VI Summary of the Endocytic Indices of I-labelled IgG 
(Batch III) for 17.5-, 19.5~ and 20.5-day rat yolk sacs
125
Age of 
yolk sacs 
(days)
No. of 
Experiments
Mean Endocytic 
Index; +_ S.D. 
(yl/h/mg 
protein)
Overall mean tissue 
radioactivity, + S.D. 
(pi/mg proteTn)
Mean rate of 
accumulation of 
tissue radioactivity 
(yl/h/mg protein)
17.5 4 13.4 + 2.0 19.8 + 3.2 3.1 +0.96
19.5 3 10.07 + 1.11 13.62 + 0,77 1.45 + 0.47
20.5 2 9.26 14.28 1,49
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Tables 7.Vila to 7.X
Each set of results relates to data from three separate, identical 
experiments in each of which a single yolk sac, taken from a different 
animal, was used.
125Table 7.Vila Release of I-labelled IgG (Batch III) by 19.5-
day rat yolk sacs re-incubated at 37°C in medium
199 alone
Time Mean Percentage radioactivity released + S.D.
(min) acid !soluble acid insoluble total radioactivity
0 1.5 + 0.4 2.3 + 0.5 3.8 + 0.7
5 6.8 1.2 8.9 1.2 15.7 1.5
15 15.3 1.5 17.1 2.4 36.9 3.8
30 22.4 3.7 28.3 4.4 50.6 4.2
45 25.6 4.5 33.7 4.9 59.3 4.8
60 27.4 4.0 37.9 6.0 65.3 3.7
75 31.7 5.0 39.8 6.9 71.5 2.0
90 32.4 5.4 41.9 6.6 74.3 2.5
120 35.3 5.4 44.1 7.5 79.3 2.2
150 36.5 5.7 46.5 7.1 83.0 3.4
180 37.7 5.0 47.1 7.1 84.8 2.6
125Table 7.VIIb Release of I-labelled IgG (Batch III) by 20.5- 
day rat yolk sacs re-incubated at 37°C in medium 
199 alone
. Mean Percentage radioactivity released + S.D.Time __________________________________________ — ___________
(min) acid soiubxe acid insoluble total radioactivity
0 -0.6 + 0.3 0.2 + 0.7 0.6 + 0.6
5 4.3 1.3 5.3 2.2 9.6 0.9
15 9.5 2.4 15.1 3.8 24.7 5.7
30 15.4 3.9 19.4 2.6 34.9 5.7
45 18.7 4.8 23.5 2.5 42.2 7.0
60 20.0 4.8 27.9 1.4 48.0 5.7
75 20.8 4.1 28.9 2.7 49.7 6.7
90 22.1 4.3 30.5 2.5 52.5 6.8
120 22.5 4.6 32.0 1.5 55.5 6.1
150 22.9 4.1 34.5 1.0 57.4 4.9
180 22.3 4.1 36.4 1.3 58.7 5.2
Table 7.Villa Release of I-labelled dBSA (Batch VIII) by
19.5-day rat yolk sacs re-incubated at 37°C in
125
medium 199 alone
Time Mean Percentage radioactivity released S.D.
(min) acid soluble acid insoluble total radioactivity
0 2.9 + 0.2 0.8 + 0.8 3.6 + 0.7
5 17.7 2.0 0.2 3.4 17.8 3.0
15 32.0 3.8 3.2 1.6 35.1 4.5
30 42.8 4.1 3.2 2.1 47.0 4.3
45 47.1 2.7 5.5 2.9 53.5 4.2
60 50.6 2.3 3.8 2.3 55.8 3.6
75 56.9 0.9 5.9 0.7 63.2 0.8
90 58.6 0.3 5.4 1.6 64.9 0.9
120 61.7 0.4 6.4 1.2 68.1 1.0
150 61.6 1.4 7.1 0.9 68.7 0.8
180 64.6 0.9 7.2 0.8 71.9 1.3
Table 7.VIIIb Release of 125I-labelled dBSA (Batch VI) by
20.5-day rat yolk sacs re-incubated at 37°C in
medium 199 alone
Time Mean Percentage radioactivity released _+ S.D.
(min) acid soluble acid insoluble total radioactivity
0 1.0 + 0.2 -0.1 + 0.3 0.9 + 0.2
5 12.3 1.5 1.7 0.7 14.0 1.3
15 28.2 4.4 1.9 0.6 30.0 4.4
30 40.9 7.3 3.6 1.3 44.5 8.5
45 46.5 8.5 3.2 1.0 49.6 7.4
60 49.2 8.0 4.2 0.2 53.2 8.1
75 52.5 9.3 4.8 0.6 57.3 9.4
90 55.1 10.1 6.9 2.3 62.0 11.7
120 59.0 10.6 9.1 4.4 68.2 14.3
150 61.1 9.5 10.3 5.0 71.3 13.5
180 64.7 4.4 11.1 5.7 73.1 13.6
125Table 7.IX Release of I-labelled PVP by 17.5-, 19.5- and
20.5-day rat yolk sacs re-incubated at 37°C in
medium 199 alone
Mean Percentage radioactivity released + S.D. T i m e _____,______________________________________ “ ____
(min) 19.5-day 20.5-day 17.5-day
0 0.3 + 0.3 0.6 + 0.8 0.3 + 0.4
5 1.2 0.2 4.0 1.6 2.0 0.5
15 1.8 0.1 5.1 1.7 2.9 0.3
30 4.0 1.7 6.5 1.9 2.9 0.6
45 3.6 0.7 7.0 1.4 3.2 0.5
60 3.7 1.0 7.4 1.7 3.1 0.5
75 3.9 0.9 8.1 1.5 3.4 0.4
90 4.3 0.9 8.6 1.7 4.0 0.7
120 4.7 1.0 9.6 1.7 4.0 0.6
150 5.4 0.9 10.3 2.0 4.4 0.2
180 6.5 0.8 20.6 7.7 5.1 0.6
Table 7.X 125Release of I-labelled IgG (Batch IV) by 15.5-day 
rat yolk sacs re-incubated at 37°C in medium 199 alone
Mean Percentage radioactivity released + S.D.T i m e ___________________________________________ Z__________
(min) acid soluble acid insoluble total radioactivity
0 1.3 + 0.6 0.2 + 0.5 1.5 + 0.2
5 11.8 2.2 3.9 1.2 15.8 2.8
15 27.9 5.3 7.5 1.6 35.4 5.7
30 37.6 5.3 10.9 3.4 48.5 8.5
45 44.7 7.7 11.5 2.0 56.2 9.6
60 49.5 7.4 11.6 3.3 61.1 9.3
75 49.7 6.9 14.0 4.6 63.7 9.8
90 54.1 6.3 11.8 2.9 65.9 8.8
120 57.4 7.8 13.1 2.3 70.6 9.7
150 59.4 7.2 13.5 2.9 72.8 9.3
180 60.9 7.6 13.8 3.3 74.7 9.4
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Fig. 7a Release of I-labelled PVP from 17.5, 19.5 and 20.5-day 
rat yolk sacs re-incubated in medium 199 alone
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125Fig. 7b Release of I-labelled IgG (Batch III) by 17.5-day rat yolk
sacs re-incubated in medium 199 alone
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I-labelled dBSA (Batch VI) from 19.5-day ratFig. 7c Release of 125
yolk sacs re-incubated in medium 199 alone
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Fig. 7d Release of I—labelled dBSA (Batch VI) from 20.5—day rat 
yolk sacs re-incubated in medium 199 alone
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Fig. 7e Release of , I-labelled IgG (Batch III) from 17.5-day 
yolk sacs re-incubated in medium 199 alone 
Same data as shown in Fig. 5e
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Fig. 7f 125Release of I-labelled IgG (Batch III) from 19.5-day rat
yolk sacs re-incubated in medium 199 alone
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Fig. 7g 125Release of I-labelled IgG (Batch III) from 20.5-day rat
yolk sacs re-incubated in medium 199 alone
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Fig. 7h Release of I-labelled IgG (Batch IV) from 17.5-day yolk 
sacs re-incubated in TC 199 alone 
(Same data as presented in Fig. 6e)
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7i Release of I-labelled IgG (Batch IV) from 15.5-day rat125
yolk sacs re-incubated in medium 199 alone
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8.1 Introduction
The existence of protein molecules within a ’fluid’ lipid bilayer 
(Singer, 1972) is now a generally accepted feature of current models 
for the structure of cellular membranes. The purpose of many of these 
proteins is to act as specific recognition or receptor sites for the 
binding of exogenous compounds. Subsequent to such binding one of a 
number of different events may occur. The proteins at such sites may 
be enzymic in nature and be responsible for effecting some change in 
the bound species, e.g. degradation. A second consequence is that the 
binding of the species (in this case a hormone) results in the trans­
mission of a ’signal’ across the membrane causing changes in the metabolic 
activity of the cell. One of the most well known examples of this 
type of effect is that shown by insulin. Alternatively, binding to 
the receptor site may result in phagocytosis or pinocytosis leading to:
(a) Degradation of the internalized substrate,
(b) Accumulation as in the case of non-digestible substrates, 
or (c) Transmission across the cell, as in the case of IgG.
In previous chapters the binding of radiolabelled substrate to the 
plasma membrane (prior to pinocytosis) by the rat yolk sac maintained in 
culture has been one area of investigation. Further to these studies 
the experiments described in this chapter, although preliminary in 
nature, have been conducted in order to ascertain the role of membrane 
proteins in the uptake of substrates by pinocytosis. Also, the 
isolation of receptor proteins has been attempted by gel chromatography 
techniques.
A number of studies both in intact erythrocyte and isolated membranes 
(Winzler etal., 1967; Tripplett and Carraway, 1972; Steck et al., 1 9 7 1) 
and similar studies on Sarcoma 180 tumour cells (Hunt and Brown, 1974; 
Huggins et al., 1975) have also been conducted. In all these studies 
attention van focussed on the digestion of receptor sites with reference
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to the released digestion products.
In this chapter mild proteolysis by trypsin was employed to study
the role of receptors during pinocytosis. This investigation utilized 
125I-labelled PVP as a substrate which was shown in previous studies
(Williams £t al., 1975a and Chapter 3) to have an Endocytic Index which
directly reflects the rate of pinocytic capture of fluid. Furthermore,
the role of the receptor(s) as binding sites for proteins was followed
125 125by the rate of uptake of I-labelled dBSA and I-labelled IgG.
A study of the digestion products released by trypsinisation was not
undertaken. Although such information would be valuable in assessing
the structural features of the receptor proteins in relation to the
the processes of pinocytosis and substrate binding, it was first
necessary to investigate the gross effect of trypsin on pinocytic events.
The second line of investigation involved the labelling of membrane
proteins with I[iodid^ using lactoperoxidase and normal yolk sacs.
The isolation of such proteins from the homogenized yolk sac by gel
chromatography was attempted. Demonstration of the binding of the
labelled receptors to protein substrates was also investigated by 
125incubation of I-labelled cell homogenate with BSA and IgG before 
chromatography and observing shifts in the elution patterns.
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METHODS
8'2 SEL^e of 125I-labelled PVP, 125T-UbelIed dBsfl ,,T,
125 - ------------ Li- ■
---r~labelled rSG by trvnsinired 17.5-day rat volfe saca
A total of 20 yolk sacs »arc removed from two 17.5-day pregnant 
rats and pooled before placing 10 in a 250 ml Erlenmeyer flask con­
taining a solution (loo ml) of bog pancreas trypsin (0.5 lg/ml; Type 
IX, Sigma London) in medium 199. The remaining 10 yolk sacs were 
placed in a similar flask containing medium 199 alone. Both flasks 
were gassed with oxygen/carbon dioxide (95:5) for 30 sec and placed in 
a shaking water-bath at 100 strokes/min at 20°c. After 10 min the 
yolk sacs were removed from the water-bath and each transferred to a 
single flask containing medium 199 (8.0 ml) and calf serum (1.0 ml) 
gassed with 02/C02 (95:5) for 10 secs and maintained at 37°c in a 
shaking water-bath at 100 strokes/min. Substrate was added after 20 
min incubation in medium 199 (1.0 ml) to give final concentrations 
of 2.0 pg/ml for I-labelled PVP and 1.0 pg/ml for both 125I-labelled 
dESA and l25I-labelled IgG. Yolk sacs were removed at regular intervals 
up to 3.0b and washed three times (2 min each) in changes of cold saline 
(1.0% w/v, 4°C) and stored at -20°C until assayed.
Incubation medium and yolk sacs were assayed as described in 
Sections 2.6 and 2.4 respectively for incubations in which 125I-labelled
PVP was used as substrate, by the methods described in Section 2 4 and
125 *
2.7 when either I-labelled dBSA or and 125I-labelled IgG was used
as substrate. The results were processed as described in Section 2.12
and 2.13 for non-digestible and digestible substrates, respectively.
In order to determine whether treatment with trypsin resulted in 
loss of cells by the yolk sac upon re-incubation, l.o ml samples of 
the incubation medium were removed from each flask, pooled and cen­
trifuged at 1,000 g for 10 min to precipitate any detached cells. The 
supernatant was removed and the cells washed with phosphate-buffered
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saline (0.1 M phosphate in 1.0% w/v saline; 5.0 ml) re-centrifuged at 
1,000 g for 10 min and the supernatant removed. Finally the cells were 
re-suspended in phosphate-buffered saline and the volume adjusted to 
0.5 ml. A small sample of the suspension was placed on a haemocyto— 
meter slide with improved Neubauer rulings (Weber and Sons, Lancing, 
Sussex) and whole cell count performed by the usual platelet counting 
method, under a phase contrast microscope. Cell integrity was judged 
by Nigrosin exclusion. From the remaining suspension two 200 pi 
samples were removed and assayed for protein content by the method of 
Lowry et_ jil. (1951) .
The rates of uptake of 125I-labelled PVP, 125I-labelled dBSA and 
125I-labelled IgG are shown in Tables 8.1, 8.11 and 8.Ill, respectively, 
and further summarized in Table 8.IV.
1258.3 Chromatography of I-labelled membrane proteins of the rat 
yolk sac
The surface proteins of the epithelial cells on the uterine surface
125of the visceral yolk sac were labelled with [ I]iodide using the
method of Hunt and Brown (1975). A single intact conceptus was
removed from a 20.5-day pregnant rat and ligatured around the yolk sac
stalk, just under the placental cone, and suspended by the thread in
2.0 ml of phosphate-buffered saline (0.05 M in 1.0% (w/v) saline).
The intact conceptus was suspended in the solution in order to minimize
the contact between the solution and the placental cone and maximize
contact between the visceral yolk sac and solution. The solution was
stirred at room temperature and sodium [ I]iodide (200 pCi) and
lactoperoxidase (200 yg) were added to the solution. To the reaction
mixture the oxidizing agent hydrogen peroxide (20 pi of 0.06%, v/v) was
added at 2 min intervals until some 10 such aliquots had been added.
The mixture was stirred for a further 10 min prior to the addition of
125KI (500 pg) to displace I-iodide which was not tightly bound. The
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conceptus was then removed from the flask and washed in phosphate- 
buffered saline containing KI (1.0 mg/ml). The yolk sac was then 
dissected free and homogenized in 2.0 ml of Tris/SDS buffer (Tris 
(hydroxymethyl) aminomethane, 0.05 M, in sodium dodecyl sulphate,
0.1% w/v, adjusted to pH 7.0 with 0.5 M H2S04) using a Virtis homogenizer 
at speed setting 6 for 2 min.
The homogenate was centrifuged and an aliquot (0.5 ml) was applied 
to a column of Sephadex G-200 (57 x 1.7, cm) and eluted with Tris/SDS 
buffer at flow rate of 0.2 ml/min. The eluted radioactivity was 
assayed on a gamma scintillation counter and plotted against fraction 
number. Two 0.5 ml samples of the homogenate were incubated; one with 
homologous IgG (10 yg/ml) and the other with BSA (10.0 yg/ral) at 4°C 
in a shaking water-bath set at 100 strokes/min for 6.0 h. The samples 
were then applied separately to a column of Sephadex G-200 and eluted 
as described above. The three elution patterns are shown in Fig. 8a.
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RESULTS
8‘4 Uptake of substrates by trypsin treated yolk sacs
Table 8.IV shows a summary of the Endocytic Indices for 125I-labelled
PVP, 125I-labclled dBSA and 125I-Ubelled IgO obtained with yolk sacs
which received prior treatment with trypsin (Section 8.2). In the
case of each of the substrates the results show a fall in the Endocytic
Index upon treatment with 0.5 yg/ml of trypsin prior to incubation.
125The data for I-labelled PVP show the Endocytic Index to drop to
61.6% of that for non-treated yolk sacs. Similarly, with 125I-labelled 
125dBSA and I-labelled IgO the Endocytic Indices dropped to 66.2% and 
58.9% of the corresponding control values, respectively.
It is clear that trypsin treatment depresses the rate of fluid 
ingestion as reflected by the uptake of 125I-labelled PVP. It is also 
evident that the rate of uptake of substrate ingested in the adsorbed 
phase is also lowered but this would seem to be as a result of an 
overall fall in the rate of pinosome formation rather than by specific 
alterations to the receptor sites.
For almost every experiment the number of detached cells and the 
amount of protein loss per yolk sac were both estimated. Generally 
trypsin treatment resulted in neither a greater detachment of cells 
nor a greater protein loss upon re-incubation compared to the non- 
trypsinised tissues.
8.5 Gel Chromatography of membrane proteins
Fig. 8a(i) shows the elution pattern on a Sephadex G-200 column 
of a centrifuged homogenate prepared from a 125I-labelled 20 5-day 
rat yolk sac. Clearly evident are two major protein peaks followed 
by a third smaller peak. (This in turn is followed by a very large 
peak of radioactivity (fractions 55-75) corresponding to that of free 
[ I] iodide.) Incubation of the yolk sac homogenate with native IgG
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and BSA followed by chromatography resulted in the elution patterns 
shown in Fig. 8a(ii) and Fig. 8a(iii). The observed patterns are 
essentially the same as that for homogenate alone, except for a slight 
change in the size of the third peak is observed in the case of IgG. 
This peak would appear to be reduced in size compared to the other two 
elution patterns.
This observation is consistent with the binding of IgG to this 
membrane protein causing a fraction of it to elute at some earlier 
position between the void volume and the original position i.e. at a 
position corresponding to a complex of IgG and the membrane protein.
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8.6 DISCUSSION
It should be noted that the studies presented in this chapter are 
of only a preliminary nature and further work must be undertaken in order 
to confirm and extend these findings. Nevertheless, the results 
collected showed a number of features worthy of discussion.
Trypsinization of yolk sacs was performed at 20°C, a temperature 
at which pinocytosis has virtually ceased (Duncan, unpublished data) in 
order to prevent internalization of the enzyme and the possible con­
sequences of internal cellular damage. The results show that when 
^■^1-labelled PVP was used as a substrate, in order to follow any changes 
in the rate of fluid ingestion, trypsin treatment caused a fall in the 
Endocytic Index compared to the matched (non-trypsinized) control 
experiments. Control experiments demonstrated good recovery of the tissue 
when transferred from medium 199 at 20°C to freshmedium in incubation 
flasks at 37°C. Furthermore, experiments, in which the rate of uptake 
0f ^-^i-labelled PVP was measured at 37°C, showed a mean Endocytic Index 
of 1.7 + 0.3 (S.D.) compared to 1.77 +_ 0.23 (S.D.) for the trypsinization 
control experiments. These findings demonstrate that the mechanical 
and culture manipulations associated with the trypsinization process 
do not interfere with the pinocytic capacity of the tissue and that 
such changes which were observed are solely the result of the presence
of trypsin during the enzyme treatment stage.
125The Endocytic Index of I-labelled PVP for trypsinized yolk
sacs was reduced by approximately a third, reflecting a fall in the
pinocytic activity of the tissue to this extent. Whether the reduced
pinocytic activity was the result of digestion of the cell membrane
proteins or because trypsin itself irreversibly inhibits pinocytosis
cannot be judged from these results.
. 125 125Similar experiments using I-labelled dBSA and I-labelled IgG
showed equivalent percentage falls in the Endocytic Indices compared
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to the appropriate control experiments. Considering these data together, 
it would seem that these changes in the Endocytic Index are due to an 
alteration in pinocytic activity of the tissue and that the binding 
process for these two proteins at least is unaffected. As a result of 
this action, trypsinization of this tissue may well be able to yield 
valuable data relating to the mechanisms involved in the pinocytic 
process itself rather than that of protein binding.
Obviously more work is required to confirm these findings and 
extension of the study to investigate the site of action of trypsin must 
be undertaken. Furthermore, analysis of the membrane protein fraction 
could yield valuable data on the effects of enzyme treatment of the 
yolk sac tissue. With this type of investigation in mind a method is 
described in this chapter using gel chromatography of the homogenized 
tissue. Gel electrophoresis methods similar to those described by 
Fairbanks et al., 1971; Triplett and Carraway, 1972; Phillips and 
Morrison, 1970; Hunt and Brown, 1974, 1975 were investigated as 
alternatives to gel filtration.
Further studies using other enzymic treatments would seem a logical
extension of this work. Two other enzymes of potential interest are
papain and neurominidase but unfortunately time did not allow work
planned with the latter to be carried out. The digestion of yolk sacs
with neurominidase may well result in interesting findings when the
125uptake and release of I-labelled IgG are investigated by the methods 
already described in Chapter 5. It has been suggested (Sonda et al., 
1973; Wild, 1975) that the glycocalyx may be involved in the binding of 
immunoglobulins prior to transport across the cell. Digestion of the 
glycocalyx with neurominidase which would result in the removal of the 
terminal sialic acids may well have profound effect on binding processes 
and transport. Studies of a similar nature (Cuatrecasas and Illiono, 
1971) have demonstrated the role of sialic acid in the action of insulin
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on adipose tissue, and similar studies (Pricer and Ashwell, 1971) using 
membranes from hepatocytes were able to show a relationship between 
de-sialation and protein binding.
Again it should be stressed that the studies reported are only 
preliminary and the lack of time prevented a more exhaustive investigation, 
I should therefore like to suggest a continuation of this investigation 
should involve attention to the following points.
1) Confirmation of existing data.
2) Monitoring of trypsin released digestion products.
3) Analysis of membrane proteins before and after trypsinization. 
and 4) Use of other enzymes; for example neurominidase and papain.
In conjunction with the above studies a method of isolating the 
receptor sites by chromatography was used, similar to that employed by 
Dufau et al. (1973). The elution patterns from a Sephadex G-200 column 
are shown in Fig. 8a. It is evident that there are three major bands 
of activity probably corresponding to membrane proteins, although these 
bands could well represent exogenous proteins associated with the yolk 
sac which became iodinated during the labelling procedure. One such 
protein may well be lactoperoxidase itself. It is therefore essential 
that the elution pattern of this enzyme be established in further 
investigations.
Incubation of the yolk sac homogenate with BSA resulted in no 
change in the elution pattern but incubation with rat IgG resulted in a 
slight reduction in size of the smallest peak. This shift in peak 
size may be a result of binding between a receptor protein and IgG,
These preliminary studies would appear to demonstrate the presence 
of proteins in the yolk sac membranes and may well offer a method of 
studying substrate-receptor interactions especially those changes induced 
by enzymic treatments of the yolk sac. Unfortunately an alternative 
method employing polyacrylamide gel electrophoresis was unsuccessful
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in isolating bands of radioactivity because of the small amount of 
sample (20 yl) applied to the gel. In order to make this method usable 
a much higher specific radioactivity would have to be achieved during 
the iodination of the tissue.
Table 8.1 Endocytic Index of I-labelled PVP in the presence and 
absence of trypsin treatment
Each row of data is for a single experiment, several of which included 
treatment of the yolk sacs with Trypsin 0.5 mg/ml for 10 mins at 20°C 
prior to incubation with the substrate. A number of experiments were 
also performed in the same manner except Trypsin was omitted from the 
medium (see Section 8.2 for method).
125
Endocytic Index 
(yl/h/mg protein) CorrelationCoefficient
Total Cell 
Count Percentage Protein loss
1.47 0.929 0.97 x 106 1.04
Without 2.00 0.960 0,93 X 106 1.00Trypsin 1.60 0.990 - 2,20
1.80 0.977 0.98 X 106 1.46
1.02 0.957 0,76 X 106 1.60
With Trypsin 0.93 0.968 0.74 X 106 0.10
1.07 0.931 0.60 X 106 0,50
1.00 0.980 - - 1.50
1.26 0.991 0.70 X 106 1.94
Table 8.II Endocytic Index of 125I-labelled dBSA (Batch VI) by 
trypsinized and non-trypsinized yolk sacs 
Each row of data is for a single experiment^ several of which included 
treatment of the yolk sacs with Trypsin 0.5 mg/mg for 10 mins at 20°C 
prior to incubation with the substrate. A number of experiments were 
also performed in the same manner except Trypsin was omitted from the 
medium (see Section 8.2 for method).
Endocytic Index 
(pl/h/mg protein) CorrelationCoefficient
Total Cell 
Count Percentage Protein loss
Without
Trypsin
89.4
42.0
63.0
0.959
0.969
0.924
1.1 x 106 
0.5 x 106 
1.7 x 106
0.8
0.9
0.2
41.7 0.957 1.44 x 106 0.9With Trypsin 42.1 0.995 1.10 x 106 1.7
45.0 0.952 0.80 x 106 0.1
Table 8.III. Endocytic Index of I-labelled IgG (Batch III) by 
trypsinized and non-trypsinized yolk sacs 
Each row of data is for a single experiment, several of which included 
treatment of the yolk sacs with Trypsin 0.5 mg/ml for 10 mins at 20°C 
prior to incubation with the substrates. A number of experiments were 
also performed in the same manner except Trypsin was omitted from the 
medium (see Section 8.2 for method).
125
Endocytic Index 
(yl/h/mg protein)
Correlation
Coefficient
Total Cell 
Count
Percentage Protein 
loss
7.2 0.913 1.42 x 106 0.7
Without 5.6 0.887 «  _ 2.8Trypsin
9.0 0.990 0.8 x 106 1.0
4.3 0.703 0.67 x 106 0.25
With Trypsin 2.2 0.406 - 1.20
6.5 0.476 1.02 x 106 1,55
Table 8.IV Summary of the Endocytic Index for 125I-labelled PVP,
125I-labelled dBSA and 125I-labelled IgG for trypsinized
and non-trypsinized yolk sacs 
Summary of data from Tables 8.1, 8. II, and 8.Ill
Substrate Mean + S.D. Endocytic Number of Trypsin
Index
yl/h/mg protein
Experiments Concentration
(yg/ml)
1.72 + 0.23 4 0.0
125I-labelled PVP 1.06 + 0.13 5 0.5
125I-labelled dBSA
64.8 + 23.8 3 0.0
42.9 + 1.8 3 0.5
125I-labelled IgG
7.3 + 1.7 3 0.0
4.3 + 2.2 3 0.5
sac onFig. 8a Chromatography of homogenized 125I-labelled rat yolk
Fraction No.
C H A P T E R  9
G E N E R A L  D I S C U S S I O N
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GENERAL DISCUSSION
The work reported in this thesis is based on the experimental 
technique for the in vitro culture of rat yolk sac, in medium 199 con­
taining calf serum, developed by Williams et al. (1975a, b). This 
technique was modified (see Chapter 3) in order to study the ability of 
this tissue to ingest substrates in the absence of calf serum and thus 
simplify the analysis of the kinetics, These findings, in the absence 
of 10% (v/v) calf serum, indicated a fluid phase rate of ingestion of 
about 2.5 1/h/mg of protein as determined by the rate of ingestion of
I O C I-labelled PVP. Williams et al. (1975b) and Moore (1977) showed
125the major route of uptake of I-labelled bovine albumin preparations
to involve adsorption to the plasma membrane; a finding which was 
. 125confirmed m  Chapter 3 for I-labelled formaldehyde-denatured BSA.
Moreover, some 99% of this substrate was found to enter the cell bound
to the plasma membrane when yolk sacs were incubated in medium 199 alone.
These findings are consistent with the mechanism proposed by Jacques
(1969) for the uptake of substrates by pinocytosis. Furthermore, the
presence of calf serum in the incubation medium lowered the value of
125the Endocytic Index of I-labelled dBSA relative to that in the absence 
of calf serum; this observation is consistent with the existence of 
non-specific binding sites on the plasma membrane.
ioc
In Chapter 4 the value of the Endocytic Index of I-labelled 
dBSA was studied as a function of the overall albumin concentration 
and was shown to fall with increased concentration indicating saturation 
of binding sites. Subsequent analysis of the kinetics enabled the 
parameters K, the substrate: binding-site dissociation constant, and 
SR, the maximal rate of ingestion, to be estimated. Unlike previous 
work by Gosselin (1966) and Normann (1974) the uptake of substrate 
by the adsorptive route was differentiated from fluid-phase ingestion, 
hence allowing the calculation of the constants for the adsorption
- 133 -
phase only without any arbitrary assumptions being made about the 
contribution from fluid phase ingestion.
Much work has been reported on the uptake of immunoglobulins by 
various mammalian tissues and in some cases the transport of intact IgG 
across such cellular barriers. Moreover, the transport of IgG has 
been postulated to depend on its binding to specific IgG receptors 
present on the cell surface (Brambell, 1966 and Wild, 1975), An 
attempt to investigate the existence of receptor sites for IgG by using 
competitive experiments, similar to those used for I-labelled dBSA, 
resulted in only limited competition being observed. The failure of 
this pair of substrates to compete effectively probably resulted from 
two causes. Firstly, IgG-receptor specificity and secondly the 
release of macromolecular IgG from the yolk sac, which makes quantitative 
assessment of uptake via analysis of Endocytic Indices impossible.
Investigation of specific IgG-binding may well be approached by
125studying the amounts of I-labelled IgG bound to the yolk sac at 4°C, 
at which temperature pinocytosis is almost 100% inhibited (Duncan, 
unpublished data). Investigations of the interaction of IgG with tissues 
have been performed by Sonda and Schlamowitz (1972) who were able to 
demonstrate specific binding of IgG to rabbit yolk sac sections. 
Unfortunately this technique involved formaldehyde-fixation of the 
tissue which probably leads to damage of the receptor sites, making 
calculated parameters such as Km the substrate/receptor binding constant 
rather arbitrary and physiologically meaningless.
125An interesting feature of the in vitro uptake of I-labelled IgG, 
in the current study, was the accumulation of this substrate within the 
yolk-sac tissue when incubations were performed in the presence of 
calf serum. However, this effect was not observed in the absence of 
calf serum. In Chapter 5 it was suggested that the site of 
accumulation may be within the vitelline capillaries and that the 
absence of calf serum results in a loss of structural integrity of
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these vessels, permitting the I-labelled IgG to leak freely into the 
re-incubation medium. An alternative explanation (Chapter 6) was that 
the presence of substantial quantities of calf serum in the medium 
results in the simultaneous ingestion of large quantities of serum 
proteins along with the radiotracer. This may cause saturation of 
the lysosomal enzymes with serum proteins and cause a slower rate of 
degradation of the radiotracer hence lead to its accumulation. 
Unfortunately, the results reported in this thesis do not permit these 
two possible explanations to be differentiated, but it should prove 
possible to design experiments to decide conclusively whether the intra- 
cellular site of accumulation of I-labelled IgG is the lysosomal 
system of epithelial cells or the vitelline capillaries. Isolation of
a lysosome rich fraction, from yolk-sac tissue that has incubated with 
125I-labelled IgG m  the presence or absence of 10% calf serum, by a 
differential centrifugation technique is one method by which intra- 
lysosomal accumulation may be investigated. By the use of auto­
radiographic techniques and sections of these same tissues, it should be 
possible to obtain evidence of accumulation within the vitelline 
vessels.
. 125The observation that I-IgG was released, apparently intact, 
from the yolk sac in the in vitro system is compatible with the in vivo 
findings of Brambell and Halliday (1956) who were able to demonstrate 
the pre-natal transmission of immunoglobulins in the rat. Although 
not ideal in design, the in vitro method of studying the release of 
ingested substrates provided an opportunity to probe certain facets of 
the mechanisms proposed for the transport of immunoglobulins (Brambell, 
1966; Wild, 1975) and to establish the atypical character of the 
behaviour of homologous IgG in the system compared with all other 
proteins investigated to date. A number of test situations proposed 
in Chapter 6 were investigated in order to attempt to define the process
125
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by which release of IgG occurs. Unfortunately the evidence was not 
wholly conclusive, but strongly supported the hypothesis advanced by 
Wild. A potential extension of this investigation is to attempt the 
isolation of vesicles of the class involved in the transport of immuno­
globulins. A promising technique for this task is density gradient 
centrifugation. By this technique Mego and co-workers (1965, 1967) were 
able to isolate liver lysosoraes and, in a later study, Goetze £t al. 
(1976) using a similar technique isolated vesicles of various sizes 
from homogenized rat yolk sacs. Applications of a variation of this 
technique to yolk sacs which have previously ingested radiolabelled 
immunoglobulins may well produce conclusive evidence for or against the 
existence of two classes of vesicle within the rat yolk sac.
Studies of the physicochemical characteristics of the IgG receptor 
is a field open to further investigations. To this end preliminary 
studies were undertaken in Chapter 8 using trypsin in attempts to 
modify the binding sites responsible for the adsorptive uptake of 
proteins. Extending this study by the use of other enzymes may well 
be informative. Neuraminidase has been used as a tool to elucidate 
the role of certain carbohydrate moieties , especially sialic acid, 
in membrane binding phenomena and is an obvious choice in further 
studies of the binding of proteins to yolk sac membranes,
Finally, further work on the radiolabelling of the surface receptor 
proteins and subsequent gel chromatography of SDS solublized fractions 
is required in order to obtain conclusive results. The data so far 
gathered seem promising and the isolation of a particular receptor 
type, specific for immunoglobulins is not now beyond the realms of
possibility.
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A P P E N D I X
The following computer programs were used to calculate the 
majority of the results presented in this thesis.
Program A Uptake of non digestible substrates by the rat yolk sac
Program B Uptake of digestible substrates by the rat yolk sac
Program C 14Uptake of [ U C]sucrose by the rat yolk sac
Program D Release of non digestible radiotracers from the rat yolk sac
Program E Release of digestible radiotracers from the rat yolk sac
1Program A
5 REM KEW 125-IPVP PROGRAM»MODIFIED NOV., 1974 
10 DIM H( 15),I(15),K(15),L(15),R(15)
12 IF W=1 THEN 84
13 LET W»1
16 PRINT "NON-DIGESTIBLE PROG. ENTERED"
17 PRINT "EXPT. NO. (DIGITS ONLY)»";
18 INPUT Z
19 PRINT "BACKGROUND IN CPM=";
20 INPUT A
35 PRINT "COUNTING TIME FOR EACH ML OF MEDIUM,SECS»";
40 INPUT C
45 PRINT "COUNTING TIME FOR EACH ML OF YS SOLUTION,SECS."; 
50 INPUT D
75 PRINT "NO. OF POINTS IN PLOT-";
80 INPUT G
82 !STOP
84 LET W-0
95 FOR X»1 TO G
98 :INPUT H (X),I(X),K(X),L(X)
99 NEXT X
100 FOR X» 1 TO G
101 LET M»(I(X)*60/C)-A
135 LET q- ((K(X)*60/D)-A)*5
136 LET N =M+Q/20
140 LET R (X)»(Q*1000)/(N *L ( X ))
145 PRINT FRE(5);H(X),FRE(6);R(X)
150 NEXT X
152 PRINT FRE(5);-1,FRE(6);Z
155 DRSPEC TO OWN
157 PRINT • i
158 PRINT >t *•
160 PRINT "INCUBATION TIME(HOURS)",
"PROTEIN IN YS"," UPTAKE"
165 PRINT
190 FOR X- 1 TO G
195 PRINT "»FRE(5);H(X),FRE(6);L(X),FRE(6) ;R(X)
200 NEXT X
205 STOP
Program B
1 REM PROTEIN PROGRAM .REVISED OUTPUT ,N0V. 1974 
10 DIM E( 12),H( 12) ,I( 12) ,J( 12) ,K( 12) ,!_( 12),S( 12)
12 IF W«1 THEN 84
13 LET W = 1
14 PRINT “PROTEIN PROGRAM ENTERED"
15 PRINT "EXPT. NO. (DIGITS ONLY)*";
16 INPUT V
19 PRINT "BACKGROUND IN CPM-";
20 INPUT A
25 PRINT "PERCENT SOLUBLES IN PREP-";
30 INPUT B
35 PRINT "COUNTING TIME MEDIUM TO TALS , SECS-";
40 INPUT C
41 PRINT "COUNTING TIME MEDIUM SOLUBLES,SECS-";
42 INPUT Z
45 PRINT "YS COUNTING TIME,SECS-";
50 INPUT D
60 PRINT "CORRECTION FACTOR FOR MEDIUM TOTALS*"; 
65 INPUT Y
67 PRINT "CORRECTION FACTOR FOR MEDIUM SOLUBLES-
68 INPUT R
75 PRINT "NO. OF POINTS IN PLOT-";
80 INPUT G 
82 STOP 
84 LET W-0 
95 FOR X-1 TO G
98 INPUT H(X),I(X),J(X),K(X),L(X)
99 NEXT X
100 FOR X-1 TO G
101 LET M=(I(X)*60/C-A)*Y
102 LET N-(J(X)*60/Z-A) *R 
105 LET 0 =N-(M*B /100)
135 LET D»((K(X)*60/D)-A)*5
136 LET P*(M-N)+0/2
137 LET F-(( 10*0) +Q)* 1000
138 LET E(X)-(Q*1000)/(L(X)*P)
139 LET S(X)-F/(L(X)*P)
140 PRINT FRE (5);H(X),FRE(6);S(X)
150 NEXT X
151 PRINT FRE(5);-1,FRE(6);V
152 DRSPEC TO OWN
153 PRINT " "
154 PRINT "
155 PRINT " INCUBATION "/’PROTEIN",
"MICROLITRES"," UPTAKE"
160 PRINT "TIME (HOURS)"," IN YS "," PER MG YS 
190 FOR X-1 TO G
195 PRINT FRE(5);H(X),FRE(6);
196 PRINT L(X),FRE(6);E(X),FRE(6);S(X)
200 NEXT X
205 STOP
Program C
5 REM 14-C PROGRAM REVISED FORMAT,FEB 1977
10 DIM J(20),H(20),1(20),K(20),L(20),R(20),M(20)
11 IF W-1 THEN 84
12 LET W-1
13 PRINT "KEN'S SUCROSE PROGRAM ENTERED"
14 PRINT " N.B.-ALL COUNTS ENTERED IN
IN PROGRAM ARE ASSUMED TO"
15 PRINT "BE C.P.M. (UNCORRD. FOR B.G. )
PER ML SOLUTION"
16 PRINT
17 PRINT "EXPT. NO. (DIGITS ONLY)-";
18 INPUT V
19 PRINT "BACKGROUND IN CPM-";
20 INPUT A
65 PRINT "MEAN COUNT OF SPIKED 1.0 
ML WATER BLANK,C.P.M.-":
70 INPUT F
75 PRINT " NO. OF POINTS IN PLOT-"; .
80 INPUT G
81 PRINT " "
82 STOP
84 LET W-0
iv
95 FOH X»1 TO G
98 INPUT J(X),H(X),I(X),K(X),L(X),R(X)
99 NEXT X
100 FOR Xs1 TO G
101 LET N «*(H (X ) —A )
105 LET 0-(I(X)-A)
110 LET P-(O-N)
115 LET Q-N*F/P 
120 LET S»(K(X)-A)
125 LET T = (L (X)-A)
130 LET Ya(T-S)
135 LET 2 aS*F/Y
140 LET U -Q + (5*Z/2 0)
142 LET M(X)»5*Z*1000/(U*R(X))
145 PRINT FRE (5);J(X),FRE(6);M(X)
150 NEXT X
153 PRINT FRE(5); - 1 ,FRE(6); V
155 DRSPEC TO OWN
156 PRINT " "
157 PRINT " "
160 PRINT "INCUBATION TIME ' (HOURS )" ,
"PROTEIN IN YS"," UPTAKE" 
190 FOR X-1 TO G 
195 PRINT " ",J(X),R(x ),M(X)
200 NEXT X 
205 STOP
Program D
5 REM EXOCYTOSIS PROGRAM , NOV. 1976
10 OIM P(30),Q(30),R(30),T(30),U(30)
11 DIM V (30)
12 IF Wa 1 THEN 56 
14 LET Wa 1
16 PRINT "EXOCYTOSIS PROGRAM ENTERED"
18 PRINT "(PROGRAM ASSUMES 1.0 ML SAMPLES"
19 PRINT "TAKEN AT EACH TIME INTERVAL )"
20 PRINT "EXPT, NO. (DIGITS ONLY)-";
22 INPUT A
24 PRINT "TOTAL VOLUME OF MEDIUM,ML-";
26 INPUT B
28 PRINT "NO. OF SAMPLES TAKEN AT EACH TIME INTERVAL-";
V30 INPUT K
32 PRINT "COUNTING TIME,SEC-";
34 INPUT C
36 PRINT "BACKGROUND ON COUNTERI , C.P.M. -";
38 INPUT D
40 PRINT "DENOMINATOR (CPM PER ML.CORRD.BG)-";
42 INPUT L
44 PRINT "CORRECTION FACTOR-";
46 INPUT M
47 PRINT "NO. OF TIMES SAMPLES WERE TAKEN-";
48 INPUT E
49 PRINT "CORR CPM. IN 5ML YS. SOLN-" ;
50 INPUT C 1
52 PRINT t it
53 PRINT
54 LET S>= 0
55 STOP
56 PRINT "SERIAL NO"," TIME OF Mf
"ACTIVITY "."ACTIVITY • *t
"% TOTAL"
57 PRINT "OF SAMPLE"."SAMPLING M»
“RELEASED “."RELEASED 
“ACTIVITY"
65 LET W-0
66 FOR X-1 TO E
68 INPUT P(X).Q(X),R(X)
70 NEXT X
72 FOR X-1 TO E
74 LET F - ((R(X)*60/C)-D) *M
76 LET S-S+K*F
78 LET T(X)-S+((B-K)*F)
80 LET U(X)-(T(X)/L)*1000 
86 NEXT X
88 LET S1 - T(E) + C1 
90 FOR X-1 TO E
95 LET V(X) . T(X) / S1 * 100.0
100 NEXT X
105 FOR X-1 TO E
110 PRINT FRE(5);P(X),FRE(5);
111 PRINT Q(X).FRE(6);T(X),FRE(5): 
115 PRINT U (X ) ,FRE(5):V(X)
120 NEXT X 
125 STOP
Program E
100 REM EXOCYTOSIS PROGRAM ,DEC. 1976 
200 DIM C (2),M(2)
300 DIM P(20),Q(20),R (20,2),T(20),U ( 2 0 )
400 DIM V (20)
500 IF W»1 THEN 3450 
600 LET W»1
700 PRINT "EXOCYTOSIS PROGRAM ENTERED"
800 PRINT "TOTAL VOLUME OF MEDIUM,ML«";
900 INPUT B
1000 PRINT "NO. OF SAMPLES IN EACH TIME INTERVAL 
1100 INPUT K
1200 PRINT "BACKGROUND»";
1300 INPUT D
1400 PRINT "DENOMINATOR«";
1500 INPUT L
1600 PRINT "NO. OF TIMES SAMPLES WERE TAKEN«"; 
1700 INPUT E
1800 PRINT "CORR CPM. IN 5ML YS. SOLN«";
1900 INPUT C1
2000 FOR 1-1 TO 2
2100 PRINT "DATA FOR ";
2200 IF I«2 THEN 2600 
2300 PRINT "TOTALS";
2400 GOTO 2700
2600 PRINT "SOLUBLES";
2700 PRINT
2800 PRINT "COUNTING TIME,SECS«";
2900 INPUT C(I)
3000 PRINT "CORRECTION FACTOR«";
3100 INPUT M(I)
3200 NEXT I 
3300 LET S«0 
3400 STOP 
3450 PRINT 
3460 PRINT
3500 PRINT "SERIAL NO"," TIME OF ",
"ACTIVITY "/’ACTIVITY , ",
"% TOTAL"
3600 PRINT "OF SAMPLE","SAMPLING ",
"RELEASED ”, "RELEASED 
"ACTIVITY"
3700 PRINT 
3800 LET W=0 
4000 FOR X-1 TO E
4100 INPUT P(X) ,Q(X),R(X,1),R(X,2)
4200 NEXT X 
4300 FOR 1-1 TO 2 
4350 LET S=0 
4400 FOR X=»1 TO E
4500 LET F-((R(X,I)*60.0/C(I))-D)*M(I)
4600 LET S=S+K*F
4700 LET T(X )-S + ((B-K)*F)
4800 LET U(X)-(T(X)/L)*1000 
4900 NEXT X
5000 IF I<>1 THEN 5200 
5100 LET S1 - T(E) + C1 
5200 FOR X-1 TO E
5300 LET V(X) - T(X) / S1 * 100.0
5400 NEXT X
5900 FOR X-1 TO E
6000 PRINT FRE(5);P(X),FRE(5);
6050 PRINT Q(X),FRE(6);T(X),FRE(5): 
6100 PRINT U(X),FRE(5);V(X)
6200 NEXT X 
6300 PRINT 
6400 PRINT 
6500 NEXT I 
6600 STOP
